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Accumulating evidence suggests that the hippocampus is functionally segregated 
along its longitudinal axis into a dorsal (dHi) and a ventral sub-region (vHi). Indeed, 
recent gene expression studies suggest that the hippocampus has a gradient of gene 
expression and that the area between the dHi and vHi, the intermediate 
hippocampus (iHi), may also be functionally independent, but it remains 
understudied. The hippocampus is also one of few brain regions where 
neurogenesis, the birth of new neurons, occurs throughout life and this process has 
been shown to play roles in learning and memory as well as in responses to stress 
and antidepressants. These diverse roles may be related to the functional 
segregation of the hippocampus along its longitudinal axis. Indeed, the dorsal 
hippocampus (dHi) plays a predominant role in spatial learning and memory, while 
the ventral hippocampus (vHi) is predominantly involved in the regulation of 
anxiety, a behaviour impacted by stress and chronic treatment with some 
antidepressants. In vivo studies have shown that chronic stress and chronic 
antidepressant treatment change neurogenesis preferentially in the vHi rather than 
the dHi. However, whether these findings are due to differential intrinsic 
sensitivities of neural progenitor cells (NPCs) resident in the dHi, iHi or vHi in 
response to the stress hormone corticosterone or in response to antidepressants is 
unknown. Moreover, the roles of the dHi, iHi and vHi in the behavioural responses 
to chronic stress, a risk factor for depression and anxiety disorders, and in the 
behavioural responses to acute and chronic antidepressant treatment have not yet 
been investigated. Thus, the aims of this thesis were to determine whether NPCs 
isolated from the dHi, iHi and vHi have differential intrinsic sensitivities in 
response to the stress hormone corticosterone, the glucocorticoid receptor agonist 




from the three hippocampal sub-regions and cultured them for 4 h or 4 days in vitro 
with either corticosterone, fluoxetine, or corticosterone with fluoxetine or for 7 days 
in vitro with either corticosterone or dexamethasone. Cell proliferation, neuronal 
differentiation and maturation, nuclear GR expression and cell viability were then 
assessed. Moreover, we also aimed to determine the roles of each hippocampal sub-
region on emotional behaviours and neuroendocrine response under baseline 
conditions, chronic psychosocial stress conditions and under chronic antidepressant 
treatment conditions. To this end, we performed stereotaxic surgeries in C57BL/6 
mice to lesion the dHi, iHi or vHi with ibotenic acid. After recovery, animals were 
submitted to emotional behaviour and neuroendocrine tests under baseline 
conditions, or after chronic psychosocial stress, or after acute and chronic fluoxetine 
treatment. As result, we determined for the first time that NPCs isolated from the 
iHi and especially vHi are more sensitive to the effects of long-term exposure (7 
DIV) to corticosterone and dexamethasone. Long-term (7 DIV) corticosterone and 
dexamethasone exposure also reduced nuclear GR expression preferentially in cells 
from the vHi. Fluoxetine alone did not have any effect on cell proliferation or 
neuronal differentiation or maturation. However, fluoxetine prevented 
corticosterone-induced reductions in neuronal differentiation after 4 DIV treatment 
and these effects were observed predominantly in the iHi and vHi cell cultures. In 
vivo experiments showed that vHi lesions reduced anxiety under baseline 
conditions. Under chronic psychosocial stress conditions, iHi lesions increased 
stress-induced social avoidance and the lesion of all sub-regions prevented chronic 
stress-induced anxiety; dHi and vHi lesions prevented stress-induced anhedonia and 
only vHi lesions caused antidepressant-like behaviour in the forced swim test and 
promoted active coping behaviour. In the antidepressant experiment, vHi lesions 




prevented the antidepressant effects of chronic fluoxetine treatment, and both iHi 
and vHi lesions prevented the anxiolytic effects of chronic fluoxetine treatment. 
Taken together, these findings show for the first time that iHi and vHi NPCs have 
increased intrinsic sensitivity to longer term exposure to the stress hormone 
corticosterone, and that the vHi seems to be an important sub-region for 
antidepressant-like effects under chronic stress. Also, both the iHi and vHi but not 
the dHi seem to modulate the antidepressant and anxiolytic effects of fluoxetine. 
 
Keywords: ventral hippocampus, intermediate hippocampus, dorsal hippocampus, 
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1.1. The Hippocampus: General Structure and Functions 
The hippocampus is a large structure of the human and other vertebrates brain. It is 
a bilateral limbic structure located in the medial temporal lobe of the brain. This 
brain region has a long-established role in certain forms of learning and memory 
(Scoville and Milner 1957, Milner and Klein 2016), playing a special role in 
declarative memory; and as the memories consolidate, they become hippocampus-
independent. Indeed, the hippocampus plays a role in the consolidation of 
information from short-term to long-term memory. In addition to that, the 
hippocampus has also been shown to play a role in spatial memory. Many previous 
and recent studies have reported that the hippocampus is actually heterogeneous in 
function, also playing central roles in emotional behaviour, response to stress, and 
the regulation of the release of stress hormone. 
 
1.1.1. Neuroanatomical structure of the hippocampus 
The hippocampal formation is a large curved shaped structure along its longitudinal 
axis, which comprises different areas, including the dentate gyrus (DG), Cornu 
Ammonis (CA1, CA2, CA3 and CA4) and the subiculum (see Fig1.1). These areas 
have mostly excitatory pathways that repeat themselves along the longitudinal axis 
of the hippocampus (Andersen et al. 1969). The hippocampus receives major inputs 
from the entorhinal cortex (medial and lateral), perirhinal cortex, postrhinal cortex, 
medial septum, locus coeruleus, raphe nucleus, nucleus reuniens and amygdala 
while its main outputs are to the lateral septum, nucleus accumbens, amygdala and 
prefrontal cortex. 
 
The entorhinal cortex provides the major cortical inputs to the hippocampus, 




pathway, the granule cells of the dentate gyrus projects to the CA3 area of the 
hippocampus, which in turn projects to the CA1 area through the Schaffer collateral 
pathway. Finally, the CA3 projects to the entorhinal cortex, closing the circuit 
called the trisynaptic loop of the hippocampus (Knierim 2015). Granule neurons 
compose the DG of the hippocampus, and they are organised into three main layers: 
the molecular layer (ML), which is occupied by the dendrites of the dentate gyrus 
granule cells, the fibres of the perforant pathway and some interneurons; the 
granular cell layer, which contains the cell bodies of the granule cells (Amaral et 
al. 2007) and comprises also the subgranular zone (SGZ). The SGZ is also the home 
for neural progenitor cells, as discussed later in this introduction. The anatomy of 
the hippocampus is illustrated in the Fig 1.1. 
 
 
Figure 1.1: Anatomy of the hippocampus. The hippocampal formation is composed 
of dentate gyrus (DG) and the hippocampus proper, which include the Cornu 
Ammonis (CA1, CA2, CA3 and CA4). In A and C, a transverse section and in B, a 






1.1.2. Functions of the hippocampus 
Since the mid-20th century, when the famous case of the patient H.M. was studied, 
it became well established that the hippocampus plays a role in the consolidation of 
memory. There are two main types of memory: declarative (explicit) and procedural 
(implicit). While procedural memory refers to the unconscious memory of skills 
which normally involve automatic sensorimotor behaviour, declarative memory is 
the memory of facts and events which are stored and then retrieved. Declarative 
memory can be subdivided into episodic and semantic memories. Episodic memory 
represents the memory of experiences, and semantic memory is a structured record 
of facts and accumulated knowledge. While the hippocampus has been shown not 
to be involved in procedural memory, it is known to play a key role in declarative 
memory (Eichenbaum 2001, Corkin 2002, Eichenbaum 2004, Wixted et al. 2018). 
 
Many studies have also shown that the hippocampus plays a key role in spatial 
learning and place discrimination. The Nobel Laureate in Physiology or Medicine, 
John O'Keefe, was the first to determine a relationship between the hippocampus 
and space learning, by showing that pyramidal cells of the hippocampus fire 
selectively in specific locations, and these were denominated place fields (O'Keefe 
and Dostrovsky 1971, O'Keefe 1976, Morris et al. 1982, O'Keefe and Speakman 
1987, Moser et al. 1995, O'Keefe et al. 1998, Moser et al. 2008). Further studies on 
place fields, head direction cells and grid cells have emphasised a role for 
hippocampus as cognitive map (Moser et al. 1995, Moser and Moser 1998, Moser 
et al. 2008). 
 
In addition to playing a role in spatial learning and memory, the hippocampus also 




hormone, corticosterone (Bannerman et al. 2004, Fanselow and Dong 2010, 
O'Leary and Cryan 2014). Indeed, the hippocampus contains a high concentration 
of both glucocorticoid and mineralocorticoid receptors (Jacobson and Sapolsky 
1991), thus rapidly responding to the effects of cortisol in humans and 
corticosterone in rodents, as discussed further in this introduction. In agreement, 
bilateral lesions of the rat hippocampus caused a hypersecretion of glucocorticoids 
(Sapolsky et al. 1984). In parallel, a reduction in the volume of the hippocampus in 
chronically stressed rats has been reported (Lee et al. 2009). Moreover, lesion 
studies have shown that hippocampal lesions cause changes in emotional 
behaviours, particularly in anxiety (Bannerman et al. 2002, Kjelstrup et al. 2002, 
Bannerman et al. 2003, Bannerman et al. 2004, Pentkowski et al. 2006). Finally, it 
is well established that the hippocampus plays an important role in the regulation 
of the response to stress, a risk factor for some psychiatric disorders, including 
depression.   
 
1.2. Stress  
Stress is an event that threatens the homeostasis of the organism and, as a result, 
causes physiological and behavioural responses that attempt to reinstate equilibrium 
(McEwen and Wingfield 2003, Day 2005, de Kloet et al. 2005). Allostasis can be 
defined as the collection of processes that are required to achieve internal and 
external stability in the face of a changing environment thus maintaining 
homeostasis (McEwen and Wingfield 2003, Day 2005, de Kloet et al. 2005). 
Allostatic load results from excessive stress or a failure to achieve homeostasis and 
may occur as a result of repeated stress from multiple stressors, poor adaptation and 
prolonged or inadequate response to stress (McEwen and Stellar 1993, McEwen 




adapt to environmental changes that occur throughout life thus promoting effective 
coping, severe or chronic stress can result in allostatic load and it is also a 
contributing risk factor for the development of several psychiatric disorders such as 
depression and post-traumatic stress disorder (PTSD) (McEwen and Wingfield 
2003, McEwen 2007). However, it is also important to note that many stress-
exposed individuals do not develop stress-related psychiatric disorders (Caspi et al. 
2003, Charney and Manji 2004, Yehuda and LeDoux 2007) and are thus more 
resilient to the negative consequences of stress than others. 
 
 Resilience to stress is the ability to cope with environmental challenges, ensuring 
survival, while susceptibility to the negative consequences of stress seems to result 
from an improper functioning of the systems of resilience or an amplification of the 
stress experience (Karatsoreos and McEwen 2013), which in turn can result in 
maladaptive physiological and behavioural responses. Such maladaptive responses 
to stress may increase the risk for the development of stress-related psychiatric 
disorders, and as such great effort is being made to elucidate the neural processes 
that underlie stress-resilience in the hope that these might be then exploited for drug 
development (Franklin et al. 2012, Hughes 2012, Russo et al. 2012, Wu et al. 2013). 
 
The response to stressors involves the activation of the hypothalamus-pituitary-
adrenal axis (HPA), the system within the body responsible for the release of 
glucocorticoid stress hormones. The activation of the HPA axis rapidly stimulates 
the secretion of corticotropin-releasing factor and vasopressin from parvocellular 
neurons of the paraventricular nucleus of the hypothalamus and this stimulates the 
release of adrenocorticotropic hormone from the anterior pituitary, which in turn 




(Cullinan et al. 1995). These glucocorticoids, cortisol in humans and corticosterone 
in rodents (Herman and Cullinan 1997), feedback onto two types of receptors in the 
brain: the mineralocorticoid receptors (MR) and glucocorticoid receptors (GR), 
which are highly expressed in limbic structures of the brain, including the 
hippocampus (Morimoto et al. 1996). Following stress termination, glucocorticoid 
concentrations slowly decrease to pre-stress levels and this recovery is primarily 
controlled by negative feedback of glucocorticoids onto their receptors in the 
anterior pituitary and the paraventricular nucleus of the hypothalamus as well as the 
hippocampus (Herman and Cullinan 1997, De Kloet et al. 1998). The role of the 
hippocampus in the negative feedback of the HPA axis is shown in Fig 1.2. 
 
1.2.1. Stress & the hippocampus 
The hippocampus is a key brain area involved in the regulation of the stress 
response, exerting negative feedback on the hypothalamic-pituitary-adrenal (HPA) 
axis (Fig 1.2) (Jacobson and Sapolsky 1991). While hippocampal MR mediates the 
effects of glucocorticoids on assessment of the stressor and initiation of the stress 
response, GR acts in the consolidation of acquired information (Morimoto et al. 
1996, De Kloet et al. 1998, de Kloet et al. 2005). Activation of these receptors in 
the hippocampus exerts negative feedback on the HPA axis, suppressing further 
release of glucocorticoids following stress termination. Thus, inappropriate 
functioning of the hippocampus could disrupt proper functioning of the HPA axis 






Figure 1.2: Stress and the activation of the hypothalamic–pituitary–adrenal (HPA) 
axis. Image from: (Schloesser et al. 2012). Abbreviations: ACTH: 
adrenocorticotropic hormone; AVP: arginine vasopressin; CRH: corticotropin-
releasing hormone; GRs: glucocorticoid receptors; MR: mineralocorticoid 
receptors. 
 
In addition to playing a key role in the regulation of stress response, the 
hippocampus is also particularly vulnerable to the effects of stress (Sapolsky 1986, 




reductions in the hippocampus have been reported in PTSD patients (Bremner et al. 
2003, Smith 2005, Felmingham et al. 2009) and PTSD patients exhibit dysfunction 
of the HPA-axis with high levels of corticotropin-releasing hormone in the 
cerebrospinal fluid (Bremner et al. 1997) and low levels of cortisol in urine (Yehuda 
et al. 1995), indicating an enhanced HPA-axis feedback regulation (de Kloet et al. 
2006). On the other hand, plasma concentrations of cortisol are often increased in 
depressed adults (Westrin et al. 1999) and it has been suggested that elevated 
glucocorticoid concentrations contribute to stress-induced atrophy of the 
hippocampus (McEwen and Sapolsky 1995) and its correlation with cognitive 
dysfunction (Lupien et al. 1998). Similarly, neuroimaging studies also report 
volumetric reductions in the hippocampus in depression (Sheline et al. 1996, 
Bremner et al. 2000, Frodl et al. 2002, Videbech and Ravnkilde 2004). In parallel, 
studies in animals report that chronic stress, which is a risk factor for depression, 
reduces hippocampal volume (Lee et al. 2009, Tse et al. 2014), causing dendritic 
atrophy (Lee et al. 2009, McEwen 2016) and reducing adult hippocampal 
neurogenesis (Gould et al. 1997, Simon et al. 2005, Dranovsky and Hen 2006, 
Schoenfeld and Gould 2012, Levone et al. 2015). Taken together, it is clear that 
there is a reciprocal relationship between the hippocampus and glucocorticoids and 
that disrupted HPA-axis activity might impact hippocampal structure and function 
which in turn might further impact hippocampal regulation of glucocorticoid 
concentrations. Also, stress-induced changes in the hippocampus seem to mirror 
the hippocampal changes that have been reported in depression. Indeed, stress is a 






1.3. The Role of the Hippocampus in Depression and 
Antidepressant Treatment 
According to the World Health Organisation (WHO), depression is a common 
mental disorder, currently being the leading cause of disability worldwide, with 
more than 300 million people of all ages affected (WHO 2017). Depression is 
characterized by a persistent sadness, a loss of interest in pleasant activities, loss of 
energy, a change in appetite; sleeping problems, anxiety, reduced concentration, 
indecisiveness, guilt, and thoughts of self-harm or suicide may also occur (WHO 
2017). Despite the continuous research that is done in an effort to try to understand 
the pathophysiology of depression, the precise mechanisms through which 
depression develops is elusive, probably because depression is a heterogeneous 
disorder. Many studies report that antidepressants are significantly better than 
placebo on the reversal of the general depressive state (Thase and Denko 2008). 
However, half of the depressed patients treated with first-line antidepressant 
treatment fail to achieve remission and a third of these patients remain treatment-
resistant (Fava 2003, Trivedi et al. 2006). 
 
Antidepressant drug development has been hampered by the fact that we do not yet 
have a complete understanding of the neurobiology underlying the pathophysiology 
of depression and its successful treatment by current antidepressants. However, one 
of the main theories is the monoamine hypothesis of depression. In this hypothesis, 
depression is suggested to be a result of a dysregulation in monoamine 
neurotransmitter systems including those of serotonin, noradrenaline, and 
dopamine, and most currently available antidepressants have been designed to 
increase extracellular concentrations of these neurotransmitters particularly 




most commonly used class of antidepressants are the selective serotonin reuptake 
inhibitors (SSRI), which selectively inhibit the serotonin transporter, thus 
increasing the availability of serotonin in the synaptic cleft. The main SSRI drugs 
include fluoxetine, paroxetine, citalopram, escitalopram, sertraline and 
fluvoxamine. Tricyclics antidepressants (TCA) were one of the first types of 
antidepressants to be developed and these block noradrenaline and/or serotonin 
transporters thus inhibiting serotonin/noradrenaline reuptake and increasing their 
availability in the synaptic cleft. Some TCA drugs include imipramine, desipramine 
and amitriptyline. Monoamine oxidase inhibitors (MAOI) prevent the degradation 
of serotonin, noradrenaline and dopamine, by acting on the enzyme that degrades 
them. Examples include phenelzine, tranylcypromine and moclobemide. Many 
other drugs are specific for blocking the reuptake of noradrenaline (NRIs) like 
reboxetine, or for blocking both noradrenaline and serotonin reuptake (SNRI), like 
venlafaxine. Other antidepressants include multi-target antidepressants which 
target both monoaminergic transporters and receptors, e.g. vortioxetine  
 
Although the pathophysiology of depression is still under debate, clinical 
neuroimaging studies report volumetric reductions in the hippocampus in 
depression (Sheline et al. 1996, Bremner et al. 2000, Frodl et al. 2002, Videbech 
and Ravnkilde 2004, Koolschijn et al. 2009). Interestingly, when exposed to 
chronic stress, animals can vary in their response to stress, and thus can be separated 
into two groups: stress-resilient or stress-susceptible. This variation in the stress 
response has been linked to hippocampal volumes whereby resilient animals exhibit 
increased hippocampal volume (by 4%), even after stress, while susceptible animals 
exhibit decreases in volume (by 1%) (Tse et al. 2014), findings which parallel the 




(Sheline et al. 1996, Felmingham et al. 2009), both of which are stress-related 
disorders. Interestingly, chronic treatment with different classes of antidepressant 
treatment has been shown to reverse stress-induced reductions in adult hippocampal 
neurogenesis (Malberg et al. 2000, Malberg and Duman 2003, Rainer et al. 2012). 
Correspondingly, human neuroimaging studies report that hippocampal volumetric 
reductions are more evident in unmedicated depressed individuals (Sheline et al. 
2003) and in poor responders to antidepressant treatments (Frodl et al. 2008). Taken 
together, it is clear that the hippocampus is recruited in antidepressant action.  
 
1.4. Adult Hippocampal Neurogenesis 
An intriguing feature of the hippocampus is that it is just one of a few areas of the 
adult brain where new neurons are born throughout adult life, through a process 
called adult hippocampal neurogenesis (AHN) (Kempermann et al. 2004, Ming and 
Song 2011, Kempermann et al. 2015). It was not until recently that this was 
accepted and recognised by the scientific community (Gage 2002). In fact, it is 
suggested that hundreds of new neurons are born in the human dentate gyrus of the 
hippocampus everyday (Spalding et al. 2013). However, recently, an important 
study did not find any immature neurons in the adult human brain, suggesting the 
absence of adult neurogenesis (Sorrells et al. 2018). However, another study 
reported that the quiescent progenitors pool does remain active throughout aging 
(Boldrini et al. 2018), thus leaving room for much further debate (Kempermann et 
al. 2018). Such studies also highlight the difficulties researchers face when trying 
to measure AHN in the human brain. Indeed, we do not yet have neuroimaging tools 
to measure the dynamic process of AHN in humans. Nevertheless, we have learned 





1.4.1. Adult hippocampal neurogenesis: Historical perspective 
Until the middle of the 20th century, neuroanatomists such as Santiago Ramón y 
Cajal, believed that the nervous system was something fixed, immutable and 
incapable of regeneration. In 1962, however, Joseph Altman found the first 
evidence of adult neurogenesis in the cerebral cortex (Altman 1962) and then, in 
1963, in the dentate gyrus of the hippocampus (Altman 1963). It was not until the 
1980s, when adult neurogenesis was shown to exist in rats (Bayer et al. 1982), and 
in birds (Goldman and Nottebohm 1983) that the interest in AHN started growing 
in the scientific community. In the 1990s, neural progenitor cells were isolated in 
the adult mammalian brain (Reynolds and Weiss 1992, Gage et al. 1995) and adult 
neurogenesis was first shown in non-human primates (Gould et al. 1999) and 
humans (Eriksson et al. 1998). Human neural progenitor cells were also 
successfully isolated and cultured in an in vitro neurogenesis assay (Roy et al. 
2000). Nowadays the presence and importance of AHN is well recognised by the 
scientific community (Boldrini et al. 2018), although there are still some 
controversies surrounding its presence and role in the human brain (Sorrells et al. 
2018). 
 
1.4.2. Adult hippocampal neurogenesis: A series of sequential developmental 
events 
AHN is a complex process; neural progenitor cells (NPCs) go through diverse 
developmental stages (Fig 1.3), including cell proliferation, neuronal 
differentiation, maturation and integration onto the neural circuitry of the 
hippocampus (Christie and Cameron 2006). Multipotent neural stem cells (NSCs) 
can give rise to NPCs, although there is no clear definition of the differences 




and differentiated cells, having a more limited capacity for self-renewal, when 
compared to NSCs. The NPCs are located in a neurogenic niche in the SGZ of the 
DG of the hippocampus. In the DG, these cells are quiescent radial glia-like neural 
progenitor cells (QNP), also known as type 1 NPC or early progenitor cells, and 
they express glia fibrillary acidic protein (GFAP), Nestin and Ki67. These QNP 
divide very slowly, but upon specific stimuli, QNP enter the cell cycle, self-
renewing, dividing and producing new radial glia-like neural progenitor cells. 
These radial glia-like neural progenitors, in turn divide to generate the proliferating 
intermediate progenitor cells (IPCs), also known as transiently amplifying 
progenitors, type 2a which expresses only nestin, and type 2b which expresses 
nestin and doublecortin - DCX). Depending upon a stimulus these IPCs eventually 
turn into neuroblasts (type 3), which expresses doublecortin (DCX). These 
neuroblasts in turn differentiate into immature neurons, which express DCX and 
Prospero Homebox 1 (Prox1). These immature neurons, once mature, express 
neuron-specific nuclear protein (NeuN) and Calbindin (Ming and Song 2011). 
These stages of the neurogenesis are shown in Fig 1.3. 
 
It takes about 1-3 days for the IPCs to differentiate into neuroblasts, which further 
develop into new immature neurons. These newly generated immature neurons 
migrate short distances into the granular cell layer (GCL) of the DG and mature 
into dentate granule cells (GCs) within approximately 1.5 to 2 weeks. Newly 
generated GCs project their dendrites to the molecular layer (ML) of the DG, and 
their axons to the CA3 of the hippocampus through the hilus. Fully integrated adult-
born granule cells can be found within 7 weeks. Newly-born neurons are silent until 
3 days from differentiation, but slow GABAergic neurotransmission is formed by 




GABAergic neurotransmission (Esposito et al. 2005, Ge et al. 2006). In this first 
month from differentiation, newly-born neurons display enhanced LTP, and 
increases in this LTP promotes further proliferation of NPCs (Bruel-Jungerman et 
al. 2006). In turn, depolarizing GABAergic effect promotes synaptic integration of 
the newly-born neurons (Ge et al. 2006).  
 
 
Figure 1.3: Hippocampal trisynaptic circuit and stages of adult hippocampal 
neurogenesis. Image from: (Ming and Song 2011). Abbreviations: BLBP: brain 
lipid-binding protein; CA1,3: Cornu Ammonis 1,3; DCX: doublecortin; DG: 
dentate gyrus; GFAP: glial fibrillary acidic protein; MCM2: minichromosome 
maintenance complex component 2; Prox1: prospero homebox 1; Sox2: SRY-box2; 
Tbr2: T-box brain protein 2. 
 
Many of the newly-born neurons do not survive to become mature GCs. Indeed, the 
proliferation and survival of neural progenitor cells are regulated by many factors 




antidepressant treatment, environmental experience, physical activity and learning 
and memory (Kempermann et al. 1997, Gould et al. 1999, Malberg et al. 2000, 
Dobrossy et al. 2003, Simon et al. 2005, Fabel and Kempermann 2008, Schloesser 
et al. 2010, Surget et al. 2011, Tanti et al. 2012, Hueston et al. 2017). 
 
1.4.3. Current methodologies for interrogating adult hippocampal 
neurogenesis   
1.4.3.1. Endogenous markers for immunohistochemical analysis of different stages 
of neurogenesis 
The cells involved in the different stages of AHN express different markers and 
these endogenous markers can be used to identify the presence and stage of 
neurogenesis. Neural progenitor cells are defined by their ability to proliferate and 
self-renew. These proliferative cells can typically be identified by the following 
markers: glia fibrillary acidic protein (GFAP), Nestin, Ki67, Aldoc, Apoe, ID4, 
Hopx, Sox2, Slc1a3, Pcna and Mcm2. Once the cells obtain a neuronal progenitor 
fate, they can be identified using markers for immature neurons, such as Neurod1, 
DCX, Tbr1, Tbr2, Neurog2, Ccnd2 and Sox11, while mature neurons can be 
identified using the markers NeuN, MAP2, Synaptophysin, PSD95, Prox1 and 
calbidin. Oligodendrocyte progenitors express Olig1, Olig2, Sox10, Pdgfra and 
Cspg4. To identify astrocytes, S100b and Fzd2 markers are used. 
 
1.4.3.2. In vitro approaches: The isolation and culture of neural progenitor cells 
The neurosphere and monolayer culture of neural progenitor cells are the gold 
standard for the study of neurogenesis in vitro. Neural progenitor cells (NPCs) can 
be obtained from the brain of the rodent embryo or from the dentate gyrus or 




the protocol for the culture of NPCs does not involve the isolation of these cells, 
because most of the cells are undifferentiated; however, in postnatal cultures, a 
protocol for the isolation of the NPCs brain tissue must be used. Isolating and 
culturing NPCs is a tool to study intrinsic characteristics of these cells when 
removed from their surrounding brain environment and can be a useful tool to study 
their intrinsic sensitivities and intracellular signalling pathways in response to 
stimuli that have direct effects on NPCs. To avoid NPCs differentiating in culture, 
these cells should be supplemented with epidermal growth factor (EGF) and 
fibroblast growth factor 2 (FGF-2), and a retinoic-acid (vitamin A) free medium is 
also recommended, because vitamin A is known to induce NPC differentiation 
(Janesick et al. 2015). NPCs have the ability to self-replicate and to differentiate 
into other neural cells, including neurons, astrocytes and oligodendrocytes. To 
promote differentiation of NPCs in vitro, changing the medium to a modified 
medium in the absence of growth factors and in the presence of vitamin A is 
sufficient. To selectively reduce the number of astrocytes and increase the number 
of neurons in culture, a serum-free medium is recommended, given that the serum 
is a potent astrocytic differentiation inducer (Chiang et al. 1996, Brunet et al. 2004). 
 
Although very useful, there are many limitations for the use of cultured NPCs, 
particularly if they are allowed to grow as neurospheres in cell suspension. It is 
difficult monitor the properties of the individual cells during this culture period, 
and, besides that, it has been reported that as the neurospheres grow, the cells in its 
centre become deprived of nutrients and die; the neurogenic capacity of the NPCs 
has also been shown to decline after a number of passages (Fricker et al. 1999). 
Moreover, neurospheres are not homogeneous cultures as many would expect; in 




(Reynolds and Weiss 1996), and even fewer can be considered neural stem cells 
(Reynolds and Rietze 2005). Monolayer cultures of NPCs, as opposed to 
neurospheres, are adhesive cultures, grown on coated substrates and overcome 
many of the problems and difficulties found in the neurospheres cultures. While 
monolayer NPCs are more isolated and more homogeneous, they are not completely 
homogeneous however as asymmetric divisions and some differentiation may also 
occur.  
 
1.4.3.3. In vivo approaches 
In the mid-20th century, the use of tritiated ([3H]) thymidine revolutionised the 
study of the nervous system (Sidman et al. 1959, Altman 1962, Altman 1963). 
Some years after its discovery, the use of [3H]-thymidine autoradiographic assays 
lead to the discovery of AHN in the subventricular zone and in the dentate gyrus of 
the rat hippocampus (Altman and Das 1965, Altman 1969). More recently, 
bromodeoxyuridine (BrdU), a thymidine analogue, has become the most widely 
used technique for labelling recently generated neurons and thus studying AHN. 
BrdU is an exogenous marker that should be injected into the animal prior its 
detection. Specifically, BrdU is not a marker of cell proliferation, but rather a 
marker of DNA synthesis; it becomes incorporated into the DNA during cell 
division. The use of BrdU staining technique allowed us to find that, in an adult 
rodent, approximately 9000 new neurons are generated per day in the DG 
(Kempermann et al. 1997, Cameron and McKay 2001), while 30000 are generated 
per day in the SVZ (Alvarez-Buylla et al. 2001). It is also important to note that 
BrdU is a toxic substance and high concentrations may lead to death or may lead to 
some heath complications and thus currently cannot be used in humans. For the 




mg/kg (intraperitoneally). The use of 50 mg/kg per day for 12 days, and the use of 
higher doses as 300 mg/kg have shown no apparent complications or toxicity 
(Cameron and McKay 2001). Depending upon the time interval between BrdU 
injection, the experimental intervention and time of death, BrdU labelling can be 
used to measure either the proliferation or survival of newly born neurons. To 
measure proliferation, an animal is injected with 50 mg/kg 1-3 times with an 
interval of 2 hours, and the animal is perfused 2 hours after the last injection; the 
number of BrdU-positive cells is then used as a measure of cell proliferation. On 
the other hand, to study the impact of experimental interventions on the maturation 
and survival of newly born neurons, 50 mg/kg is normally injected 1 to 3 times with 
2 hours interval and the animal is perfused at least 3-4 weeks later. When coupled 
with neuron-specific markers, BrdU labelling permits the survival of newly born 
neurons to be measured. Many studies have used this technique to show that 
hippocampal neural progenitor cells proliferate throughout adult life in many 
mammalian species (Gould et al. 1997, Eriksson et al. 1998, Gould et al. 1999, 
Ming and Song 2011). Other thymidine analogues including chlorodeoxyuridine 
and iododeoxyuridine have also been used for to study adult neurogenesis, but BrdU 
is still the most commonly used one. Nevertheless, these other markers are useful 
when studying newly generated neurons born at different timepoints within the 
same animal.  
 
Besides the use of markers to study AHN, the use of viral vectors, injected by 
stereotaxic surgery directly into the hippocampus has also revolutionised the study 
of AHN. While the adenoviruses infect the cells of interest without integrating to 
their genome, lentiviruses are transcribed into the genome, being permanently 




can be labelled using a reporter gene, such as EGFP; moreover, a siRNA can be 
used to knockdown a particular protein of interest. Using this single-cell gene 
knockout approach, it has been shown that the survival of new neurons is regulated 
by their own NMDA-type glutamate receptor during a critical period after neuronal 
birth. (Tashiro et al. 2006). Moreover, the use of promoters for genetically-
engineered animals (e.g. nestin-GFP expressing) are also useful for gain- or loss-
of-function. 
 
1.4.3.4. Methods for experimental manipulation of adult hippocampal neurogenesis 
One of the methods used to study AHN in vivo is to inhibit or ablate adult 
neurogenesis and determine the impact of this on brain and behaviour. Inhibition of 
AHN can be achieved by chemical (i.e. methylazoxymethanol - MAM) (Jayatissa 
et al. 2009, Mateus-Pinheiro et al. 2013), genetic (Yu et al. 2008, Schloesser et al. 
2010, Snyder et al. 2011) and irradiation-based methods (Santarelli et al. 2003, Wu 
and Hen 2014). Nestin-TK mice are also useful in the study of the AHN (Snyder et 
al. 2016). These mice express the herpes simplex virus thymidine kinase (HSV-tk) 
under the control of the nestin and thus expressing HSV-tk in NPCs. The 
administration of ganciclovir (GCV) kills actively HSV-tk expressing cells 
(dividing cells expressing this transgene). This method can be used to impair 
neurogenesis in vivo at a given time (time of the injection of GCV) and then the 
effects of the reduction of neurogenesis on a variety of behavioural tests. Recent 
studies have shown that the use of this model of mice to ablate neurogenesis did not 
alter anxiety or depressive-like behaviour (Santarelli et al. 2003, Lagace et al. 2010, 
Deng and Gage 2015). Interestingly, using a method very similar to this, a Nestin-
CreERT2 mice, in which the injection of tamoxifen reduces neurogenesis, a study 




induced hypophagia and depressive-like behaviour in the tail suspension test in 
mice (Yun et al. 2016).  
 
Another useful tool is the use of the transgenic mouse line iBax, in which the pro-
apoptotic gene Bax can be selectively ablated in neural progenitor cells, following 
tamoxifen injection. Thus, this enhances the survival and the functional integration 
of newly born neurons at any specific timepoint (Sahay et al. 2011, Hill et al. 2015, 
Culig et al. 2017). The use of these mice showed that, increasing neurogenesis 
counteracts some effects of stress (Culig et al. 2017), reducing anxiety and 
depressive-like behaviour (Hill et al. 2015) and improving pattern separation 
(Sahay et al. 2011). Taken together, this suggests that the transgenic studies could 
be very useful to study the roles of AHN, however, special attention should be given 
to the model of animal used and timing since the inhibition of neurogenesis and the 
initiation of the behavioural testing. 
 
1.4.4. Functional roles of adult hippocampal neurogenesis 
1.4.4.1. Properties that distinguish immature from mature granule cells 
In their first month after neuronal differentiation, immature newly-born neurons 
display diverse properties from those exhibited by mature, integrated granule cells 
(GC) (Lopez-Rojas and Kreutz 2016). Specifically, immature GC show enhanced 
long-term potentiation (LTP) and reduced threshold for LTP induction (Wang et al. 
2000, Schmidt-Hieber et al. 2004, Ge et al. 2007), lower action potential amplitude 
(Liu et al. 1996, Mongiat et al. 2009), lower GABAergic inhibition (Esposito et al. 
2005) and lower dendritic complexity (Schmidt-Hieber et al. 2004, Esposito et al. 




mature GC, and to assess AHN in vivo and suggest that immature neurons may play 
distinct functional roles compared to fully integrated mature GCs.  
 
1.4.4.2. Role of adult hippocampal neurogenesis in learning and memory 
As discussed before, the hippocampus plays important roles in learning and 
memory. However, the roles of AHN in spatial learning and memory are not yet 
fully understood. Interestingly, learning and memory have been shown to increase 
AHN in rats (Gould et al. 1999, Dobrossy et al. 2003) and in turn, AHN is required 
for hippocampal-dependent learning (Marin-Burgin and Schinder 2012). Indeed, 
spatial learning has been shown to cause LTP in rats (Whitlock et al. 2006), while 
LTP facilitates cell proliferation and survival in the hippocampus (Bruel-Jungerman 
et al. 2006). Moreover, using transgenic mice, the selective ablation of the pro-
apoptotic gene Bax in NPCs increased NPC survival and also promoted an 
improvement in pattern separation (Sahay et al. 2011). 
 
Due to their high excitability and increased plasticity, immature newly-born GC are 
suggested to have key roles in learning and memory (Cameron and McKay 2001, 
Ninkovic et al. 2007), while mature GC are less excitable and not as plastic. Indeed, 
AHN has been linked to formation of contextual fear memory (Saxe et al. 2006, Ko 
et al. 2009, Gao et al. 2018). AHN has also been shown to regulate forgetting 
(Akers et al. 2014). Interestingly, increasing AHN immediately after the training of 
the fear conditioning reduced conditioned freezing, indicating memory erasure 
(Gao et al. 2018). However, the role of AHN in memory erasure seems to be timing 
dependent, as the modulation of AHN at a later timepoint after learning (after 
consolidation) did not change the fear conditioning response (Gao et al. 2018). 




learning and memory to forgetting. In addition to playing these roles, AHN is also 
known to play a role in stress-related disorders. 
 
1.4.4.3. The role of adult hippocampal neurogenesis in stress and stress-related 
psychiatric disorders 
Stress and high levels of glucocorticoids in adulthood impact not only the 
hypothalamus-pituitary-adrenal (HPA) axis, but they also have been shown to 
decrease all stages of AHN (Simon et al. 2005, Dranovsky and Hen 2006, Jayatissa 
et al. 2006, Mitra et al. 2006, Jayatissa et al. 2009, Surget et al. 2011, Schoenfeld 
and Gould 2012, Lehmann et al. 2013). Specifically, different forms of stress 
reduce AHN, including predator odour (Galea et al. 2001), social stress (Gould et 
al. 1997, Czeh et al. 2001), and chronic mild stress (Alonso et al. 2004). Moreover, 
the neurogenic niche in which NPCs reside is located near blood vessels (Wurmser 
et al. 2004), which makes these cells vulnerable to blood-transported molecules and 
hormones, such as cytokines (Bauer 2009), growth factors (Oliveira et al. 2013) 
and the stress hormone, corticosterone. Indeed, it has been shown that chronic 
treatment with corticosterone reduces AHN in mice (David et al. 2009) and rats 
(Ekstrand et al. 2008, Brummelte and Galea 2010). Adrenalectomy, and the 
consequent removal of circulating plasma glucocorticoids, is also known to increase 
hippocampal cell proliferation (Krugers et al. 2007). In turn, AHN facilitates 
normalization of glucocorticoid levels after stress in mice (Snyder et al. 2011, 
Surget et al. 2011, Culig et al. 2017). Interestingly, it has been reported that a 
transgenic mouse model of neurogenesis inhibition exhibits a transient increase in 
the corticosterone response to stress as well as an attenuated dexamethasone-
induced suppression of corticosterone release (Snyder et al. 2011), thus suggesting 




it has been reported that ablation of AHN by X-ray irradiation does not impair basal 
HPA axis activity (Surget et al. 2011). 
 
Similarly, prenatal stress may influence adult phenotypes and early-life stress has 
been implicated in susceptibility to depression and anxiety in later life (Seckl and 
Holmes 2007). Accordingly, the exposure of pregnant animals to stress or 
glucocorticoids may affect foetal brain development of the offspring (Brummelte 
et al. 2006, Lucassen et al. 2009) and it may also lead to anxiety and depressive 
behaviour, increased HPA axis activity, memory impairment (Henry et al. 1994, 
Vallee et al. 1997, Fenoglio et al. 2006) as well as reduced hippocampal 
neurogenesis in both rodents (Lemaire et al. 2000, Mandyam et al. 2008, Lucassen 
et al. 2009) and non-human primates (Coe et al. 2003) later in adult life. 
Importantly, these changes induced by prenatal stress may depend upon the genetic 
background (Bosch et al. 2006, Lucassen et al. 2009), thus highlighting that gene-
environment interactions may modulate AHN and as well as susceptibility and 
resilience to stress. Similarly, adverse experience in early postnatal life, such as 
maternal separation, can reduce AHN (Mirescu et al. 2004, Kikusui et al. 2009, 
Lajud et al. 2012), although these effects may be sex-dependent as one study 
reported decreases in females but increases in male rats (Oomen et al. 2009). 
Maternally separated pups can exhibit decreased hippocampal cell proliferation in 
adulthood (Mirescu et al. 2004) In addition to prenatal and early life stress 
protocols, exposure to stressors in adult life have also been shown to decrease AHN, 
including chronic restraint (Luo et al. 2005, Rosenbrock et al. 2005, Snyder et al. 
2011), chronic unpredictable mild stress (Jayatissa et al. 2006, Jayatissa et al. 2009, 
Surget et al. 2011), social defeat stress (Simon et al. 2005, Schloesser et al. 2010), 




of HPA axis overactivity, has also been shown to decrease AHN (Ekstrand et al. 
2008, Brummelte and Galea 2010). However, while many studies have investigated 
the effects of stress on AHN, relatively few have determined whether stress-induced 
changes in AHN occur specifically in animals that are more resilient or more 
susceptible to the behavioural and neuroendocrine effects of stress. 
 
While there is a general agreement that chronic stress can decrease AHN (Pham et 
al. 2003, Simon et al. 2005, Dranovsky and Hen 2006, Jayatissa et al. 2006, Mitra 
et al. 2006, Jayatissa et al. 2009, Perera et al. 2011, Schoenfeld and Gould 2012, 
Lehmann et al. 2013, Fa et al. 2014), it is also important to note that negative 
findings have also been reported (Lee et al. 2009, Lyons et al. 2010, Hanson et al. 
2011, Parihar et al. 2011, O'Leary et al. 2012). While these negative findings might 
be stressor, species, sex or strain-dependent (Westenbroek et al. 2004, Hanson et 
al. 2011, Lisowski et al. 2011, Schoenfeld and Gould 2012), it is also important to 
consider that interindividual variation in the behavioural susceptibility to stress 
might contribute to conflicting findings. This also raises the question as to whether 
changes in AHN may predict resilience or susceptibility to stress-induced changes 
in behaviour (Alves et al. 2017). Alternatively, an individual's behavioural response 
to stress may be independent of the effects of stress on AHN. One approach to 
investigating the relationship between stress resilience and AHN is to compare 
neurogenesis in stress-susceptible and stress-resilient animals, although to our 
knowledge few studies to date have approached this question in such a manner. 
Given the evidence that stress decreases AHN in an antidepressant-reversible 
manner, one might expect stress-induced decreases in neurogenesis to be correlated 
with increased stress susceptibility. Surprisingly, however, it has been reported that 




that were susceptible to developing social avoidance behaviour following social 
defeat stress, while similar effects were not observed in resilient mice (Lagace et 
al. 2010). The association of increased AHN with stress susceptibility is also 
supported by a study in primates that demonstrated increased neurogenesis and 
improvements in learning in primates housed under stressful conditions (alone or 
with an unknown male), versus standard conditions (with a familiar male) (Lyons 
et al. 2010). Thus, exposure to some protocols of stress can increase AHN, even in 
susceptible animals.  
 
Predictability or controllability of the stressor seems to be an important determining 
factor of whether stress increases or decreases AHN (Van der Borght et al. 2005, 
Parihar et al. 2011). While unpredictable chronic stress increased depressive-like 
behaviour (Lucas et al. 2014), predictable stress, which consisted of a daily 5-min 
session of restraint at the same time each day, decreased anxiety and depressive 
behaviour and increased AHN (Parihar et al. 2011). Similarly, a study reported that 
controllable stress in the form of chronic exposure to escapable foot shocks, did not 
change cell proliferation in dentate gyrus of the hippocampus (Van der Borght et 
al. 2005). These data suggest that some types of stress protocols may actually 
increase AHN (Van der Borght et al. 2005, Parihar et al. 2011) and that increased 
survival of newly born cells in the hippocampus might also be associated with 
increased susceptibility to the negative effects of stress (Van der Borght et al. 2005, 
Lagace et al. 2010, Parihar et al. 2011).  
 
Most studies report that ablating neurogenesis in rodents either with X-irradiation 
or with methylazoxymethanol (MAM) does not increase their susceptibility to 




stressed neurogenesis-intact animals (Jayatissa et al. 2009, Schloesser et al. 2010, 
Surget et al. 2011, Lehmann et al. 2013). For example, chemical ablation of 
neurogenesis in rats with chronic injection of MAM did not induce anhedonia, a 
behaviour frequently observed following chronic stress, even though MAM 
reduced hippocampal cell proliferation to a similar extent as exposure to a stress 
protocol (Jayatissa et al. 2009). Moreover, ablating neurogenesis prevented the 
ability of social defeat stress to induce social avoidance behaviour, thus suggesting 
that inhibiting neurogenesis may promote resilience rather than susceptibility to 
behavioural changes induced by this particular stressor (Lagace et al. 2010). 
Conversely, some studies have reported that neurogenesis ablated animals show a 
depressive-like phenotype and increased susceptibility to stress-induced 
depression-like behaviour, including anhedonia and increased immobility in the 
forced swim test (Snyder et al. 2011, Mateus-Pinheiro et al. 2013). On the other 
hand, a recent study showed that increasing AHN is sufficient to prevent chronic 
stress-induced depressive-like behaviour (Culig et al. 2017) in mice. Taken 
together, although there are some negative reports showing that some types of 
stressors do not change adult neurogenesis, it seems that at least chronic 
unpredictable stress does decrease AHN, although more studies are needed to 
determine the precise role of AHN in behavioural responses to stress. The effects 
of stress and other factors in the AHN are represented in Fig 1.4. 
 
1.4.4.4. Role of adult hippocampal neurogenesis in antidepressant action 
In addition to the chronic stress influence in AHN, chronic treatment with different 
types of antidepressant treatments such as SSRIs, TCAs, MAOIs, electroconvulsive 
shock and vagus nerve stimulation have all been shown to increase AHN in rodents 




2009, Zhou et al. 2016). In addition, human post-mortem studies have reported that 
antidepressant treatment increases hippocampal neural progenitor cell proliferation 
(Boldrini et al. 2009, Boldrini et al. 2012). Interestingly, the neurogenic effects of 
sertraline, an SSRI drug, on human neural progenitor cells occur through activation 
of the glucocorticoid receptor (Anacker et al. 2011). In addition, in vivo studies in 
C57BL/6 mice have shown that fluoxetine increased the proliferation of NPCs, 
preferentially in the transition between the intermediate and ventral hippocampus 
(Zhou et al. 2016). 
 
There are several studies which show that the behavioural effects of the SSRI 
antidepressant fluoxetine (Santarelli et al. 2003, David et al. 2009) and the TCA 
imipramine (David et al. 2009), seem to be, at least in part, neurogenesis-dependent. 
Indeed, a study showed that X-ray irradiated (i.e. neurogenesis-ablated) animals did 
not show behavioural recovery from stress after fluoxetine administration, which 
was observed in neurogenesis-present animals (David et al. 2009). Although this 
result was observed on the novelty-suppressed feeding, a test for anxiety, 
fluoxetine-induced recovery from stress in the open field and forced swim tests 
occurred in a neurogenesis-independent manner (David et al. 2009). Moreover, 
neurogenesis-dependent behavioural effects of fluoxetine have also been reported 
in adult non-human primates under chronic stress conditions (Perera et al. 2011). 
Interestingly, it has also been proposed that normalisation of HPA-axis overactivity 






Figure 1.4: Learning, environmental enrichment, physical exercise and 
antidepressant are known to increase adult hippocampal neurogenesis, while 
stress, inflammation and aging reduce it. Neurogenesis, in turn, has been shown to 
play a role in the HPA axis response to stress and antidepressants, in the 
behavioural response to chronic antidepressant, in spatial learning and memory, 
in pattern separation and in memory erasure. Image from: (O'Leary and Cryan 
2014). 
 
On the other hand the antidepressant-like effects of non-monoaminergic based 
antidepressant-like drugs, such as CRH1 or V1b antagonists, are not affected by 
inhibition of AHN (Bessa et al. 2009, Surget et al. 2011) which is in contrast to 
many findings with antidepressants that target the monoaminergic system such as 
fluoxetine and imipramine (Santarelli et al. 2003, Perera et al. 2011, Surget et al. 
2011). Taken together, it has been suggested that antidepressant drugs increase 




increases in AHN might not be the final process in the recovery from stress-induced 
depressive-like behaviour (Bessa et al. 2009). 
 
 1.5. The Hippocampus is Functionally Segregated Along its 
Longitudinal Axis 
Precisely how the hippocampus and AHN play a role in functions as seemingly 
diverse as spatial learning and memory and the response to stress and 
antidepressants is currently unclear, but accumulating anatomical, 
electrophysiological, molecular and lesion studies suggest that the hippocampus is 
functionally segregated (see Fig 1.5) along its longitudinal axis into dorsal and 
ventral regions in rodents and anterior and posterior regions in humans.  
 
1.5.1. Anatomical evidence of segregation along the hippocampal longitudinal 
axis 
Previous anatomical studies have shown in rodents that the hippocampus is 
anatomically segregated along its longitudinal axis (Fanselow and Dong 2010, 
Strange et al. 2014). Indeed, the dHi and vHi in rodents exhibit distinct inputs and 
outputs to and from other brain regions. While the dHi receives afferents from the 
retrosplenial cortex and the anterior cingulate cortex (Cenquizca and Swanson 
2007), sending projections to structures involved in the processing of visuospatial 
information, the vHi, connects with the bed nucleus of the stria terminalis, nucleus 
accumbens, and hypothalamus, structures that regulate neuroendocrine and 
behavioural responses to stress, anxiety, motivation, (Fanselow and Dong 2010, 
Poppenk et al. 2013). Neuroimaging studies have also shown differences in the 
anatomical connectivity of the anterior and posterior human hippocampus (ventral 




anatomical evidences supporting that the hippocampus might be functionally 
segregated along its longitudinal axis. 
 
 
Figure 1.5: The mouse hippocampus is segregated into dorsal (dHi) and ventral 
(vHi) sub-regions, while the human hippocampus is segregated into anterior 
(equivalent to the vHi in rodents) and posterior hippocampus (equivalent to the dHi 
in rodents). Image from: (O'Leary and Cryan 2014). 
 
1.5.2. Electrophysiological evidence of segregation along the hippocampal 
longitudinal axis 
Preliminary electrophysiological studies indicated identified dissociable properties 
in the dorsal versus ventral hippocampus in mammals (Elul 1964, Racine et al. 
1977). More recent studies have shown that some electrophysiological properties 
are indeed diverse along the longitudinal axis of the hippocampus, and these sub-




plasticity (Papatheodoropoulos and Kostopoulos 2000, Maggio and Segal 2007) in 
rodents. Electrophysiological diversity was also observed along the hippocampal 
axis in non-human primates (Colombo et al. 1998) and in humans (Staresina et al. 
2012). Place cells are cells within the hippocampus, normally in the CA1 or CA3, 
which fire when an animal walks in a given location and thus they mediate spatial 
discrimination. These place cells exist in a greater proportion in the dHi versus the 
vHi (Jung et al. 1994). In agreement, the dHi is preferentially involved in spatial 
navigation. In non-human primates, the preferential role of the posterior 
hippocampus (dorsal in rodents) in spatial learning and memory is in accordance 
with an electrophysiological study which demonstrates that a spatial learning task 
activates a higher proportion of neurons in the posterior hippocampus as opposed 
to the anterior hippocampus (Colombo et al. 1998). A study also showed that 
corticosterone reduced the frequency of spontaneous inhibitory postsynaptic 
currents preferentially in the vHi, also suppressing paired-pulse facilitation of 
evoked inhibitory synaptic currents, in a MR-dependent mechanism, in rat’s brain 
slices (Maggio and Segal 2009). Moreover, a similar magnitude of long-term 
depression (LTD) was found between dHi and vHi, but stress enhanced LTD only 
in the dHi, while converted LTD to long-term potentiation (LTP) in the vHi 
(Maggio and Segal 2009). 
 
1.5.3. Molecular evidence of segregation along the hippocampal longitudinal 
axis 
A growing body of evidence has been supporting the idea that the hippocampus is 
a gradient and differential gene expression is found along its longitudinal axis 
(Leonardo et al. 2006, Thompson et al. 2008, Strange et al. 2014, Cembrowski et 




differential gene expression in the dorsal DG versus the ventral DG in rats 
(Christensen et al. 2010) and in mice (Cembrowski et al. 2016). Some studies have 
shown that the vHi has a higher expression of genes involved serotonergic (Tanaka 
et al. 2012), cholinergic and GABAergic neurotransmission (Lee et al. 2017). In 
addition, a recent study also supports the idea that the dHi and vHi have distinct 
epigenetic responses to acute stressors (Floriou-Servou et al. 2018), with the vHi 
being particularly more sensitive to the stressor. Taken together, these data support 
that the diverse hippocampal sub-regions display diverse gene expression, which 
could be one factor for the functional dissociation between dHi, and vHi. 
 
1.5.4. Functional evidence of segregation along the hippocampal longitudinal 
axis 
The hippocampus can be divided along its septotemporal axis into dorsal and 
ventral regions in rodents and into anterior and posterior regions in primates, based 
on their distinct afferent and efferent connections (Fanselow and Dong 2010). 
Lesion, optogenetic and electrophysiological studies in rodents suggest that this 
anatomical segregation results in a dichotomy in the function of the dorsal 
hippocampus (dHi) and the ventral hippocampus (vHi) (Bannerman et al. 2004, 
Fanselow and Dong 2010). While the dHi (analogous to the posterior hippocampus 
in primates) seems to play a preferential role in spatial learning and memory 
processes, the vHi (analogous to the anterior hippocampus in primates) 
preferentially regulates anxiety and the response to stress (Moser and Moser 1998, 
Bannerman et al. 2004, Fanselow and Dong 2010). 
 
Specifically, lesion studies have reported a functional dissociation of the 




in rats, tested in the light-dark box (Bannerman et al. 2003), elevated plus maze 
(Kjelstrup et al. 2002), hyponeophagia (Bannerman et al. 2002, Bannerman et al. 
2003) and open field tests (Bannerman et al. 2003). On the other hand, dHi lesions 
but not vHi lesions impaired spatial learning and memory in rats (Moser et al. 1995, 
Bannerman et al. 2002, Pothuizen et al. 2004). 
 
The precise vHi neural pathway underlying anxiety have yet to elucidated but 
several optogenetic and pharmacogenetic studies have reported that vHi-mediated 
pathways have been reported to regulate anxiety behaviour in the open field and 
elevated plus maze, including projections from the amygdala (Felix-Ortiz et al. 
2013) or to the prefrontal cortex (Adhikari et al. 2011, Padilla-Coreano et al. 2016). 
In addition, a recent paper describes the presence of “anxiety cells” in the ventral 
hippocampus which project to the lateral hypothalamic area (Jimenez et al. 2018), 
and play a role on the modulation of anxiety. This is in accordance with a previous 
study that show that the stimulation of the ventral hippocampus causes inhibition 
of the HPA axis (Casady and Taylor 1976). Moreover, glutamatergic projections 
from the vHi to the nucleus accumbens have been shown to control stress resilience 
to chronic social defeat stress, and optogenetic attenuation of the neurotransmission 
from vHi to accumbens is suggested to induce stress resilience, shown by an 
increase in the time spent in the interaction zone in the social interaction test (Bagot 
et al. 2015). 
 
1.5.5. Is adult neurogenesis segregated along the longitudinal axis of the 
hippocampus?  
Since AHN has been implicated in processes preferentially regulated by the dHi 




neurogenesis might be regulated preferentially in the dHi or the vHi, depending 
upon the stimulus (see Fig 1.6) (Winocur et al. 2006, Tanti and Belzung 2013, 
O'Leary and Cryan 2014, Wu and Hen 2014, Levone et al. 2015, O'Leary et al. 
2015). Indeed, new neurons in the dHi are preferentially required for contextual 
discrimination and memory tasks in rats (Winocur et al. 2006), while new neurons 
in the vHi are necessary for anxiolytic effects of the antidepressant fluoxetine in 
mice (Wu and Hen 2014). A recent study suggests that the mouse dHi has more 
active neurogenesis than vHi and is enriched with maturing neurons markers, such 
as NeuroD1 and DCX, while the vHi is enriched of radial glia markers, such as 
Sox2 and Hes5 (Zhang et al. 2018). Accordingly, dHi neural progenitor cells have 
been shown to mature faster, associated with higher basal network activity (Piatti 
et al. 2011). 
 
Moreover, several studies have reported that stress affects several stages of adult 
neurogenesis, preferentially in the vHi rather than the dHi (Tanti and Belzung 2013, 
O'Leary and Cryan 2014). Some (but not all) studies also report that antidepressant-
induced increases in cytogenesis and neurogenesis occur preferentially in the vHi 
but not dHi (Banasr et al. 2006, Jayatissa et al. 2006, O'Leary et al. 2012, Tanti et 
al. 2012, O'Leary and Cryan 2014). Specifically, it has been reported that chronic 
stress decreases cell proliferation (Jayatissa et al. 2006, Tanti et al. 2012), neuronal 
differentiation, maturation and survival (Hawley and Leasure 2012, Lehmann et al. 
2013), preferentially in the vHi of rodents. Indeed, our laboratory and others have 
reported that AHN is differentially regulated by stress and antidepressant-like 
treatments within the sub-regions of the hippocampus in rats and mice (Jayatissa et 
al. 2006, O'Leary et al. 2012, Tanti and Belzung 2013, O'Leary and Cryan 2014, 




number of immature neurons in the anterior hippocampus, but not in the posterior 
hippocampus of non-human primates (Perera et al. 2011). Moreover, some studies 
have reported that antidepressant-induced increases in cytogenesis and 
neurogenesis occur preferentially in the vHi under basal conditions (Banasr et al. 
2006, Soumier et al. 2009, Paizanis et al. 2010) and under stress conditions in mice 
(Banasr et al. 2006, Jayatissa et al. 2006, O'Leary et al. 2012, Tanti et al. 2012, 
O'Leary and Cryan 2013). Antidepressant effects on neurogenesis also seem to 
occur preferentially in the anterior hippocampus (equivalent to vHi in rodents) in 
humans (Boldrini et al. 2009, Boldrini et al. 2012). 
 
To date, few studies have investigated whether adult neurogenesis specifically in 
the vHi correlates with stress resilience or the antidepressant response. 
Nevertheless, in non-human primates, the number of immature neurons that were 
at the threshold of complete maturation was reduced by chronic stress in the anterior 
but not posterior hippocampus, and this effect was correlated with stress-induced 
anhedonia (Perera et al. 2011). Our laboratory recently reported that GABAB(1b)
-/-
 
mice, which are resilient to stress-induced anhedonia, exhibit increased 
proliferation and survival of newly-born cells predominantly in the vHi, and are 
also resilient to stress-induced decrease in the survival of newly-born cells in the 
vHi (O'Leary et al. 2014). Furthermore, Jayatissa and colleagues reported that rats 
that exhibit escitalopram-induced behavioural recovery from stress also exhibit 
increased hippocampal cell proliferation in the vHi, while this selective effect in the 
vHi was not observed in rats that failed to respond to escitalopram treatment 
(Jayatissa et al. 2006). Moreover, it was recently demonstrated that ablation of 
neurogenesis in the vHi but not dHi prevents the anxiolytic effects of fluoxetine in 




Future studies investigating whether the effects of fluoxetine and other 
antidepressants on recovery from stress-induced changes in behaviour, such as 
anhedonia, are dependent on neurogenesis in specifically the vHi will be of interest. 
Ultimately, AHN may be a key factor linking stress to anxiety- and depression-like 
behaviours (Snyder et al. 2011). However, as discussed earlier, studies have shown 
contradictory results linking stress susceptibility and AHN. In addition to 
methodological differences, we suggest that such incongruences might also be due 
to the absence of segregation of the hippocampus into dorsal and ventral regions 
(O'Leary and Cryan 2014). Therefore, future studies investigating the relationships 
between AHN and stress-related factors such as stress susceptibility/resilience and 
the antidepressant response should specify whether changes in AHN occur in the 







Figure 1.6: Segregation of the mouse hippocampus along its longitudinal axis and 
the adult neurogenesis in the dHi versus vHi. The dorsal hippocampus is 
represented in pink, while the ventral hippocampus is represented in green. The 
hippocampus has different brain connections along its axis. While the dHi is 
connected to structures that play a role in spatial learning and memory, the vHi is 
connected to structures which regulate the stress hormone (corticosterone) release, 
anxiety, and motivation. While the lesion of dHi impairs spatial learning, the lesion 
of vHi reduces anxiety and the stress-induced corticosterone release. Adult 
hippocampal neurogenesis also seems to be differentially regulated along the 
hippocampal axis. vHi neural progenitor cells mature slower, are more sensitive to 
the chronic stress and to the antidepressants effects. Abbreviations: ACC, anterior 
cingulate cortex; Acb, nucleus accumbens; AD, antidepressant; AMY, amygdala; 
BST, bed nucleus of the stria terminalis; FLX, fluoxetine; Hi, hippocampus; Hyp, 
hypothalamus; mPFC, medial prefrontal cortex (infralimbic and prelimbic cortex); 
LM, lateral mammillary nucleus; MM, medial mammillary nucleus; NG, 
neurogenesis; NPCs, neural progenitor cells; RSP, retrosplenial cortex; VTA, 
ventral tegmental area. Figure from: (O'Leary and Cryan 2014), adapted. 
 
Although it is clear that AHN is important for some of the behavioural effects of at 
least some antidepressants, few studies have investigated whether the rate of 




induced behavioural recovery from stress. Nevertheless, it has been reported that 
the number of newly-born cells in the hippocampus of stressed rats was restored 
only in the group of rats that showed a behavioural response to the antidepressant 
escitalopram, thus suggesting that the restoration of cell proliferation rates at least 
within a certain area of the dentate gyrus (ventral region) may be important for 
escitalopram-induced recovery from stress-related behaviours (Jayatissa et al. 
2006). Similarly, a primate study showed that fluoxetine treatment prevented the 
onset of depression-like behaviours and increased the number of newly-born 
neurons that were at the threshold of maturation within a specific region of the 
dentate gyrus (anterior region), thus leading to the suggestion that AHN may 
contribute to the recovery promoted by fluoxetine (Perera et al. 2011). Together, 
these data suggest that AHN specifically in the vHi may be an important 
determinant of the behavioural responses to stress and antidepressant drugs. 
 
1.5.6. The intermediate hippocampus - a functionally distinct hippocampal 
sub-region? 
A growing body of evidence has been supporting the idea that the hippocampus is 
actually a gradient and differential gene expression is found along its longitudinal 
axis (Leonardo et al. 2006, Thompson et al. 2008, Strange et al. 2014, Cembrowski 
et al. 2016, Cembrowski et al. 2016). Besides demonstrating a clear differential 
expression of genes between dHi and vHi, studies also support the presence of an 
intermediate hippocampus (see Fig 1.7) (Leonardo et al. 2006, Thompson et al. 
2008, Strange et al. 2014, Cembrowski et al. 2016, Cembrowski et al. 2016). The 
intermediate hippocampus does not have clearly defined projections, but it is 
suggested that it projects to anterior and ventromedial hypothalamic nucleus, which 





Figure 1.7: The rodent hippocampus is segregated into dorsal (dHi), intermediate 
(iHi) and ventral (vHi) sub-regions. 
 
Most studies that describe the functional roles of the dHi and vHi use coordinates 
of coronal slices of the hippocampus for the segregation into its sub-regions and 
many of them disagree on the definition of the boundaries of the dorsal versus the 
ventral sub-regions of the hippocampus (see Fig 1.8) (Tanti and Belzung 2013). 
Indeed, some of these definitions of the dHi or vHi sometimes include the 
intermediate hippocampus (iHi), a sub-region which may in its own right be 
functionally independent but has been understudied (Bast 2007, Thompson et al. 
2008, Bast et al. 2009, Strange et al. 2014). Although the roles of the iHi have yet 
to be determined, the introduction of this third hippocampal sub-region might 
somewhat explain some of the conflicting reports of whether AHN is preferentially 







Figure 1.8: Different coordinates were used to define the boundaries of dorsal and 
ventral hippocampal sub-regions. Example of four studies and the coordinates they 
used in coronal sections in mice. Coordinates are shown in mm from bregma, 
defining the dHi (blue) and vHi (orange). Figure from: (Tanti and Belzung 2013). 
 
Very few functional studies have considered this third hippocampal sub-region 
isolation, but there are reports that it is not only a transitional area between dorsal 
and ventral hippocampus, but also an integrative region (Bast 2007, Bast et al. 
2009), which mediates the integration of diverse sensory modalities (Bast et al. 




engaging in rapid place encoding (Bast et al. 2009). In addition, a study showed 
that intermediate hippocampus engages in the processing of spatial information 
differently than the dorsal hippocampus in rats; specifically, the exposure to novel 
spatial cues facilitate long-term depression in the dorsal hippocampus, while this 
phenomenon is not observed in the intermediate hippocampus under the same 
conditions (Kenney and Manahan-Vaughan 2013). Besides playing a role in 
cognition and place encoding, the intermediate hippocampus has also been shown 
to play a functional role in anticipatory neuronal firing prior to the release of a 
reward in trained rats (Burton et al. 2009). Finally, a study has also shown that 
fluoxetine-induced increases on proliferation of NPCs in vivo occur preferentially 
in the area that transitions from the intermediate to the ventral hippocampus (Zhou 
et al. 2016). Taken together, there is enough evidence to suggest that the 
intermediate hippocampus may indeed be an independent hippocampal sub-region, 
but precisely which functional roles it plays are yet to be fully understood. Indeed, 
the specific roles of the dorsal, intermediate and ventral hippocampus in the 
behavioural and neurogenic responses to chronic stress or antidepressant treatment 
have yet to be interrogated. 
 
1.6. Methodological Approaches to Interrogate the Role of 
Hippocampal Sub-Regions in Behaviours Related to Stress, 
Anxiety, Depression and Antidepressant Action 
 
1.6.1. Methodological approaches to interfering with hippocampal function 
In the present days, many techniques can be used to interfere with hippocampal 




lesion approach. In this approach, the hippocampus or its sub-regions are 
stereotaxically injected with a chemical - usually ibotenic acid - which is a potent 
glutamatergic agonist and causes excitotoxicity, followed by cell death in the region 
in contact. On the other hand, the injection of muscimol, a GABAergic agonist, 
allows the transient inactivation of specific areas of the hippocampus, without 
causing death (Zhang et al. 2014). Lidocaine, a fast voltage-gated Na+ channel 
blocker, has also been injected into the hippocampus for its short, transient 
inactivation (Pierard et al. 2017). 
 
More recently, the use of optogenetics and chemogenetics have opened new 
possibilities for the study of the hippocampal function. Optogenetics consists in the 
injection of proteins that modify the activity of the cell in which they are expressed 
when that cell is exposed to light. One example of these proteins is the 
Channelrhodopsins (ChRs), which are ion channels discovered in a unicellular 
green alga. Interestingly, when illuminated with blue light ChR2, the light-gated 
nonspecific cation channel opens and allows the passage of cations, depolarising 
the cell. Moreover, halorhodopsin (NpHR) was identified in an archaeon, and 
pumps chloride ions into the cell upon light activation, resulting in 
hyperpolarization, being an interesting technique to study the inhibition of 
specifically tagged cells. Chemogenetics consists of engineered G-protein coupled 
receptors, specifically activated by small molecules that act like drugs, but would 
otherwise be inert. Specifically, the use of designer receptors exclusively activated 
by designer drugs (DREADDs), initially developed by Bryan Roth, has been the 
most used chemogenetics technique (Armbruster et al. 2007). Viral constructs 
encoding DREADDs, most notably Cre-dependent adeno-associated viruses 




thus, the activation of the DREADDs receptors by the specific drug would change 
the function only on those specific cells. 
 
1.6.2. Animal models and tests of stress, anxiety, depression and 
antidepressant-like behaviour 
Animal models are powerful tools to determine the impact of stress and 
antidepressant treatment on brain and behaviour can be used to determine the 
neurobiology underlying the negative consequences of chronic stress and the 
mechanisms of antidepressant action. Several animal models of stress have been 
used to induce depression and anxiety-like behaviour, for example chronic social 
defeat stress, maternal separation, chronic unpredictable mild stress, and these are 
summarised in Table 1.1.  
 
Table 1.1: Animal models of stress 





Animals are exposed to an aggressive unfamiliar 
animal and physical contact is allowed, followed 
by sensory contact through a perforated 
plexiglass. Protocol can also include 
overcrowding, which consists in placing 10 
animals that are usually singly-housed into the 
same cage. This stress protocol is known to 
induce anxiety and some studies also report 
depressive-like behaviour, which are reversed 
by antidepressants 
(Berton et al. 
2006, Kinsey et 
al. 2007, 





Animals are submitted to diverse unpredictable 
stressors, which alternate each day. This stress 
protocol induces anxiety and depressive-like 
behaviour which are reversed by antidepressants 
(Willner 1997, 






On the first postnatal days, animals are daily 
separated from the mother for some time and this 
can cause depressive-like behaviour later in life 








In addition, as summarised in Table 1.2, several tests can be used for assessment of 
depression-like and antidepressant-like behaviour, including the novelty-induced 
hypophagia, elevated plus maze, marble burying, light-dark box, open field, forced 
swim test, tail suspension test, learned helplessness, saccharin preference test and 
female urine sniffing test. 
 







Animals are trained for 3 days (30 min/day) to 
drink a palatable sweet milk solution. The 
latency to drink is measured on its own 
homecage and then measured in a novel highly 
anxiogenic environment. The latency 
difference between homecage and novelty is a 
measure of anxiety. 
(Santarelli et al. 
2003, Dulawa and 





Animal are tested in a plus maze, elevated 
from the ground, which consists of two open 
and two closed arms. Normally the animals 
avoid the open arms and an increase of the 
exploration of the open arms is an anxiolytic 
effect. 
(File et al. 2004, 
Braun et al. 2011, 
Cryan and 
Sweeney 2011) 
Marble burying Animals are placed in a cage containing 20 
marbles, which tends to be aversive to them. 
The number of marbles buried (2/3 buried) in 
a period of 30 min is a measure of anxiety. 
(Deacon 2006, 
Nicolas et al. 
2006, Thomas et 
al. 2009) 
Light/dark box It consists of an apparatus with a bright and a 
dark box. Normally, animals tend to avoid the 
bright box, and an increase in the exploration 
of the light box is an anxiolytic effect. 
(Bourin et al. 
1996, Bourin and 
Hascoet 2003) 
Open field Animals are placed in an open, bright arena. 
The animals tend to spend more time near the 
walls, avoiding the centre of the open field. An 
increase on the exploration of the central 
quarter of the arena is an anxiolytic effect 
(Lucki et al. 
1989, Cryan and 
Sweeney 2011) 
Forced swim test Animals are place in a glass cylinder with 
water, and display escape-oriented swimming. 
An increase in the immobility is a measure of 
depressive-like behaviour and antidepressants 
are known to reduce this immobility time  
(Porsolt et al. 
1977, O'Leary 
and Cryan 2013) 
Tail suspension 
test 
Mice are hung by the tail and display escape-
oriented movements. An increase in the 
immobility is a measure of depressive-like 
behaviour and antidepressants are known to 
reduce this immobility time 








Animals are submitted to inescapable 
footshocks and fail to escape when are allowed 
to. Antidepressants are thought to increase the 
number of escapes 
(Seligman et al. 
1975, O'Leary 
and Cryan 2013) 
Saccharin 
preference test 
In this anhedonia test, animals are allowed to 
drink either water or a saccharin solution. 
Animals tend to drink the palatable solution, 
but chronic stress has been shown to decrease 
it, which is reversed by antidepressants 




In this anhedonia test, animals are allowed to 
sniff a cotton bud with urine from females in 
oestrus cycle. A reduction on the time spent 
sniffing the urine is caused by chronic stress. 
(Malkesman et al. 
2010, Finger et al. 
2011) 
 
Such animal models and behavioural tests could be used to determine the 
contribution of the dHi, iHi and vHi to the behavioural responses to chronic stress 
and antidepressant treatment.  
 
1.7. Aims of This Thesis 
The overall goal of this thesis is to test the hypothesis that the dorsal, intermediate 
and ventral hippocampus have differential roles in modulation of anxiety and 
depression-like behaviour as well as differential roles in the neurogenic and 
behavioural responses to chronic stress and antidepressant treatment. This 
hypothesis was tested via the following experimental aims:  
 
Aim 1: To determine the roles of each hippocampal sub-region, dHi, iHi and vHi, 
in vivo in sociability, anxiety, anhedonia and antidepressant-like behaviours 
(Chapter 2). 
 
Aim 2: To determine the roles of each hippocampal sub-region, dHi, iHi and vHi, 
in vivo in the anxiolytic, antidepressant and neuroendocrine effects of acute and 





Aim 2: To determine the roles of each hippocampal sub-region, dHi, iHi and vHi, 
in the in vivo behavioural and neuroendocrine responses to chronic psychosocial 
stress (Chapter 3). 
 
Aim 1: To determine in vitro whether NPCs isolated from the dHi, iHi and vHi 
exhibit differential intrinsic sensitivity to the effects of the stress hormone, 
corticosterone, on cell proliferation, neuronal differentiation and maturation, cell 
viability and glucocorticoid nuclear translocation (Chapter 4). 
 
Aim 5: To determine in vitro whether NPCs isolated from the dHi, iHi and vHi 
exhibit differential intrinsic sensitivity to the effects of fluoxetine on cell 
proliferation and neuronal differentiation (Chapter 5). 
 
Aim 6: To determine in vitro whether NPCs isolated from the dHi, iHi and vHi 
exhibit differential intrinsic sensitivity to the effects of fluoxetine on corticosterone-
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Depression is one of the leading causes of disability worldwide and yet, 
antidepressant treatments remain suboptimal. This is due in part to our incomplete 
understanding of the neurobiology underlying the pathophysiology and successful 
treatment of depression. However, clinical neuroimaging and preclinical studies 
suggest that the hippocampus is a key area of the brain in depression. Accumulating 
studies suggest that in rodents the hippocampus may be functionally segregated 
along its longitudinal axis into a dorsal region (dHi) which is predominantly 
involved in spatial learning and memory, and a ventral region (vHi) which regulates 
anxiety (a behaviour often co-morbid with depression) and the response to stress (a 
risk factor for depression). However, gene expression studies suggest that the area 
between them, the intermediate hippocampus (iHi), might also be functionally 
independent but few studies have interrogated its function. Similarly, little is known 
about the roles of these specific hippocampal sub-regions in the antidepressant 
response. Thus, the present study investigated the impact of ibotenic acid-induced 
lesions of the dHi, iHi or vHi on the regulation of social, anxiety and depressive-
like behaviour in the absence or presence of the antidepressant fluoxetine. In the 
absence of fluoxetine, vHi lesions reduced anxiety, while none of the lesions 
affected sociability or depressive-like behaviour under these conditions. On the 
other hand, only vHi lesions prevented the acute antidepressant effects of fluoxetine 
in the tail suspension test and the anxiolytic effects of chronic fluoxetine treatment 
in the novelty-induced hypophagia test. Interestingly, iHi lesions prevented the 
antidepressant effect of chronic fluoxetine treatment in the forced swim test. dHi 
lesions did not impact behaviour either in the absence or presence of fluoxetine. 




and its modulation by chronic fluoxetine treatment, and that both the iHi and vHi 






Depression is currently one of the leading causes of disability worldwide (WHO 
2017). Up to half of depressed patients treated with first-line antidepressant 
treatment fail to achieve remission and a third of these patients remain treatment-
resistant (Fava 2003, Trivedi et al. 2006). Antidepressant drug development has 
been hampered by the fact that we do not yet have a complete understanding of the 
neurobiology underlying the pathophysiology of depression and its successful 
treatment by current antidepressants. However, clinical neuroimaging studies report 
volumetric reductions in the hippocampus in depression (Sheline et al. 1996, 
Bremner et al. 2000, Frodl et al. 2002, Videbech and Ravnkilde 2004). In parallel, 
studies in animals report that chronic stress, which is a risk factor for depression, 
reduces hippocampal volume (Lee et al. 2009, Tse et al. 2014), causing dendritic 
atrophy (Lee et al. 2009, McEwen 2016) and reducing adult hippocampal 
neurogenesis (Gould et al. 1997, Simon et al. 2005, Dranovsky and Hen 2006, 
Schoenfeld and Gould 2012, Levone et al. 2015). These depression-related changes 
are reversed by chronic treatment with antidepressants including fluoxetine in 
animals (Malberg et al. 2000, Malberg and Duman 2003, Nollet et al. 2012, Rainer 
et al. 2012, Tanti et al. 2012) and humans (Sheline et al. 2003). 
 
It is now well established that the hippocampus plays a critical role in spatial 
learning and memory in rodents (Morris et al. 1982, Moser et al. 1995, Moser and 
Moser 1998) and in humans (Maguire et al. 2000, Maguire et al. 2006). In addition, 
it also plays a role in the modulation of anxiety and the stress response (Bannerman 
et al. 2002, Bannerman et al. 2003, Bannerman et al. 2004, Fanselow and Dong 
2010, Levone et al. 2015). Precisely how this brain region can modulate such 




hippocampus is functionally segregated into dorsal and ventral regions in rodents 
whereby the dorsal hippocampus plays a predominant role in spatial learning and 
memory and the vHi is predominantly involved in anxiety and response to stress 
(Bannerman et al. 2004, Fanselow and Dong 2010, O'Leary and Cryan 2014). 
Indeed, some studies have reported a greater density of place cells in the dHi when 
compared with the vHi (Jung et al. 1994), while the presence of anxiety cells, cells 
that are involved in the modulation of anxiety, is enriched in the vHi when 
compared to the dHi (Jimenez et al. 2018). This hypothesis is further supported by 
lesion studies which have also shown a functional dissociation of the hippocampus. 
Indeed, lesions of the dHi but not the vHi have been shown to impair spatial learning 
and memory (Moser et al. 1995, Bannerman et al. 2002, Pothuizen et al. 2004). On 
the other hand, it has been reported that the vHi plays a role in the response to stress 
(Fanselow and Dong 2010, Tanti and Belzung 2013, O'Leary and Cryan 2014, 
Levone et al. 2015), as well as a role in anxiety (Bannerman et al. 2002, Bannerman 
et al. 2003, Bannerman et al. 2004) and social behaviours (Bannerman et al. 2002, 
McHugh et al. 2004, Felix-Ortiz and Tye 2014, Okuyama et al. 2016). Recently, it 
has been proposed that the hippocampus exhibits a gradient of gene expression 
along its longitudinal axis and an intermediate sub-region (iHi) has been proposed 
(Leonardo et al. 2006, Thompson et al. 2008, Strange et al. 2014, Cembrowski et 
al. 2016, Cembrowski et al. 2016) although some studies have suggested that this 
area has overlapping characteristics with both the dHi and vHi (Cenquizca and 
Swanson 2007). Nevertheless, the specific roles of the iHi have yet to be determined 
although it has been reported that it may mediate the integration of diverse sensory 





Together, such studies suggest that anxiety and response to stress are mediated 
predominantly by the vHi. Although chronic stress is a risk factor for depression 
and anxiety is often co-morbid in depression, to date no studies have interrogated 
whether the beneficial effects of antidepressants are also mediated specifically by 
discrete sub-regions areas along longitudinal axis of the hippocampus. Thus, the 
aim of this study was to determine whether social, anxiety and depressive-like 
behaviour in the absence or presence of antidepressant treatment is modulated by 
distinct sub-regions of the longitudinal axis of the hippocampus. To this end, we 
induced excitotoxic lesions of the mouse dHi, iHi or vHi and interrogated their 
impact on a battery of behavioural and neuroendocrine tests in the presence or 





2.2. Materials and Methods 
 
2.2.1. Experimental design 
Ibotenic acid-induced lesions of the dHi, iHi and vHi were performed and the 
impact of these on the regulation of social, anxiety and depression-like behaviour 
with or without chronic treatment with the antidepressant, fluoxetine was examined 
in two separate experiments as summarised in Fig 2.1A and Fig 2.1B.  
 
We first examined the roles of the dHi, iHi and vHi in social behaviour, anxiety, 
anhedonia and antidepressant-like behaviour (Experiment 1; Fig 2.1A). Mice 
underwent either sham surgery or ibotenic-induced lesions of the dHi, iHi, or vHi. 
Seven days following surgery, animals underwent a battery of behavioural tests as 
shown in Fig 2.1A. The experimental groups, sample number (after surgery 
corrections), surgery success rate and number of misplaced (excluded) animals 
were: (1) dHi-sham, n = 10 (83.3% success, 2 excluded); (2) dHi-lesion, n = 8 
(66.7% success, 4 excluded); (3) iHi-sham, n = 9 (75% success, 3 excluded); (4) 
iHi-lesion, n = 9 (57.1% success, 6 excluded); (5) vHi-sham, n = 10 (55.6% success, 
8 excluded) and (6) vHi-lesion, n = 9 (52.9% success, 8 excluded). 
 
We then examined the roles of the roles of the dHi, iHi and vHi in the antidepressant 
and anxiolytic effects of fluoxetine treatment (Experiment 2; Fig 2.1B). Ibotenic-
induced lesions of the dHi, iHi and vHi of the mouse hippocampus were performed, 
while some animals underwent a sham surgery. Seven days following surgery, 
animals were injected with either saline (sham-saline group) or fluoxetine (all other 
groups; 10mg/kg i.p. per day, PHR1394, Sigma-Aldrich,) daily for 21 days and then 




saline injections as shown in Fig. 2.1B. 30 min after the first injection with 
fluoxetine, animals underwent the tail suspension test, to assess the effects of acute 
fluoxetine. After 21 days of injections, the anxiolytic and antidepressant effects of 
chronic fluoxetine were tested. The impact of lesions and chronic fluoxetine 
treatment on acute swim stress-induced increases in plasma corticosterone 
concentrations was also investigated. The experimental groups, sample number 
(after surgery corrections), surgery success rate and number of misplaced 
(excluded) animals were: (1) sham-saline, n = 10 (100% success, 0 excluded); (2) 
dHi sham-fluoxetine, n = 10 (83.3% success, 2 excluded); (3) dHi lesion-fluoxetine, 
n = 10 (83.3% success, 2 excluded); (4) iHi sham-fluoxetine, n = 9 (81.8% success, 
2 excluded); (5) iHi lesion-fluoxetine, n = 10 (83.3% success, 2 excluded); (6) vHi 
sham-fluoxetine, n = 8 (66.7% success, 4 excluded) and (7) vHi lesion-fluoxetine, 
n = 8 (72.7% success, 3 excluded). 
 
2.2.2 Animals  
Male C57BL/6 mice (Envigo, UK) aged 8-weeks old, were housed in groups of 3-
4 at arrival in a temperature controlled (21±2°C) room and allowed to acclimatise 
to the holding room for 7-days prior to initiation of experiments. Laboratory chow 
and water were provided ad libitum on a 12/12 h light/dark cycle (lights on at 7:30 
am). All procedures were conducted with approval from the Animal 
Experimentation Ethics Committee (AEEC) at University College Cork, under 
Individual Authorisations and a Project Authorisation approved the Health Products 
Regulatory Authority (HPRA) Ireland and in accordance with the recommendations 





2.2.3. Stereotaxic brain surgery and excitotoxic lesion of the dorsal, intermediate 
of ventral hippocampus  
Mice (20-26g) were anaesthetised with isoflurane (5% induction, 1.7-2.5% 
maintenance) and received analgesia (5mg/kg, s.c., Carprofen, Norbrook,) prior to 
being placed in a stereotaxic frame. Fig 2.1C shows the definition of dHi, iHi and 
vHi in coordinates. As shown in Fig 2.1D, small volumes (0.15-0.2 µl) of ibotenic 
acid (10 mg/ml, I2765, Sigma-Aldrich) diluted in PBS (pH 7.4) were injected 
bilaterally into either the dHi, iHi or vHi using coordinates from the Paxinos and 
Franklin’s atlas for mouse brain (Paxinos 2012). The ibotenic acid causes 
excitotoxicity, damaging cells without affecting passaging fibres. Sham surgeries 
involved opening holes at the relevant areas of the skull but not injecting anything. 
Holes in the skull were covered with Bone-Wax (SMI, Z046) and the skin was 
sutured (Mersilk Suture 4-0, W329). An analgesic (Carpofen, Norbrook, 20 µg/ml) 
was added to the drinking water for 2 days post-surgery. 
 
At the end of the experiment, mice were deeply anaesthetised with pentobarbital 
(250mg/kg, i.p., Euthanal, Merial,) and transcardially perfused with PBS followed 
by 4% PFA. Brains were removed, post-fixed in 4% PFA overnight, cryoprotected 
in 30% sucrose and then frozen at -80°C. Brains were sectioned coronally (at 35 
µm) through the entire rostro-caudal axis of the hippocampus and collected onto 
gelatinised slides. Sections were stained with cresyl violet (0.1%, Sigma-Aldrich, 
C5042). Injection site were identified by light microscopy examination by an 
experimenter blind to the experimental treatment groups. Only animals with 
confirmed lesions in the specific sub-region were included (see Fig 2.1E for shams 






Figure 2.1: Dorsal (dHi), intermediate (iHi) or ventral (vHi) hippocampus were 
lesioned and animals followed with a battery of behavioural testing with or without 
chronic treatment with fluoxetine. A, schematic of the experiment in which animals 
had their dHi, iHi or vHi lesioned and followed with a battery of behavioural testing 
under baseline. In B, after surgery, animals followed with a battery of behavioural 
and neuroendocrine testing under chronic fluoxetine treatment. C, illustration of 
the definitions and coordinates of dHi, iHi and vHi. D, stereotaxic coordinates used 
to lesion dHi, iHi and vHi, bilaterally. E-H, representative images of the dHi, iHi 
and vHi. Lesions were confirmed using cresyl violet staining, E, dHi, iHi and vHi 
sham groups. F, dHi lesion, showing that iHi and vHi were intact. G, iHi lesion, 
showing that dHi and iHi were intact. H, vHi lesion, showing that dHi and iHi were 
intact. Coordinates in the representative images are in relation to bregma. 
Abbreviations: 3-Ch: three-chambers test, AP: anteroposterior, DV: dorsoventral, 
EPM: elevated plus maze, FLX: fluoxetine, FST: forced swim test, FUST: female 
urine sniffing test, L: lateral, MBT: marble burying test, NIH: novelty-induced 






2.2.4. Three-chambers test of sociability and social novelty preference  
Sociability and preference for social novelty were assessed in a three-chamber 
apparatus (Desbonnet et al. 2014). The apparatus consists of a box with three 
chambers (left and right and a smaller centre chamber) with small circular openings 
allowing easy free access to all compartments. The test is composed of three 
sequential 10 min trials or stages. In the first stage, the test animal is allowed to 
explore the three empty chambers. The second stage tests sociability whereby an 
unfamiliar animal is placed in an inner mesh wire cage in one chamber and an object 
is placed in a mesh wire cage in the other chamber. The final stage, tests social 
novelty preference whereby the object is replaced by a novel animal. All animals 
were age- and sex-matched and each chamber was cleaned and lined with fresh 
bedding between trials. In each of the three stages, behaviour was recorded by a 
video camera mounted above the apparatus and the time spent in each chamber was 
measured in each individual trial. 
 
2.2.5. Tests of anxiety. 
2.2.5.1. Elevated Plus Maze (EPM) 
The elevated plus maze is a test used to measure anxiety-like behaviour (File et al. 
2004, Sweeney et al. 2014). Each animal was placed in the centre of the elevated 
plus maze (a cross shaped maze with 2 open arms and 2 closed arms, elevated from 
the ground) and their behaviour was monitored and tracked for 5 minutes. Time and 
percentage of time and number of entries in the open and closed arms were analysed. 
Mice tend to spend more time in the protected closed arms than the open arms. Thus, 
an increase in the percentage of time spent in the open versus closed arms is 





2.2.5.2. Novelty-induced hypophagia (NIH) 
The novelty-induced hypophagia test is a test of anxiety sensitive to chronic 
antidepressant treatment (Dulawa and Hen 2005, O'Leary et al. 2013). In this test, 
mice were trained to drink a diluted solution of sweetened condensed milk (3:1, 
water to milk) from a 10 ml serological pipette through the lid of the cage for 30 
minutes per day for 3 days. On the fourth day, the latency to drink the milk in their 
homecage was measured. On the fifth day, mice were placed in a novel brightly-lit 
cage (1200 lux) without bedding, and their latency to drink the milk was recorded. 
Placement in the novel cage increases the latency to drink the milk which is taken 
as an index of anxiety. Chronic antidepressant treatment decreases this latency. The 
data are presented as latency difference (i.e. the latency to drink in the novel cage 
minus latency to drink in the home cage). 
 
2.2.5.3. Marble Burying Test (MBT) 
The marble burying test is a test used to measure phenotypes related to anxiety and 
obsessive compulsive-like behaviour (Deacon 2006). A cage (35 x 28 cm) was 
filled with clean corncob bedding overlaid with 20 glass marbles equidistant from 
each other in a 4×5 arrangement (Savignac, Kiely et al., 2014). Mice were placed 
in the cage for 30 minutes and the number of marbles that are more than 2/3 buried 
were counted. An increase in the number of marbles buried is considered to be a 
proactive response to an anxiogenic stimulus and has also been described as a 
compulsive behaviour to relieve anxiety (Deacon 2006). Chronic fluoxetine 
treatment has been shown to decrease the number of marbles buried (Greene-





2.2.5.4. Open field test (OF) 
The open field test was used to measure locomotor activity as well as anxiety-like 
behaviour. This test consisted of a rectangle box (perspex sides and base: 40 x 33 
cm²) in a dimly lit room (4 lux). Mice were placed in the centre of the open field 
and allowed to explore the apparatus for 10 minutes. Locomotor activity was 
recorded by a camera placed over the open field and distance travelled were 
automatically analysed using Ethovision 11.5 software. The time spent in the centre 
quarter (10 x 8.25 cm2) of the chamber was also measured as an index of anxiety 
behaviour. 
 
2.2.6. Tests of anhedonia 
2.2.6.1. Female Urine Sniffing Test (FUST) 
The female urine sniffing test assesses anhedonia (a reduction in the ability to 
experience pleasure) which is a core feature of depression (Malkesman et al. 2010, 
Finger et al. 2011, O'Leary et al. 2014). This test takes advantage of the fact that 
rodent males are attracted to pheromonal odours from the opposite sex and thus is 
used in male mice as an index of sexual interest. Before the test, mice were 
transferred to a dimly-lit (4 lux) room and habituated to the presence of a cotton tip 
applicator in their home cage for 1 hour. Following habituation, mice were 
immediately presented with a cotton tip applicator with 60 µL of sterile water for a 
period of 3 minutes and the time spent sniffing the water was measured. 45 min 
later, a cotton tip with 60 µL of fresh urine from female mice in oestrus was 
presented to the mice for 3 minutes and the time spent sniffing the urine was 
measured. Data are presented as the percentage of time spent sniffing urine over the 





2.2.6.2. Saccharin preference test (SP) 
The saccharin preference test (Harkin et al. 2002) was used as another test for 
anhedonia. Mice were given access to both a water bottle and a saccharin solution 
(0.1%) bottle for a total period of 48 h. Cumulative saccharin and water intake were 
measured every 12 hours (at 7:30 a.m. and 7:30 p.m. each day). Every 12 h, the 
position of the bottles was reversed to avoid the development of preference for 
drinking from a particular side of the cage. Mice normally show a preference to 
consume the saccharin over water and chronic antidepressant treatment counteracts 
stress-induced decreases in this preference for saccharin (Harkin et al. 2002). The 
data are expressed as the cumulative percentage preference for saccharin over water 
[(saccharin consumption volume/water consumption volume) * 100]. 
 
2.2.7. Tests of antidepressant-like behaviour. 
2.2.7.1. Tail Suspension Test (TST) 
The tail suspension test is a test of antidepressant-like activity and behavioural 
despair (Steru et al. 1985, O'Leary 2009). In this test, the mouse was suspended by 
the tail from a horizontal bar for 6 minutes. Initially, the mouse displays escape-
oriented behaviours but after several minutes adopts an immobile posture. 
Antidepressant drugs are known to decrease the time the mouse spends immobile 
in this test. In the present experiment, a single dose of fluoxetine was given 30 mins 
prior to the start of the test to examine the role of hippocampal sub-regions in the 
acute antidepressant-like effects of fluoxetine. The results show the effects of acute 
fluoxetine and are expressed as time spent immobile. 
 




The forced swim test is the most widely used experimental paradigm to assess 
antidepressant drug-like activity (Porsolt et al. 1977, Cryan and Mombereau 2004). 
In this test, mice were allowed to swim for 6 min in a glass cylinder (24 × 21 cm) 
filled with water (23–25 °C) to a depth of 17 cm. The test was videorecorded and 
the time spent immobile during the last 4 min of the 6-min test was measured. 
Antidepressant drugs decrease immobility in this test. 
 
2.2.8. Plasma corticosterone measurements 
Blood was withdrawn from the tail vein to measure changes in concentrations of 
the stress hormone corticosterone before and after the acute stress of the forced 
swim test (FST). Blood was withdrawn 30 min before the FST and 30 and 120 min 
after the beginning of the test. 
 
Blood was centrifuged at 4000g for 15 min at 4°C. Plasma was removed and kept 
at -80°C until analysis. Plasma corticosterone was measured using an ELISA kit 
(Enzo, ADI-901-097) and light absorbance was read with a multi-mode plate reader 
(Synergy HT, BioTek Instruments, Inc.) at 405 nm. Samples were analysed in 
duplicate within a single assay and the minimum threshold of detection was less 
than 32 pg/mL. The limit for the coefficient of variation used was 20% and the final 
concentrations are expressed in ng/mL.  
 
2.2.9. Statistical analysis 
Data is shown as mean + S.E.M. Statistical analysis was performed using the 
software IBM SPSS Statistics 23. Data were analysed using two-way ANOVA for 
the experiment that investigated the roles of dHi, iHi and vHi on emotional 




1). Three chambers test in Experiment 1 was analysed using three-way ANOVA. 
Data from the experiment that investigated the roles of dHi, iHi and vHi on 
emotional behaviours under acute and chronic fluoxetine treatment were analysed 
using one-way ANOVA (Experiment 2). When appropriate, ANOVA was followed 
by Fishers LSD post-hoc test for group-wise comparisons. For all comparisons, 








2.3.1. The role of the dHi, iHi and vHi on sociability, anhedonia, anxiety and 
depressive-like behaviour (Experiment 1) 
2.3.1.1. Sociability and social novelty preference are unaffected by dHi, iHi or vHi 
lesions 
The three chambers test was used to assess the effects of hippocampal sub-region 
lesions on sociability and social novelty preference. The effects of sub-region-
specific lesions on sociability are shown in Fig 2.2A. Three-way ANOVA revealed 
that, animals prefer to explore the chamber containing the unfamiliar animal rather 
than that containing the object (F1,94=179,67, p<0.001). There was no main effect 
of hippocampal sub-region (F2,94=0.04, p=0.96), lesion (F1,94=0.05, p=0.83); nor a 
hippocampal sub-region x lesion interaction (F2,94=0.19, p=0.8), nor a lesion x 
preference for animal interaction (F1,94=2.87, p=0.09). However, there was a trend 
towards an interaction between hippocampal sub-region x preference for animal 
(F1,94=2.87, p=0.054) Finally, there was no interaction between the three factors 
(F2,94=2.03, p=0.14). Specifically, post-hoc analysis revealed that each group 
preferred to explore the chamber containing the animal (dHi lesion group p=0.037, 
all other groups p<0.001). Interestingly, dHi-lesioned animals spent less time 
exploring the chamber with the animal than the dHi sham animals (p=0.046). 
 
The effects of sub-region-specific lesions on the preference for social novelty are 
shown in Fig 2.2B. Three-way ANOVA demonstrated that animals preferred to 
explore the chamber containing the novel animal rather than the one containing the 
familiar animal (F1,94=45.62, p<0.001). There was no effect of hippocampal sub-




interactions between hippocampal sub-region x lesion (F2,94=0.008, p=0.99), 
hippocampal sub-region x preference for animal (F2,94=1.51, p=0.23), lesion x 
preference for animal (F1,94=0.84, p=0.36) or between the three main factors 
(F2,94=0.1, p=0.9). Post-hoc analysis revealed that all groups showed a preference 
for the novel animal (dHi-sham, p=0.016; dHi-lesion, p=0.018; iHi-sham, p=0.001; 
iHi-lesion, p<0.001; vHi-sham, p=0.009; vHi-lesion, p=0.005), with no differences 
between them. 
 
We also calculated the percentage preference for the animal (time spent in the 
chamber with the animal over the total time spent in chambers), and this result is 
shown in Fig 2.2C. Two-way ANOVA revealed no effect of lesion (F1,48=2.38, 
p=0.13), hippocampal sub-region (F2,48=0.96, p=0.39) nor an interaction between 
them (F2,48=0.64, p=0.53). We then calculated the percentage preference for social 
novelty (time spent in the chamber with the novel animal over total time spent in 
chambers), and this result is shown in Fig 2.2D. Two-way ANOVA also showed no 
effect of lesion (F1,48=0.61, p=0.44), hippocampal sub-region (F2,48=0.45, p=0.64) 





Figure 2.2: Roles of dHi, iHi and vHi in sociability and preference for social 
novelty. A, all animals preferred to explore the chamber with the animal rather than 
the one with the object, however, dHi-lesion reduced the time spent in the chamber 
with animal in relation to dHi-sham group. B, all animals preferred to explore the 
chamber with the novel animal rather than the one with the familiar animal. C, the 
percentage preference for the animal was calculated as an index of sociability and 
no differences were found between groups. D, the percentage preference for the 
novel animal was calculated as an index of preference for social novelty and no 
differences were found between groups. *p<0.05, ***p<0.001, in relation to time 
spent in the chamber with the object; #p<0.05, in relation to sham group, according 
to Fishers LSD post-hoc test. 
 
2.3.1.2. Anhedonia and depressive-like behaviour are unaffected by dHi, iHi or vHi 
lesions 
The effects of hippocampal sub-region-specific lesions in the saccharin preference 
test is shown in Fig 2.3A-D. All experimental groups preferred the sweet solution. 
Two-way ANOVA revealed that there were no significant effects of lesion (12 h, 
F1,49=1.52, p=0.22; 24 h, F1,49=1.1, p=0.3; 36 h, F1,49=1.61, p=0.21; 48 h, F1,49=1.66, 




p=0.084; 36 h, F2,49=1.05, p=0.36; 48 h, F2,49=1, p=0.38), nor lesion x hippocampal 
sub-region interaction (12 h, F2,49=0.22, p=0.8; 24 h, F2,49=0.11, p=0.9; 36 h, 
F2,49=0.05, p=0.96; 48 h, F2,49=0.07, p=0.93) at any of the time points measured. 
 
The effects of hippocampal sub-region-specific lesions in the female urine sniffing 
test is shown in Fig 2.3E. All experimental groups spent more time sniffing urine 
than water. Two-way ANOVA revealed a significant main effect of lesion 
(F1,48=5.47, p=0.024) but no main effect of hippocampal sub-region (F2,48=0.2, 
p=0.82) nor a lesion x hippocampal sub-region interaction (F2,48=0.29, p=0.75). 
Although there was an overall effect of lesion, subsequent post hoc analysis did not 
reveal any statistically significant differences between individual groups. 
 
The effects of hippocampal sub-region-specific lesions on time spent immobile in 
the forced swim test (FST) is shown in Fig 2.3F. Two-way ANOVA revealed no 
significant effects of lesion (F1,49=0.06, p=0.81), hippocampal sub-region 






Figure 2.3: The lesion of any of the hippocampal sub-regions did not alter 
anhedonia or depressive-like behaviour. A-D, the lesion of the hippocampus did not 
alter the anhedonia in the saccharin preference test at different timepoints, 12 h 
(A), 24 h (B), 36 h (C) or 48 h (D). E, the lesion of the hippocampus did not alter 
anhedonia in the female urine sniffing test (FUST). F, the lesion of the hippocampus 
did not alter depressive-like behaviour in the forced swim test (FST). 
 
2.3.1.3. Lesions of the vHi (but not dHi or iHi) reduce anxiety  
The effects of hippocampal sub-region-specific lesions on anxiety were measured 




2.4A), the marble burying test (Fig 2.4B), the elevated plus maze (Fig 2.4C) and 
the open field (Fig 2.4D).  
 
In the novelty-induced hypophagia test (Fig 2.4A), two-way ANOVA revealed a 
significant lesion x hippocampal sub-region interaction (F2,47=5.73, p=0.006), and 
a main effect of hippocampal sub-region (F2,47=3.65, p=0.034) but no main effect 
of lesion (F1,47=0.5, p=0.48). Specifically, post hoc analysis showed that vHi lesions 
reduced latency to drink the sweet solution when compared with the vHi sham 
group (p=0.003).  
 
In the marble burying test (Fig 2.4B), two-way ANOVA revealed a significant main 
effect of lesion (F1,49=5.85, p=0.019), but no effect of hippocampal sub-region 
(F2,49=1.61, p=0.21), and no lesion x hippocampal sub-region interaction 
(F2,49=1.74, p=0.19). Specifically, post hoc analysis revealed that vHi lesions 
reduced the number of marbles buried when compared with the vHi-sham group 
(p=0.005). 
 
In the elevated plus maze (Fig 2.4C), two-way ANOVA revealed a significant 
lesion x hippocampal sub-region interaction (F2,49=3.67, p=0.033) and a main effect 
of hippocampal sub-region (F2,49=6.39, p=0.003) but not of lesion (F1,49=1.56, 
p=0.22). Specifically, post hoc analysis revealed that vHi lesions increased the 
percentage of time spent in the open arms when compared to the vHi-sham group 
(p=0.005). 
 
In the open field test (Fig 2.4D), two-way ANOVA revealed a trend towards a main 




region interaction (F2,49=3.57, p=0.036) but no main effect of hippocampal sub-
region (F2,49=1.83, p=0.17). Specifically, post hoc analysis revealed that vHi lesions 
increased the time spent in the centre of the open field when compared to the vHi 
sham group (p=0.002). 
 
4.3.1.4. Lesions of the dHi, iHi or vHi do not alter locomotor activity 
The effects of dHi, iHi and vHi lesions on distance travelled in the open field test 
are shown in in Fig. 2.4E. Two-way ANOVA revealed no effect of lesion 
(F1,49=0.39, p=0.54), hippocampal sub-region (F2,49=0.92, p=0.41), nor a lesion x 






Figure 2.4: The lesion of the vHi caused a decrease in anxiety in several 
behavioural tests, including A, the novelty-induced hypophagia test, B, the marble 
burying test, C, the elevated plus maze (EPM) and D, the time spent in the centre 
quarter of the open field. E, these results were not due to an increased locomotor 
activity in the open field. **p<0.01, in relation to its own sham group, according 
to Fishers LSD post-hoc test. 
 
2.3.2. The role of the dHi, iHi and vHi in antidepressant regulation of emotional 
behaviours and neuroendocrine response  
When assessing the roles of the dHi, iHi and vHi under basal conditions, we 
observed that vHi lesions affected anxiolytic behaviours. Our previous studies 
(Levone et al., unpublished) also found that the vHi but not other sub-regions 
regulated anxiety behaviour in the open field test as well as antidepressant-like 




stress-induced anhedonia in the saccharin preference test. Given that such 
behaviours are modulated by chronic antidepressant treatment, we then sought to 
investigate whether lesions of the vHi, and also dHi or iHi affect antidepressant-
induced changes in anxiety and depressive-like behaviour as well as the 
corticosterone response to acute stress. 
 
2.3.2.1. Only vHi lesions prevent the antidepressant effects of acute fluoxetine 
treatment in the tail suspension test (TST) 
The effects of acute (30 min after the first injection) fluoxetine or saline on 
immobility in the tail suspension are shown in Fig 2.5. One-way ANOVA revealed 
a main effect of fluoxetine (F6,57=13.02, p<0.001). However, subsequent post hoc 
analysis revealed that fluoxetine-induced decreases in immobility were prevented 
in vHi-lesioned animals (p=0.1 vs sham-saline group; all other groups p<0.001 vs 
sham-saline group). The fluoxetine-treated vHi-lesion group also exhibited higher 
immobility when compared to the fluoxetine-treated vHi-sham group (p<0.001).  
 
Figure 2.5: Animals treated with acute fluoxetine (FLX) showed a decrease in the 
immobility time in the tail suspension test. However, vHi lesion prevented this 
fluoxetine effect. ***p<0.001, in relation to sham-saline group; ###p<0.001, in 





2.3.2.2. Lesions of the vHi prevent the anxiolytic effects of chronic fluoxetine 
treatment in the novelty-induced hypophagia test but not in the marble burying test 
nor the open field test 
The effects of chronic fluoxetine treatment and hippocampal sub-region-specific 
lesions on latency difference to drink milk in the novelty-induced hypophagia test 
are shown in Fig 2.6A. One-way ANOVA revealed a main effect of fluoxetine 
(F6,58=4.91, p<0.001). Subsequent post hoc analysis revealed that chronic 
fluoxetine reduced the latency difference in all sham groups when compared to the 
sham-saline group (dHi sham, p<0.001; iHi sham, p=0.001; vHi sham, p=0.001). 
This anxiolytic effect was unaffected by dHi lesions (p=0.002 vs sham saline) 
although it was somewhat attenuated by iHi lesions (p=0.055 vs sham saline). On 
the other hand, vHi-lesions prevented fluoxetine-induced reduction in anxiety in 
this test (p=0.78 vs sham saline). The latency in the fluoxetine treated vHi-lesion 
group was also significantly longer than the fluoxetine-treated vHi-sham group 
(p=0.004). 
 
The effects of chronic fluoxetine treatment and hippocampal sub-region-specific 
lesions in the marble burying test are shown in Fig 2.6B. One-way ANOVA 
revealed a main effect of fluoxetine (F6,57=32.73, p<0.001). Subsequent post hoc 
analysis revealed that fluoxetine significantly reduced the number of marbles buried 
in all groups when compared to the sham-saline group (all p<0.001).  
 
The time spent exploring the centre of the open field is shown in Fig 2.6C. 
Fluoxetine had no effect in this measure of anxiety (F6,57=0.53, p=0.78). We also 








Figure 2.6: Fluoxetine showed an anxiolytic effect in the novelty-induced 
hypophagia and marble burying tests. However, vHi lesion prevented these effects 
in the novelty-induced hypophagia test (A), but not in the marble burying test (B). 
Fluoxetine did not show an effect on the time spent in the centre of the open field 
(C) or on the locomotor activity (D). **p<0.01, ***p<0.001, in relation to sham-
saline group; ##p<0.01, in relation to vHi-sham group, according to Fishers LSD 
post-hoc test. 
 
2.3.2.3. Fluoxetine had no effect in the female urine sniffing test 
In the female urine sniffing test, the percentage of preference for urine over water 
was measured and the results shown in the Fig 2.7A. Fluoxetine did not exert any 





2.3.2.4. Lesions of the iHi only prevent the antidepressant effects of chronic 
fluoxetine in the forced swim test 
The effects of chronic fluoxetine treatment and hippocampal sub-region-specific 
lesions on immobility in the forced swim test are shown in Fig 2.7B. There was a 
significant effect of fluoxetine in this test (F6,57=5.67, p<0.001). Specifically, post 
hoc analysis revealed that, when compared with the sham saline group, fluoxetine 
decreased immobility in all other sham groups (sham dHi, p=0.003; sham iHi, 
p=0.001; sham vHi, p<0.001) and that this was (p=0.003, <0.001, 0.001, <0.001, 
<0.001), and this was unaffected by lesions of the dHi (p<0.001) and the vHi 
(p<0.001). However, iHi lesions prevented fluoxetine induced reductions in 
immobility in this this test (p=0.17 vs sham saline). In addition, the fluoxetine-
treated iHi-lesion group exhibited higher immobility time when compared to the 
fluoxetine-treated iHi-sham group (p=0.028). 
 
 
Figure 2.7: A, fluoxetine showed no effect in the female urine sniffing test (FUST), 
but showed an antidepressant effect in the forced swim test (FST), which was 
mediated by the lesion of the iHi (B). **p<0.01, ***p<0.001, in relation to sham-






2.3.2.5. Lesions of the dHi amplified stress-induced increases in corticosterone 30 
min after the forced swim test 
The effects of fluoxetine on plasma corticosterone concentrations 30 mins before 
the FST and 30 min and 120 min after the FST are shown in Fig 2.8. Two-way 
repeated measures ANOVA revealed an overall effect of timepoint (F2,57=415.4, 
p<0.001), but no effect of treatment (F6,57=1.81, p=0.11) and no interaction between 
them (F12,57=1.33, p=0.21). Post hoc analysis at each timepoint revealed that the 
concentration of corticosterone increased 30 min after the FST in all groups in 
comparison to baseline (all p<0.05). This swim stress-induced increase in 
corticosterone at the 30 min timepoint was greater in fluoxetine-treated animals in 
comparison to sham-saline animal (p<0.05 for dHi-sham, dHi-lesion, iHi-sham and 
vHi-sham vs sham-saline), except for iHi-lesioned and vHi-lesioned groups.  
 
 
Figure 2.8: Fluoxetine-treated animals had an increase in the corticosterone 
release 30 min after the FST in comparison to sham-saline group, which is 






Understanding the circuits underlying antidepressant action may result in novel 
insights into developing newer therapies for depression. Therefore, this study 
highlights differential roles for the dHi, iHi or vHi on the regulation of social, 
anxiety and depressive-like behaviour in the absence or presence of the 
antidepressant fluoxetine.  
 
Although the hippocampus has been shown to be involved in social behaviour 
(Montagrin et al. 2017) we found that none of the hippocampal sub-region-specific 
lesions affected sociability or preference for social novelty in the 3-Chamber test. 
This is in contrast with previous studies, which support a role for the vHi in social 
behaviour. Indeed, neonatal vHi lesions have been shown to cause deficits in social 
behaviour in rats in adulthood (Sams-Dodd et al. 1997). On the other hand, it has 
been reported that vHi lesions in adulthood increase social behaviour in the social 
interaction test in rats (Bannerman et al. 2002, McHugh et al. 2004). More recently, 
glutamatergic neuronal projections of the basolateral amygdala to the vHi have also 
been shown to modulate social behaviour in the social interaction test in C57BL/6 
mice while inhibition of this pathway increased social interaction (Felix-Ortiz and 
Tye 2014). Similarly, it has been reported that vHi CA1 projections to nucleus 
accumbens store social memory in the social discrimination test in C57BL/6 mice 
(Okuyama et al. 2016). The reasons underlying our conflicting data are unclear but 
may be due to differences in the methodological approaches used such as the 
boundary definition of the vHi. In the present study, we defined the vHi as the most 
ventral third of the hippocampus and the lesion of this area on its own did not affect 
social behaviour; while the other lesion studies defined the vHi as the most ventral 




Okuyama et al. 2016). Alternatively, our findings may be test-specific effect, as 
none of the published studies used the three-chamber test to assess social behaviour 
per se.  
 
In the present study, we demonstrated that lesions of the vHi but not of the dHi or 
iHi robustly reduced anxiety in the elevated plus maze, novelty-induced 
hypophagia, marble burying and open field tests in mice. In agreement with 
previous findings in rats, dHi lesions did not alter anxiety-like behaviours 
(Bannerman et al. 2002, Bannerman et al. 2003, Bannerman et al. 2004). Our 
findings of vHi modulation of anxiety are in agreement with previous reports, which 
showed that vHi lesions in rats reduced hyponeophagia (Bannerman et al. 2002, 
Bannerman et al. 2003, McHugh et al. 2004) and decreased anxiety behaviour in 
the light-dark box (Bannerman et al. 2002, Bannerman et al. 2003, McHugh et al. 
2004), the elevated plus maze (Kjelstrup et al. 2002) and in the cat-odour test 
(Pentkowski et al. 2006). Many of these studies defined the ventral hippocampus 
as the most ventral half of the hippocampus, and the dorsal hippocampus as the 
most dorsal half (Bannerman et al. 2002, Kjelstrup et al. 2002, Bannerman et al. 
2003, McHugh et al. 2004). Given the increasing evidence supporting the 
hypothesis that the iHi may have discrete roles, it was important to determine its 
potential contribution to anxiety behaviour. Here, we show for what is to our 
knowledge the first time, that the modulation of anxiety behaviour is restricted to 
the most ventral third of the hippocampus, while the iHi and dHi lesions did not 
affect anxiety-like behaviour. Recent optogenetic studies have provided insight into 
the neural pathways that may underlie the role of the vHi in modulating anxiety. 
Optogenetic inhibition of glutamatergic projections from the basolateral amygdala 




field test while stimulation of this pathway increases anxiety in this test (Felix-Ortiz 
et al. 2013). In addition, others have shown that the vHi and the medial prefrontal 
cortex (mPFC) exhibit synchronised activity in response to anxiogenic stimuli 
(Adhikari et al. 2010, Adhikari et al. 2011), and that inhibition of the vHi to mPFC 
pathway in 129SvevTac mice decreases anxiety in the open field (Padilla-Coreano 
et al. 2016). Another study has demonstrated that vHi projections to lateral septum 
and medial prefrontal cortex mediate anxiety in the elevated plus maze, novelty 
suppressed feeding and open field tests in C57BL/6 mice (Parfitt et al. 2017). In 
fact, they found that the activation of the vHi to lateral septum pathway reduced 
anxiety and its inhibition increased anxiety; interestingly, manipulation of vHi to 
medial prefrontal cortex resulted in opposite effects (Parfitt et al. 2017). Taken 
together, we hypothesise that in the present study, the removal of vHi influences to 
or from these brain regions may have caused the observed anxiolytic profile.  
 
In the present study, we found that none of the hippocampal sub-region lesions 
affected anhedonia (in the saccharin preference and female urine sniffing tests), or 
depressive-like behaviour in the forced swim test, or locomotor activity in the open 
field. Few studies have described the roles of sub-regions of the longitudinal axis 
of the hippocampus in anhedonia or depressive-like behaviour (Carreno et al. 
2016). However, we have previously found (Levone et al., unpublished; Chapter 3) 
that chronic stress induced-anhedonia was prevented by the lesion of the dHi and 
vHi, but not iHi, in the saccharine preference test and reduced anxiety novelty-
induced hypophagia, which are test sensitive to chronic antidepressant treatment. 
Interestingly, optogenetic and chemogenetic activation of the vHi to medial 
prefrontal cortex pathway mimicked the antidepressant effects of ketamine in the 




alter behaviour in tests of anxiety which are sensitive to chronic antidepressant 
treatment, we next investigated the roles of each hippocampal sub-region in the 
antidepressant and anxiolytic effects of fluoxetine.  
 
In agreement with previous studies, we found that in sham mice, chronic fluoxetine 
treatment had anxiolytic effects in the novelty-induced hypophagia test (Santarelli 
et al. 2003, Dulawa et al. 2004, Dulawa and Hen 2005), and in the marble burying 
test (Nicolas et al. 2006, Greene-Schloesser et al. 2011). However, we did not 
observe an anxiolytic effect of fluoxetine in the open field. vHi lesions prevented 
the anxiolytic effects of chronic fluoxetine treatment in the novelty-induced 
hypophagia test but not in the marble burying test. The reasons underlying this 
differential effect are currently unclear but may indicate that fluoxetine-induced 
anxiolytic effects occur through different mechanisms or different pathways in 
these two tests.  
 
Considering that anxiety is modulated by the vHi, under influence of diverse brain 
regions including the amygdala (Felix-Ortiz et al. 2013) and the medial prefrontal 
cortex (Adhikari et al. 2010, Adhikari et al. 2011, Padilla-Coreano et al. 2016), the 
diverse effects observed in different behavioural tests in the present study may be 
due to the recruitment of differential neural pathways for different tests. Indeed, 
these tests may measure different aspects of anxiety, for example, the marble 
burying test is also used as a test for compulsive obsessive behaviour (Thomas et 
al. 2009). Moreover, vHi pathways have been shown to modulate other behaviours, 
e.g. the vHi to lateral septum pathway was shown to regulate feeding behaviour 





We found that vHi lesions prevented the antidepressant effects of acute fluoxetine 
treatment in the tail suspension test (TST). In agreement, acute fluoxetine treatment 
has been shown to reduce immobility time in the TST (Cryan et al. 2005, O'Leary 
et al. 2007, O'Leary 2009, Liu et al. 2010). To the best of our knowledge, this is the 
first time that the vHi is shown to mediate the antidepressant effects of acute 
fluoxetine treatment. 
 
Chronic fluoxetine treatment decreased immobility in the FST in all sham animals, 
which is in agreement with previous studies in rats (Contreras et al. 2001, Vazquez-
Palacios et al. 2004), and in BALB/c, but not C57BL/6 mice (Cryan et al. 2002, 
Dulawa et al. 2004). Here, we showed that iHi lesions prevented the antidepressant 
effects of chronic fluoxetine in the forced swim test. This is to our knowledge the 
first time that the iHi has been shown to play a role in the antidepressant effects of 
fluoxetine. Others have reported that chemogenetic activation of the vHi to medial 
prefrontal cortex pathway is required for the sustained antidepressant-like effects 
of a single dose of ketamine in this test in rats (Carreno et al. 2016). In contrast, we 
did not observe an effect of vHi lesions on fluoxetine antidepressant effects in the 
FST. The mechanisms underlying the effects of iHi lesion on antidepressant effects 
of chronic fluoxetine treatment are unknown. We then investigated whether there 
may be a possible relationship with FST-induced modulation of corticosterone. We 
found that, similarly to other studies in female mice (Machado et al. 2012), chronic 
fluoxetine significantly increased stress-induced increase in plasma corticosterone 
in most groups. However, this effect was not significant in both the iHi and vHi 
lesioned groups. Thus, changes in FST-induced increases in plasma corticosterone 
do not correlate with the behavioural phenotype observed in the FST. An alternative 




behavioural effects of fluoxetine may include role of adult hippocampal 
neurogenesis. Interestingly, a recent study that divided the hippocampus into 12 
individual sub-regions found that the effects of fluoxetine on the proliferation of 
hippocampal stem cells occurred specifically in the area in which the iHi transits to 
the vHi, thus including both iHi and vHi (Zhou et al. 2016). This raised the 
possibility that fluoxetine increases neurogenesis in the iHi to produce its 
antidepressant effects in the FST. However, such effects of the iHi were not 
apparent in the NIH, a test known to be dependent on adult hippocampal 
neurogenesis. In addition, it has been reported that the antidepressant effects of 
fluoxetine in the forced swim test are neurogenesis-independent in C57BL/6 mice 
(David et al. 2009), although in this study neurogenesis was inhibited in the whole 
hippocampus, and the specific roles of discrete hippocampal sub-region were not 
assessed. Interestingly, we also speculate that the effects of iHi lesion could be due 
to a disconnection between the dHi and vHi and the disruption of the coherence 
between these other two sub-regions. 
 
In summary, we have shown in the present study for what is to our knowledge the 
very first time that the iHi is involved in the antidepressant and anxiolytic effects 
of chronic fluoxetine. Moreover, we illuminate a novel role for the ventral third of 
the hippocampus in anxiety behaviour, while dHi and iHi seem not to be involved. 
For the very first time, we show that the vHi mediates the antidepressant effects of 
acute fluoxetine and the anxiolytic effects of chronic fluoxetine treatment. Here, we 
suggest that the iHi and vHi sub-regions of the hippocampus are promising targets 
for studies aimed at identifying novel biochemical or molecular targets for 
antidepressant and anxiolytic drug development and that such future studies should 




future studies using a greater sample number should consider grouping the animals 





























Sub-Regions of the Longitudinal Axis of the Hippocampus Mediate 
Specific Behavioural Responses to Chronic Psychosocial Stress 
 
 
Brunno Rocha Levone1, John F. Cryan1,2, Olivia F. O’Leary1,2* 
 
1 Department of Anatomy and Neuroscience, University College Cork, Cork, 
Ireland. 
2 APC Microbiome Ireland, University College Cork, Cork, Ireland. 
 















Accumulating evidence suggests that the hippocampus is functionally segregated 
along its longitudinal axis into a dorsal region (dHi) and a ventral region (vHi). 
Some studies now also suggest that the intermediate hippocampus (iHi) might also 
be functionally independent. However, the roles of these three sub-regions in the 
response to chronic stress, a risk factor for depression and anxiety disorders, has 
not yet been investigated. First, we examined if there was heterogeneity in the 
expression of stress-related genes along the longitudinal axis of the hippocampus. 
Next excitotoxic lesions of the dHi, iHi or vHi in male C57BL/6 mice were used to 
investigate the roles of these sub-regions in the behavioural (anxiety, anhedonia, 
depression) and corticosterone responses to chronic psychosocial stress. RNAseq 
analysis revealed sub-regional differences in the expression of stress-related genes. 
iHi lesions increased stress-induced social avoidance. Stress-induced increases in 
anxiety in the novelty-induced hypophagia and marble burying tests were prevented 
by all lesions however, only vHi lesions attenuated stress-induced anxiety in the 
open field. Stress-induced anhedonia was reduced in dHi- and vHi- but not iHi- 
lesioned mice. Only vHi lesions induced an antidepressant effect in the forced swim 
test and reduced agonistic behavioural responses during social defeat. Although, all 
hippocampal sub-regions are involved in the anxiogenic effects of chronic stress, 
here we describe what is to our knowledge for the first time a role for the iHi in 
stress-induced social avoidance and the vHi in antidepressant-like behaviour under 







The hippocampus is known to play a role in spatial learning and memory (O'Keefe 
and Dostrovsky 1971, O'Keefe 1976, Morris et al. 1982, O'Keefe and Speakman 
1987, Moser et al. 1995, O'Keefe et al. 1998, Moser et al. 2008), anxiety (Moser 
and Moser 1998, Bannerman et al. 2002, Bannerman et al. 2003, Bannerman et al. 
2004, Mineur et al. 2006, Allsop et al. 2014, Jimenez et al. 2018) and the stress 
response (McEwen et al. 1992, Herman and Cullinan 1997, Buchanan et al. 2009, 
Ulrich-Lai and Herman 2009, Herman et al. 2016, Sousa 2016). Precisely how the 
hippocampus plays such diverse functions is not completely understood. However, 
accumulating evidence suggests that the hippocampus may be segregated along its 
longitudinal axis into dorsal and ventral regions in rodents and corresponding 
posterior and anterior regions in primates (Moser and Moser 1998, Fanselow and 
Dong 2010). 
 
Anatomical studies in rats have shown that the afferent and efferent connections of 
the hippocampus change from dorsal to ventral poles (Swanson and Cowan 1977). 
In rodents, the vHi is more predominantly anatomically connected with brain 
regions involved with anxiety and response to stress (e.g. amygdala, hypothalamus 
and medial prefrontal cortex), while the dHi is predominantly anatomically 
connected to brain regions associated with spatial learning and memory such as the 
retrosplenial cortex (Fanselow and Dong 2010, Strange et al. 2014). Such 
anatomical evidence for potential functional segregation is further supported by 
electrophysiological studies which have reported that there is a greater density of 
place fields in the dHi than in the vHi, and that the place fields in the vHi are 
functional, but less selective for specific locations than those in the dHi (Jung et al. 




hippocampus have suggested that there is heterogeneity in gene expression between 
dHi and vHi (Leonardo et al. 2006, Thompson et al. 2008, Dong et al. 2009, 
Christensen et al. 2010, Strange et al. 2014). Moreover, lesion studies have reported 
a functional dissociation of the hippocampus, whereby lesions of the vHi, but not 
dHi attenuated anxiety behaviour in rats, tested in the light-dark box (Bannerman 
et al. 2003), elevated plus maze (Kjelstrup et al. 2002), hyponeophagia (Bannerman 
et al. 2002, Bannerman et al. 2003) and open field tests (Bannerman et al. 2003). 
On the other hand, dHi lesions but not vHi lesions impaired spatial learning and 
memory in rats (Moser et al. 1995, Bannerman et al. 2002, Pothuizen et al. 2004). 
Such preclinical studies are also supported by neuroimaging studies in humans 
(Maguire et al. 1997, Maguire et al. 2000, Burgess et al. 2002) and non-human 
primates (Colombo et al. 1998) and suggest that the posterior hippocampus 
(corresponding to the dorsal in rodents) is implicated in spatial learning and 
memory (Colombo et al. 1998, Maguire et al. 2000, Poppenk et al. 2013), whereas 
the anterior hippocampus (ventral in rodents) is recruited under stressful conditions 
(Weerda et al. 2010).  
 
While there is now a growing body of evidence of a functional segregation of the 
hippocampus into the dHi and the vHi, genomic heterogeneity in rodents 
(Thompson et al. 2008, Strange et al. 2014), and neurofunctional differences in 
humans (Robinson et al. 2015) have been shown to occur along the longitudinal 
axis of the hippocampus. It is now also suggested that that the area between the dHi 
and the vHi, the intermediate hippocampus (iHi), may also be functionally 
independent although only a few studies have investigated the functional roles of 
the iHi and this has been in the context of place learning (Bast 2007, Bast et al. 





Drug development for stress-related psychiatric disorders has been hampered by 
our lack of understanding of the processes in the brain that play a critical role in the 
pathophysiology of depression, anxiety, and the behavioural responses to stress. 
While much attention has been paid to the potential role of the hippocampus in this 
regard, relatively few studies have interrogated the potential contribution of specific 
regions along its longitudinal axis. Nevertheless, there is a growing body of 
evidence that the dHi and vHi are differentially regulated in response to stress. For 
example, it has been reported that the dHi and vHi have distinct epigenetic 
responses to acute stressors (Floriou-Servou et al. 2018) and it has been reported 
that chronic stress causes atrophy of apical dendrites in the CA1 and CA3 of the 
dHi, while stress increases the density of apical dendrites in the CA3 of the vHi 
(Pinto et al. 2015). In addition, several studies have reported that the impact of 
stress on adult hippocampal neurogenesis is frequently more apparent in the vHi 
than the dHi (Tanti and Belzung 2013, O'Leary and Cryan 2014, Levone et al. 
2015). Moreover, we recently reported that neurons differentiated from neural 
progenitor cells derived from the vHi are more sensitive to corticosterone-induced 
reductions in neuronal differentiation and maturation than those derived from the 
dHi (Levone et al., in preparation; Chapter 4). Taken together, it is clear that stress 
seems to differentially impact the dHi and vHi however to date no studies have 
investigated the potential differential roles of the dHi, iHi and vHi in the 
behavioural responses to chronic stress. Thus, in the present study, we first 
investigated if there is a heterogeneity in the expression of genes associated with 
stress, anxiety, depressive-like behaviour or antidepressant action along the 
longitudinal axis of the hippocampus of mice. We then used ibotenic acid-induced 




stress-induced changes in anxiety (novelty-induced hypophagia, marble burying 
and open field tests), anhedonia and depressive-like behaviour (saccharin 
preference and female urine sniffing tests) and antidepressant-like behaviour 





3.2. Methods and Materials 
 
3.2.1 Gene expression analysis of “Hipposeq” database 
A RNAseq database from the Janelia Research Campus (http://hipposeq.janelia.org) 
(Cembrowski et al. 2016) was used to investigate whether any stress-related genes 
are differentially expressed along the longitudinal axis of the dentate gyrus and CA1 
regions of the mice hippocampi. For the dentate gyrus, data from the dorsal and 
ventral regions were available and for the CA1, dorsal, intermediate and ventral 
regions were available. To generate this database, the authors had used transgenic 
mice to fluorescently label the populations of hippocampal principal cells of 
interest, euthanised the animals at P25-P32 and dissected the cells from brain slices. 
Three samples were obtained per dataset and the RNA was isolated, cDNA 
amplified and sequenced showing the output as FPKM (fragments per kilobase of 
exon per million reads mapped). The false discovery rate cutoff used was of 5%, 
for more details, please see Cembrowski et al., 2016 (Cembrowski et al. 2016).  
 
We selected 175 genes for analysis based on their previous links to stress and 
emotional behaviour or their regulation by antidepressants. These genes included 
neurotransmitter receptors and transporters, growth factors, and genes related to 
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Hhip, Stx1a, Il1b, 
Il6, Rgs2 
Rgs2↓ None None None 
 
3.2.2. Experimental design of behavioural studies 
Ibotenic-induced lesions of the dHi, iHi and vHi of the mouse hippocampus were 




following surgery, some sham animals (sham-stress) and all lesioned animals 
underwent a daily psychosocial stress paradigm consisting of an unpredictable 
schedule (Fig 3.1B) of intermittent social defeat/overcrowding for 19 days (Reber 
et al. 2006, Finger et al. 2011) prior to the start of behavioural testing and 
corticosterone measurements (Fig 3.1B). Daily social defeat stress continued 
throughout the behavioural testing period unless the animal was undergoing a 
behavioural test on that particular day. Control mice (sham-no stress group) were 
left undisturbed in their homecage, being handled only three times per week either 
for cage changing or for weighing. The experimental groups, sample number (after 
surgery corrections), surgery success rate and number of misplaced (excluded) 
animals were: (1) sham-no stress, n = 9 (100% success, 0 excluded); (2) sham-
stress, n = 10 (100% success, 0 excluded); (3) dHi lesion-stress, n = 9 (75% success, 
3 excluded); (4) iHi lesion-stress, n = 8 (80% success, 2 excluded) and (5) vHi 
lesion-stress, n = 8 (50% success, 8 excluded).  
 
3.2.3 Animals  
Male C57BL/6 mice (Envigo, UK) aged 8-weeks old, were housed in groups of 3-
4 at arrival in a temperature controlled (21±2°C) room and allowed to acclimatise 
to the holding room for 7-days prior to surgery, after which they were singly housed. 
Laboratory chow and water were provided ad libitum on a 12/12 h light/dark cycle 
(lights on at 7:30 am). All procedures were conducted with approval from the 
Animal Experimentation Ethics Committee (AEEC) at University College Cork, 
under Individual Authorisations and a Project Authorisation approved the Health 
Products Regulatory Authority (HPRA) Ireland and in accordance with the 






3.2.4. Stereotaxic brain surgery and excitotoxic lesion of the dorsal, intermediate of 
ventral hippocampus  
Mice (20-26g) were anaesthetised with isoflurane (5% induction, 1.7-2.5% 
maintenance) and received analgesia (5mg/kg, s.c., Carprofen, Norbrook,) prior to 
being placed in a stereotaxic frame. As shown in Fig 3.1C, small volumes (0.15-0.2 
µl) of ibotenic acid (10 mg/ml, I2765, Sigma-Aldrich) diluted in PBS (pH 7.4) were 
injected bilaterally into either the dHi, iHi or vHi using coordinates from the 
Paxinos and Franklin’s atlas for mouse brain (Paxinos 2012). Sham surgeries 
involved opening holes at the relevant areas of the skull but not injecting anything. 
Holes in the skull were covered with Bone-Wax (SMI, Z046) and the skin was 
sutured (W329, Mersilk Suture 4-0). An analgesic (20 µg/ml, Carpofen, Norbrook,) 
was added to the drinking water for 2 days post-surgery. All animals were singly 
housed after surgery and allowed to recover for 1 week prior to the initiation of the 
stress paradigm. 
 
At the end of the experiment, mice were deeply anaesthetised with pentobarbital 
(250mg/kg, i.p., Euthanal, Merial,) and transcardially perfused with PBS followed 
by 4% PFA. Brains were removed, post-fixed in 4% PFA overnight, cryoprotected 
in 30% sucrose and then frozen at -80°C. Brains were sectioned coronally (at 35 
µm) through the entire rostro-caudal axis of the hippocampus and collected onto 
gelatinised slides. Sections were stained with cresyl violet (C5042, 0.1%, Sigma-
Aldrich). Lesions were identified by light microscopy examination by an 
experimenter blind to the experimental treatment groups. Only animals with 






Figure 3.1: Definition of the hippocampal sub-regions: dorsal (dHi), intermediate 
(iHi) and ventral (vHi). A, a schematic image of the dHi, iHi and vHi, with the 
coordinates according to the Paxinos atlas for mice brain (in relation to bregma). 
B, timeline of the experiment, including the surgery, psychosocial stress and 
behavioural tests. C, surgery coordinates and volume of ibotenic acid injected 
(bilaterally). D, images of cresyl violet-stained slices showing the dHi, iHi and vHi 
lesions. Abbreviations: AP: anteroposterior, DEX: dexamethasone suppression 
test, DV: dorsoventral, FST: forced swim test, FUST: female urine sniffing test, L: 
lateral, MBT: marble burying test, NIH: novelty-induced hypophagia, OC: 
overcrowding, OF: open field, SD: social defeat, SI: social interaction test, SP: 





3.2.5. Chronic psychosocial stress paradigm 
The chronic psychosocial stress paradigm consisted of 19 days of alternating 
between social defeat and overcrowding (Fig 3.1B). In the social defeat sessions, 
male C57BL/6 mice were placed into the homecage of an aggressive male CD1 
mouse and their interaction was allowed until the C57BL/6 mouse adopted a defeat 
posture. Upon the first defeat within each session, mice were immediately 
physically separated from each other by a perforated plexiglass wall (that allows 
visual, olfactory and auditory contact) for two hours, after which the separator was 
removed, and another social defeat session took place until the C57BL/6 mouse 
assumed a defeat posture. Animals were then separated and returned to their 
homecage. For the overcrowding sessions, C57BL/6 animals (n=9-10) were housed 
in one standard holding cage for either 24 or 48 h (Fig 3.1B). Control animals were 
singly housed and handled three times per week. 
 
3.2.6. Social Interaction Test (SI) 
Twenty-four hours after the last stressor (experimental day 26), social avoidance 
behaviour was assessed using the social interaction test. Previous studies have 
shown that chronic psychosocial stress paradigms that use social defeat stress 
decrease social interaction (Berton et al. 2006, Finger et al. 2011, Golden et al. 
2011, O'Leary et al. 2014). Mice were placed into a plastic box (31×39 cm3) 
containing an empty wire mesh cage (9.5×7.5 cm2) and allowed to explore for 2.5 
min. The test was conducted under red light to reduce interference of general 
anxiety-like behaviour with social interaction behaviour. The mouse was then 
removed and transferred back to its homecage for 1 minute, while an unfamiliar 
CD1 mouse (social target) was placed into the wire mesh cage. The test mouse was 




2.5 min. At the end of the test, both mice were transferred back to their respective 
homecages and the arena and mesh cage were cleaned with 70% ethanol. All data 
were analysed using the software Ethovision 11.5. Results are expressed as the 
interaction ratio (time spent in the interaction zone) in the presence of a social target 
divided by time in spent in the interaction zone in the absence of a social target). 
Corners ratio was also assessed as a measure of social avoidance (time spent in the 
corners of the box in the presence of a social target divided by time spent in the 
corners in the absence of a social target), as socially stressed animals tend to spend 
more time in the corners, the farthest region of the social target. The distance 
travelled in the arena in the absence of the social target was also analysed as a 
measure of locomotor activity. 
 
3.2.7. Tests of anxiety.  
3.2.7.1. Novelty-induced hypophagia (NIH) 
The novelty-induced hypophagia test is a test of anxiety sensitive to chronic 
antidepressant treatment (Dulawa and Hen 2005, O'Leary et al. 2013). In this test, 
mice were trained to drink a diluted solution of sweetened condensed milk (3:1, 
water to milk) from a 10 ml serological pipette through the lid of their cage for 30 
minutes per day for 3 days. On the fourth day, the latency to drink the milk in their 
homecage was measured. On the fifth day, mice were placed in a novel brightly-lit 
cage (1200 lux) without bedding, and their latency to drink the milk was recorded. 
Placement in the novel cage increases the latency to drink the milk which is taken 
as an index of anxiety. The data are presented as latency difference (i.e. the latency 
to drink in the novel cage minus the latency to drink in the home cage). 
 




The marble burying test is a test used to measure phenotypes related to anxiety and 
obsessive compulsive-like behaviour (Deacon 2006). A cage (35 x 28 cm) was 
filled with clean corncob bedding overlaid with 20 glass marbles equidistant from 
each other in a 4×5 arrangement (Savignac et al. 2014). Mice were placed in the 
cage for 30 minutes and the number of marbles that are more than 2/3 buried were 
counted. An increase in the number of marbles buried is considered to be a proactive 
response to an anxiogenic stimulus and has also been described as a compulsive 
behaviour to relieve anxiety (Deacon 2006).  
 
3.2.7.3. Open field test (OF) 
The open field test consists of a rectangle box (perspex sides and base: 40 x 33 cm²) 
in a dimly lit room (4 lux). Mice were placed in the centre of the open field and 
allowed to explore the apparatus for 10 minutes. Locomotor activity was recorded 
by a camera placed over the open field and distance travelled was automatically 
analysed using Ethovision 11.5 software. The time spent in the centre quarter (10 x 
8.25 cm2) of the chamber was also measured as an index of anxiety behaviour. 
 
3.2.8. Tests of anhedonia 
3.2.8.1. Female Urine Sniffing Test (FUST) 
The female urine sniffing test assesses anhedonia (a reduction in the ability to 
experience pleasure) which is a core feature of depression and has been shown to be 
induced by chronic stress (Malkesman et al. 2010, Finger et al. 2011, O'Leary et al. 
2014). This test takes advantage of the fact that rodent males are attracted to 
pheromonal odours from the opposite sex and thus is used in male mice as an index 
of sexual interest. Before the test, mice were transferred to a dimly-lit (4 lux) room 




hour. Following habituation, mice were immediately presented with a cotton tip 
applicator with 60 µL of sterile water for a period of 3 minutes and the time spent 
sniffing the water was measured. 45 min later, a cotton tip with 60 µL of fresh urine 
from female mice in oestrus was presented to the mice for 3 minutes and the time 
spent sniffing the urine was measured. Data are presented as the percentage of time 
spent sniffing urine over the total time spent sniffing urine plus water. 
 
3.2.8.2. Saccharin preference test (SPT) 
The saccharin preference test (Harkin et al. 2002) was used as another test for 
anhedonia. Mice were given access to both a water bottle and a saccharin solution 
(0.1%) bottle for a total period of 48 h. Saccharin and water intake were measured 
every 12 hours (at 7:30 a.m. and 7:30 p.m. each day). Every 12 h, the position of 
the bottles was reversed to avoid the development of preference for drinking from 
a particular side of the cage. Mice normally show a preference to consume the 
saccharin over water although chronic stress decreases this preference for saccharin 
(Harkin et al. 2002). The data are expressed as the cumulative percentage 
preference for saccharin over water [(saccharin consumption volume/water 
consumption volume) * 100]. 
 
3.2.9. Test of antidepressant-like behaviour: The Forced Swim Test (FST) 
The forced swim test is the most widely used experimental paradigm to assess 
antidepressant drug-like activity (Porsolt et al. 1977, Cryan and Mombereau 2004). 
In this test, mice were allowed to swim for 6 min in a glass cylinder (24 × 21 cm) 
filled with water (23–25 °C) to a depth of 17 cm. The test was video-recorded and 




Antidepressant drugs decrease immobility in this test (Porsolt et al. 1977, Cryan 
and Mombereau 2004). 
 
3.2.10. Plasma corticosterone measurements and the dexamethasone test 
Blood was withdrawn from the tail vein to measure changes in concentrations of 
the stress hormone corticosterone before and after the acute stress of the forced 
swim test (FST) or following a dexamethasone suppression challenge (DEX).  
 
Blood was withdrawn 30 min before and again 30 and 120 min after the beginning 
of the FST. For the dexamethasone suppression test, mice were injected with 
dexamethasone (DEX, Sigma-Aldrich) and then two hours later, mice were acutely 
stressed by placement in a brightly lit cage with no bedding (1200 lux) for 5 min. 
Blood was withdrawn 15 min after the stressor (2h 15min after DEX) and then again 
1h 45min after the stressor (i.e. after four hours after DEX). Corticosterone 
concentrations of the blood sample taken 30 mins prior to the FST was used as time 
point 0 in both the FST and DEX datasets.  
 
Blood was centrifuged at 4000g for 15 min at 4°C. Plasma was removed and kept 
at -80°C until analysis. Plasma corticosterone was measured using an ELISA kit 
(ADI-901-097, Enzo) and light absorbance was read with a multi-mode plate reader 
(Synergy HT, BioTek Instruments, Inc.) at 405 nm. Samples were analysed in 
duplicate within a single assay and the minimum threshold of detection was less 
than 32 pg/mL. The limit for the coefficient of variation used was 20% and the final 
concentrations are expressed in ng/mL.  
 




Data is shown as mean + S.E.M. Statistical analysis was performed using the 
software IBM SPSS Statistics 23. Data were analysed using One-way ANOVA and 
when appropriate, followed by Fishers LSD post hoc test for group-wise 
comparisons. Two-way repeated measures ANOVA was used to compare different 
timepoints of corticosterone concentrations after the FST or dexamethasone 









3.3.1. Stress-related genes are differentially expressed along the longitudinal axis 
of the hippocampus 
 
3.3.1.1. Genes related to neurotransmitter systems, GR and MR function, growth 
factors and neurogenesis/plasticity were differentially expressed in the ventral 
dentate gyrus (vDG) versus the dorsal dentate gyrus (dDG) 
Of the 175 genes analysed, 38 (21.71%) were differentially expressed in the ventral 
dentate gyrus (vDG) versus the dorsal dentate gyrus (dDG), as shown in Fig 3.2A 
and Table 3.1. These included genes related to various neurotransmitter systems. 
Of those genes, the following were expressed at a lower level in the vDG when 
compared to the dDG: adenosine receptor A1, adrenergic receptor α1d, muscarinic 
receptor 1, nicotinic receptor β1, dopamine receptor D1, NMDA receptor 1, 
metabotropic glutamatergic receptors 2 and 3, serotonergic receptor 6. On the other 
hand, the following genes were expressed at a higher level in the vDG when 
compared to the dDG: nicotinic receptors α3, α4 and α6, dopamine transporter, 
GABA A receptor subunits α1 and α2, GABA transporters 1 and 3, NMDA receptor 
3A, glutamate transporter, serotonergic receptors 1a and 5b.  
 
Also, several genes related to glucocorticoid receptor (GR) and mineralocorticoid 
(MR) receptor function were differentially expressed in the vDG versus dDG. Of 
those, the mineralocorticoid receptor and serum/glucocorticoid regulated kinase 1 





Also, genes related to growth factors were differentially expressed in the vDG 
versus dDG. Of those, the following were expressed at a lower level in the vDG 
when compared to the dDG: fibroblast growth factor receptor 1, nerve growth factor 
and transforming growth factor ß2. On the other hand, the following genes were 
expressed at a higher level in the vDG when compared to the dDG: fibroblast 
growth factor 1, fibroblast growth factor receptor 2, multiple EFG-like domains 6 
and transforming growth factor ß receptor 1.  
 
Also, genes related to hippocampal neurogenesis were differentially expressed in 
the vDG versus dDG. Of those, the following were expressed at a lower level in the 
vDG when compared to the dDG: neuronal differentiation 2, neural cell adhesion 
molecule 1 and Notch1. On the other hand, the following genes were expressed at 
a higher level in the vDG when compared to the dDG: inhibitor of DNA binding 4, 
connective tissue growth factor 2, neural cell adhesion molecule 2 and Notch2. 
Finally, a gene previously related to chronic stress was differentially expressed in 
the vDG versus dDG. The Rgs2 gene was expressed at a lower level in the vDG 
when compared to the dDG. 
 
3.3.1.2. Genes related to neurotransmitter systems, GR and MR function, growth 
factors and plasticity were differentially expressed in the dorsal CA1 (dCA1) versus 
intermediate CA1 (iCA1) versus ventral CA1 (vCA1) 
Of the 175 genes analysed, 20 (11.43%) were differentially expressed in the vCA1 
versus dCA1, as shown in Fig 3.2B and Table 3.1. These included genes related to 
various neurotransmitters system. Of those genes, the following were expressed at 
a lower level in the vCA1 when compared to the dCA1: muscarinic receptor 3, 




2a and serotonergic receptor 1a. On the other hand, some genes were expressed at 
a higher level in the vCA1 when compared to the dCA1including: GABA A 
receptor subunit α3, GABA A receptor subunit β1, NMDA receptor 3a, AMPA 
receptor 4 and serotonergic receptors 2c and 5a. Also, a gene related to GR and MR 
function was differentially expressed in the vCA1 versus dCA1. The 
mineralocorticoid receptor was expressed at a lower level in the vCA1 when 
compared to the dCA1. 
 
Some genes related to growth factors were differentially expressed in the vCA1 
when compared to dCA1. Of those gene, the fibroblast growth factor 2 and BDNF 
were expressed at a lower level and the fibroblast growth factor receptor 3 and 
transforming growth factor ß2 were expressed at a higher level in the vCA1 when 
compared to dCA1. Finally, genes related to plasticity were differentially expressed 
in the vCA1 when compared to dCA1. Of those genes, neural cell adhesion 
molecules 1 and 2 were expressed at a higher level in the vCA1 when compared to 
dCA1. 
 
When we compared the dCA1 with the iCA1, the proportion of genes differentially 
expressed was much smaller than the dCA1 vs vCA1 comparisons. Of the 175 genes 
analysed, 4 (2.29%) were differentially expressed in the dCA1 versus the iCA1, as 
shown in Fig 3.2B and Table 3.1. These included genes related to various 
neurotransmitters system. Of those genes, the serotonergic receptor 1a was 
expressed at a lower level in the iCA1 when compared to the dCA1. On the other 
hand, some genes were expressed at a higher level in the iCA1 when compared to 
the dCA1, including the NMDA receptor 3A and metabotropic glutamatergic 




and, in this case, transforming growth factor β2 was expressed at a higher level in 
the iCA1 in comparison to dCA1. 
 
Similar to the dCA1 vs iCA1 comparisons, a much smaller proportion of genes were 
differentially expressed in the vCA1 vs iCA1 than what we observed in the dCA1 
vs vCA1 comparisons. Of the 175 genes analysed, 6 (3.43%) were differentially 
expressed in the vCA1 versus iCA1, as shown in Fig 3.2B and Table 3.1. These 
included genes related to various neurotransmitters system. Of those genes, GABA 
A receptor subunit α1 and NMDA receptor 2a were expressed at a lower level, while 
NMDA receptor 3a and serotonergic receptor 2c were expressed at a higher level 
in the vCA1 when compared to iCA1. Also, the BDNF gene was expressed at a 
lower level and the neural cell adhesion molecule 2 was expressed at a higher level 







Figure 3.2: Genes which are differentially expressed in mice, according to the 
“Hipposeq database”. A, between dorsal DG (dDG) and ventral DG (vDG), B, 
between dorsal CA1 (dCA1), intermediate CA1 (iCA1) and ventral CA1 (vCA1). 
Gene expression heatmaps are logged, green represents a lower expression while 
red, a higher expression. Genes names: Adora1: adenosine A1 receptor; Adra1d: 
adrenergic receptor α1d; Bdnf: brain derived neurotrophic factor; Ccnd2: cyclin 
D2; Chrm1: muscarinic receptor 1; Chrm3: muscarinic receptor 3; Chrna3: 
nicotinic receptor α3; Chrna4: nicotinic receptor α4; Chrna5: nicotinic receptor 
α5; Chrna6: nicotinic receptor α6; Chrnb1: nicotinic receptor ß3; Drd1a: 
dopaminergic receptor 1a; Fgf1: fibroblast growth factor 1; Fgf2: fibroblast 
growth factor 2; Fgfr1: fibroblast growth factor receptor 1; Fgfr2: fibroblast 
growth factor receptor 2; Fgfr3: fibroblast growth factor receptor 3; Gabra1: 
GABAergic receptor A subunit α1; Gabra2: GABAergic receptor A subunit α2; 
Gabra3: GABAergic receptor A subunit α3; Gabra4: GABAergic receptor A 
subunit α4; Gabrb1: GABAergic receptor A subunit ß1; Gria4: AMPA receptor 
subunit 4; Grin1: NMDA receptor subunit 1; Grin2a: NMDA receptor subunit 2A; 
Grin3a: NMDA receptor subunit 3A; Grm3: glutamate metabotropic receptor 3; 
Htr1a: serotonergic receptor 1a; Htr2c: serotonergic receptor 2c; Htr5a: 
serotonergic receptor 5a; Htr5b: serotonergic receptor 5b; Htr6: serotonergic 
receptor 6; Id4: inhibitor of DNA binding 4; Megf: multiple epidermal growth 
factor; Ncam1: neural cell adhesion molecule 1; Ncam2: neural cell adhesion 
molecule 2; Neurod2: neuronal differentiation 2; Nr3c2: mineralocorticoid 
receptor; Rgs2: regulator of G protein signalling 2; Sgk1: serum/glucocorticoid 
regulated kinase 1; Slc1a4: glutamate transporter; Slc6a1: GABA transporter 1; 
Slc6a11: GABA transporter 3; Slc6a3: dopamine transporter; Tgfb2: transforming 
growth factor ß2; Tgfbr1: transforming growth factor receptor ß1; Vgf: nerve 





3.3.2. Lesions of the iHi exacerbate stress-induced social avoidance, while vHi 
lesions increase the latency to assume a defeated posture during the first exposure 
to social defeat  
The effects of sub-region-specific lesions on stress-induced reductions in social 
interaction are shown in Fig 3.3A. One-way ANOVA revealed an overall effect on 
the social interaction ratio (F4,39=12.24, p<0.001). Specifically, post hoc analysis 
revealed that stress decreased the social interaction ratio in the sham group and in 
all lesion groups when compared to the non-stressed sham group (all p<0.001). 
Interestingly however, the stress-induced reductions in the social interaction ratio 
were exacerbated in the iHi-lesioned (p=0.021) mice when compared with the 
stressed sham group (Fig 3.3A). Moreover, one-way ANOVA also revealed an 
overall effect on the corners ratio (F4,39=6.83, p<0.001; Fig 3.3B) whereby stress 
increased the corner ratio in iHi-lesioned mice only when compared with both the 
non-stressed and stressed sham groups (both p<0.001, Fisher’s LSD). Similarly, the 
corners ratio was also higher in the iHi lesioned group when compared with the dHi 
(p=0.003) and vHi lesioned groups (p=0.006). Locomotor activity measured in the 
absence of the social target was not different between treatment groups (F4,39=0.9, 
p=0.48; Fig 3.3C). 
 
As described previously (Krishnan et al. 2007), we also classified mice as 
susceptible or resilient to stress, based on their interaction ratio. Animals were 
classified as resilient when they had an interaction ratio >1, and as susceptible if the 
interaction ratio was <1. In the present study, the proportion of animals susceptible 
to stress was highest in the iHi-lesion-stress and vHi-lesion-stress groups (100% 
were susceptible), followed by the dHi-lesion-stress group (88.9% were 





We also analysed the latency to adopt a defeat posture during the first social defeat 
of each day during all the social defeat sessions included in the 19-days protocol 
previous to the start of the behavioural tests (Fig 3.1). We calculated the average 
latency for the first social defeat, for the second (which took place 2 h after the first) 
and an average of both. The average latency for the defeated posture on the first 
social defeat is shown in Fig 3.3D. One-way ANOVA revealed a main effect 
(F3,31=4.11, p=0.015). Post hoc analysis revealed that vHi-lesioned animals took a 












Figure 3.3: Social interaction test and latency to assume defeated posture. A, stress 
induces social avoidance, reducing interaction ratio. B, iHi lesion increases social 
avoidance, increasing corners ratio. C, stress and/or hippocampal lesions did not 
alter exploration of the social interaction chamber. D, average latency to assume a 
defeated posture in the first social defeat session is increased in vHi-lesioned 
animals. *p<0.05, ***p<0.001, in relation to sham-no stress group; #p<0.05, 
###p<0.001, in relation to sham-stress group, according to Fishers LSD post-hoc 
test. 
 
3.3.3. All hippocampal sub-regions mediate stress-induced anxiety in the novelty-
induced hypophagia test and the marble burying test 
The effects of sub-region-specific lesions on stress-induced anxiety in the novelty-
induced hypophagia test (NIH) are shown in Fig 3.4A. One-way ANOVA revealed 
an overall effect on the difference in latency to drink the milk (F4,39=13.01, 
p<0.001). Post hoc comparisons revealed that chronic psychosocial stress increased 




prevented in the dHi- iHi- and vHi-lesioned mice (all p<0.001 vs sham-stress 
group).  
 
Similarly, one-way ANOVA revealed an overall effect in the marble burying test 
(F4,39=7.74, p<0.001; Fig 3.4B). Post hoc comparisons revealed that chronic 
psychosocial stress increased the number of marbles buried in sham animals 
(p=0.002) but that this effect was completely prevented in the dHi- (p<0.001), iHi- 
(p<0.001) and vHi-lesioned groups (p=0.005).  
 
3.3.4. Only lesions of the vHi attenuate stress-induced anxiety in the open field, 
and this effect is not due to alterations in locomotor activity 
The effects of sub-region-specific lesions on stress-induced decreases on the time 
spent in the centre of the open field are shown in Fig 3.4C. One-way ANOVA 
revealed an overall effect on the time spent in the centre of the open field arena 
(F4,39=5.26, p=0.002). Specifically, post hoc analysis revealed that chronic 
psychosocial stress in sham animals increased anxiety as indicated by decreased 
time spent in the centre of the open field when compared to the non-stressed sham 
group (p=0.01). Chronic psychosocial stress also decreased time spent in the centre 
of the open field in dHi- and iHi-lesioned mice when compared to the non-stressed 
sham control group (p<0.001; p=0.001, respectively). Interestingly, this effect of 
stress was not observed in vHi-lesioned mice (p=0.135 vs. non-stressed sham 
group).  
 
The absence of significant stress-induced anxiety in vHi-lesioned mice was not due 
to alterations in general locomotor activity in the open field (Fig 3.4D). While one-




(F4,39=6.04, p=0.001). Post hoc analysis revealed that this effect was driven by 
increased locomotor activity in dHi- and iHi-lesioned groups [(p<0.001 and 
p=0.003 respectively, vs. sham non-stressed group); (p=0.002 and p=0.016, 
respectively vs. stressed sham group); (p=0.003 and p = 0.018, respectively vs. vHi-
lesioned group)], while vHi lesions had no effect on locomotor activity (p=0.49 vs 
non-stressed sham; p=0.95 vs stressed sham group).  
 
 
Figure 3.4: All hippocampal sub-regions are critical for stress-induced anxiety. A, 
lesions of all hippocampal sub-regions prevent stress-induced anxiety in the 
novelty-induced hypophagia test. B, lesions of all hippocampal sub-regions prevent 
stress-induced anxiety in the marble burying test. C, lesions of the vHi attenuate 
stress-induced anxiety in the time spent in the centre of the open field, and this effect 
is not due to increased locomotor activity (D). D, lesions of the dHi and iHi 
increased locomotor activity. *p<0.05, **p<0.01, ***p<0.001, in relation to sham-
no stress group; #p<0.05, ##p<0.01, #p<0.001, in relation to sham-stress group, 






3.3.5. The dHi and vHi mediate stress-induced anhedonia 
The effects of sub-region-specific lesions on stress-induced anhedonia in the 
saccharin preference test are shown in Fig 3.5A-D. One-way ANOVA showed an 
overall effect on the preference for saccharin after 12 h consumption (F4,39=3.41, 
p=0.018; Fig 3.5A) and after 24 h consumption (F4,39=3.9, p=0.009; Fig 3.5B). 
Specifically, post hoc analysis showed that stress significantly decreased saccharin 
preference in sham animals after 12 and 24 h consumption (p=0.014, p=0.003, 
respectively) and in the iHi-lesioned group (p=0.027, p=0.003, respectively), but 
not in the dHi (p=0.81, p=0.34, respectively) nor vHi-lesioned (p=0.12, p=0.22, 
respectively) groups. Indeed, the dHi-lesioned group was significantly different 
from the sham-stressed group after 12 and 24 h consumption (p=0.014, p=0.03, 
respectively) and the vHi-lesion group showed a similar trend of effect at 12 h 
consumption (p=0.08), which became more apparent following 36 and 48 h of 
exposure (Fig 3.5C,D). 
 
A similar pattern of effects on saccharin preference were observed following 36 h 
(F4,39=4.02, p=0.008; Fig 3.5C) and 48 h of exposure (F4,39=3.54, p=0.015; Fig 
3.5D). Specifically, post hoc analysis revealed that chronic psychosocial stress 
significantly decreased saccharin preference in sham animals (36h: p=0.004; 48h 
p=0.008) as well as in the iHi-lesioned group (36h: p=0.024; 48h p=0.03) but not 
in the dHi-lesioned (36h p=0.85; 48h p=0.91) or the vHi-lesioned groups (36h 
p=0.74; 48h p=0.8). Indeed, both the dHi-lesioned (36h p=0.006; 48h p=0.01) and 
vHi-lesioned groups (36h p=0.012, 48h: p=0.019) had a significantly higher 





The effects of sub-region-specific lesions on stress-induced anhedonia in the female 
urine sniffing test (FUST) are shown in Fig 3.5E. One-way ANOVA revealed an 
overall effect on the preference for urine in the FUST (F4,39=2.79, p=0.04). 
Specifically, post hoc analysis revealed chronic psychosocial stress significantly 
reduced the preference for urine in the sham (p=0.006) and iHi-lesioned (p=0.018) 
groups but not in the dHi (p=0.089) nor the vHi-lesioned groups (p=0.39) when 







Figure 3.5: dHi and vHi mediate stress-induced anhedonia. A-B, lesions of the dHi 
prevents and lesions of the vHi attenuates stress-induced anhedonia after 12 h (A) 
and 24 h (B) of the saccharin preference test. C-D, lesions of the dHi and vHi 
prevent stress-induced anhedonia after 36 h (C) and 48 h (D) of the saccharin 
preference test. E, lesions of both dHi and vHi attenuate stress-induced anhedonia 
in the female urine sniffing test. *p<0.05, **p<0.01, in relation to sham-no stress 
group; #p<0.05, ##p<0.01, in relation to sham-stress group, according to Fishers 







3.3.6. vHi lesions in stressed mice induce antidepressant-like effects in the forced 
swim test 
The effects of sub-region-specific lesions on immobility in the forced swim test 
(FST) are shown in Fig 3.6. One-way ANOVA revealed an overall effect on 
immobility time in the FST (F4,39=3.74, p=0.011). Specifically, post hoc analysis 
revealed that while stress alone did not alter immobility in the sham group (p=0.88), 
vHi lesions in stressed mice decreased immobility when compared to both the non-
stressed sham group (p=0.002) and the stressed sham groups (p=0.001). Immobility 
time of the vHi group was also significantly lower when compared with the dHi- 
and iHi-lesioned groups (p=0.048 and p=0.025, respectively). 
 
 
Figure 3.6: vHi mediates antidepressant-like behaviour in stressed mice in the FST. 
**p<0.01, in relation to sham-no stress group; ##p<0.01, in relation to sham-stress 
group, according to Fishers LSD post-hoc test. 
 
 
3.3.7. Behavioural effects of hippocampal lesions on chronically stressed mice 




The effects of stress and hippocampal lesion on the CORT release at baseline, 30 
min and 120 min after the FST are shown in Fig 3.7A. Two-way repeated measures 
ANOVA revealed an overall effect of timepoint (F2,39=300.8, p<0.001), but no 
effect of group (F4,39=1.92, p=0.13) and no interaction between them (F8,39=1.75, 
p=0.1). Post hoc analysis at each timepoint revealed that neither chronic stress nor 
hippocampal sub-region lesion affected baseline plasma CORT concentrations (all 
p>0.05), and that swim stress increased corticosterone 30 min after the start of the 
FST in all groups (all p<0.001). This swim stress-induced increase in CORT was 
greater in all hippocampal sub-region lesioned groups when compared to the sham-
control group (dHi, iHi and vHi lesion p=0.001, p=0.014 and p=0.008, 
respectively). However, dHi lesions (but not other sub-region lesions) further 
amplified stress-induced increases in corticosterone when compared to the sham-
stress group (p=0.003). However, such group differences were no longer apparent 
120 min after the FST. 
 
The effects of stress and hippocampal lesion on plasma corticosterone 
concentrations after a dexamethasone (DEX) and a stress challenge are shown in 
Fig 3.7B. Two-way repeated measures ANOVA revealed an overall effect of 
timepoint (F2,39=39.52, p<0.001), but no effect of group (F4,39=1.25, p=0.31) and 
no interaction between them (F8,39=1.71, p=0.11). However, post hoc analysis 
revealed that the iHi group had higher CORT levels at baseline compared to all 
other groups (p<0.001 vs. sham-no stress; p=0.005 vs. sham-stress; p=0.005 vs. dHi 
lesion; p=0.012 vs. vHi lesion. Dexamethasone suppressed acute stress-induced 
increases in CORT in all groups when measured 15 min after the acute stress (e.g. 
2h 15min after DEX injection), sham-stress (p=0.008), dHi lesion (p=0.016), iHi 




statistical significance in the sham-control group (p=0.083). 2h after stressor (and 
4h after DEX injection), all groups still had lower CORT in comparison to baseline 
(sham-control, p=0.014; sham-stress, p<0.001; dHi lesion, p=0.03; iHi lesion, 
p<0.001; vHi lesion, p=0.001), with no differences between them.   
 
 
Figure 3.7: Chronic stress did not alter the plasma concentration of corticosterone. 
A, plasma concentration of corticosterone at different timepoints (30 and 120 min) 
after the forced swim test. B, plasma concentration of corticosterone after different 





Accumulating evidence suggests that the rodent hippocampus is functionally 
segregated along its longitudinal axis into dorsal (dHi) and ventral (vHi) regions 
and most recent studies now also suggest that the area between them, the 
intermediate hippocampus (iHi) might also be functionally independent. Although 
the hippocampus is known to play a role in the pathophysiology and treatment of 
stress-related psychiatric disorders, the functional roles of these three sub-regions 
in the response to chronic stress have not yet been investigated and thus were the 
focus of these experiments. We performed a search on the RNAseq database from 
the Janelia Research Campus (http://hipposeq.janelia.org) (Cembrowski et al. 
2016) and found a heterogeneity in the expression of stress-related genes along the 
longitudinal axis of the hippocampus. Subsequently, we found that sub-regions of 
the longitudinal axis of the hippocampus mediate specific behavioural responses to 
chronic psychosocial stress. For what is to our knowledge the first time we show a 
predominant role of iHi in the stress-induced social avoidance and a predominant 
role of vHi in active coping behaviours and antidepressant effect following chronic 
stress. 
 
A growing body of evidence has been supporting the idea that the hippocampus 
operates across a functional neuroanatomical gradient coincident with different 
gene expression along its longitudinal axis (Moser and Moser 1998, Thompson et 
al. 2008, Strange et al. 2014, Cembrowski et al. 2016, Cembrowski et al. 2016). 
Using an RNAseq database (Cembrowski et al. 2016), we found differences in the 
expression of stress-related genes in the dentate gyrus of the dHi (dDG) versus vHi 
(vDG) of the mouse hippocampus. In agreement, several studies have reported 




and in mice (Cembrowski et al. 2016). Specifically, we found differences in the 
expression of receptors of several systems of neurotransmissions, growth factors, 
neurogenesis and glucocorticoid/mineralocorticoid receptors functioning. Genes 
involved in cholinergic, GABAergic and serotonergic neurotransmission are 
increased while those relevant to glutamatergic neurotransmission is reduced in the 
vDG when compared with the dDG. This is in agreement with previous literature 
which shows that the vHi is enriched with genes involved serotonergic (Tanaka et 
al. 2012), cholinergic and GABAergic neurotransmission (Lee et al. 2017). 
Together with the lower glutamatergic neurotransmission, this might be a reason 
for the vHi to support a less robust long-term potentiation than the vHi in rats 
(Maggio and Segal 2007). Moreover, stress has been shown to regulate 
glutamatergic expression in the hippocampus (Nasca et al. 2015), and both stress 
and corticosterone impair GABAergic neurotransmission in the hippocampus 
(Maggio and Segal 2009, Hu et al. 2010), preferentially in the vHi sub-region 
(Maggio and Segal 2009). Besides that, we also found that the mineralocorticoid 
receptor (MR) and serum and glucocorticoid regulated kinase 1 were expressed at 
lower levels in the vDG when compared with the dDG. Interestingly, MR receptor 
has also been shown to be reduced in depressed patients, specifically in the anterior 
hippocampus (vHi in rodents) (Medina et al. 2013). Also, differential expression in 
growth factor genes and genes related to neurogenesis in the vDG compared to dDG 
support that the vHi expresses more genes that favour cell proliferation, while dHi 
expresses more genes that favour neuronal differentiation. In agreement, a recent 
study suggests that the dHi has more active neurogenesis and is enriched of 
maturing neurons markers, such as NeuroD1 and DCX, while the vHi is enriched 




Accordingly, dHi neural progenitor cells have been shown to mature faster, 
associated with higher basal network activity (Piatti et al. 2011). 
 
More recent gene expression studies support however the concept that genes are 
expressed as a gradient along the hippocampal longitudinal axis in mice (Thompson 
et al. 2008, Strange et al. 2014, Cembrowski et al. 2016), and as such, the presence 
of an intermediate hippocampus is suggested. Thus, we also used the database to 
determine whether the CA1 of the dHi (dCA1), iHi (iCA1) and vHi (vCA1) 
differentially express stress-related genes. Although less changes were found, here 
we also found that some of the analysed genes were differentially expressed along 
the longitudinal axis of the hippocampal CA1, mainly when comparing the in the 
vCA1 with the dCA1. In agreement, previous studies have shown that genes are 
differentially expressed along the longitudinal axis of the CA1 (Leonardo et al. 
2006, Dong et al. 2009, Cembrowski et al. 2016, Pacheco et al. 2017) and CA3 
(Thompson et al. 2008) areas of the hippocampus. Here, we also found that the 
vCA1 has a more pronounced serotonergic neurotransmission in comparison to 
dCA1 and iCA1, while the changes in the other systems of neurotransmission were 
not as clear as the ones found in the vDG versus dDG. Interestingly, MR was 
expressed at lower level in the vCA1 versus dCA1, while the iCA1 had an 
intermediate expression, supporting a gradient expression of the MR along the 
longitudinal axis of the hippocampus. Also, vCA1 showed an increased expression 
of FGF2 in comparison with the dCA1, while a lower expression of BDNF in 
comparison with the dCA1 and iCA1. However most of the studies compared only 
the dorsal half versus the ventral half of the hippocampus, a study dissected the rat 
hippocampus into the most dorsal third and the most ventral third, ignoring the 




versus the dHi (Lee et al. 2017). Interestingly, a study shows that acute social defeat 
downregulates the fibroblast growth factor and its receptor in the hippocampus of 
rats (Turner et al. 2008), which was also observed in post-mortem study in 
depressed individuals (Evans et al. 2004). In addition, a recent study also supports 
the idea that the dHi and vHi have distinct epigenetic responses to acute stressors 
(Floriou-Servou et al. 2018), with the vHi being particularly more sensitive to the 
stressor. 
 
Since we observed differential expression of stress-related genes along the 
longitudinal axis of the hippocampus, we next used ibotenic lesions of the dHi, iHi, 
or vHi to investigate whether these hippocampal sub-regions play distinct roles on 
the behavioural responses to chronic psychosocial stress. In agreement with other 
studies that incorporate social defeat in psychosocial stress paradigms, we found 
that all treatment groups, irrespective of lesions, were susceptible to stress-induced 
social avoidance, as indicated by significant reductions in the social interaction ratio 
(Krishnan et al. 2007, Finger et al. 2011, Huang et al. 2013, Hammels et al. 2015, 
Burokas et al. 2017). However, we did observe that the percentage of susceptible 
mice was lower in sham animals thus suggesting that the hippocampus likely plays 
a role in stress resilience. Interestingly, we also observed that iHi lesions 
exacerbated stress-induced social avoidance as indicated by an increase in the 
corners ratio in the social interaction test. To the best of our knowledge, this is the 
first time that a role for the iHi in stress-induced social avoidance has been reported. 
However, previous studies have implicated the vHi in resilience to social defeat 
stress (Calfa et al. 2007, Kenworthy et al. 2014, Laine et al. 2017, Hultman et al. 
2018). In accordance, glutamatergic projections from the vHi to the nucleus 




stress, and optogenetic attenuation of the neurotransmission from vHi to accumbens 
is suggested to induce stress resilience, shown by an increase in the time spent in 
the interaction zone in the social interaction test (Bagot et al. 2015). In contrast, in 
the present study vHi and dHi lesions did not alter stress-induced social avoidance. 
However, we did observe that vHi lesions increased the latency to adopt a defeat 
posture suggesting increased active coping behaviour.   
 
Our psychosocial stress paradigm increased anxiety in sham animals in several 
behavioural tests including marble burying, novelty-induced hypophagia and the 
open field test. This is in agreement with reports from previous studies, which 
showed that this particular stress paradigm and the chronic social defeat stress 
model increased anxiety in the elevated plus maze in mice (Slattery et al. 2012, 
Burokas et al. 2017), open field (Kinsey et al. 2007, Burokas et al. 2017) and in the 
light-dark box tests (Keeney and Hogg 1999, Kinsey et al. 2007, Finger et al. 2011, 
Huang et al. 2013). In our study, we also found that lesions of either the dHi, iHi or 
vHi all prevented stress-induced anxiety in the marble burying and in novelty-
induced hypophagia tests. To the best of our knowledge, this is the first time that 
this is shown in these behavioural tests under stress conditions. While the present 
results might suggest that all hippocampal sub-regions mediate stress-induced 
anxiety, this effect may be test-dependent, as a different picture emerged in the open 
field test, whereby lesions of the vHi had an anxiolytic effect attenuating the stress-
induced decrease in time spent in the centre of the open field. This effect was not 
due to alterations in locomotor activity. In agreement, it has been reported the that 
vHi, but not dHi, is required for the expression of anxiety behaviours in rats in the 
hyponeophagia and light-dark box (Bannerman et al. 2003) and elevated plus maze 




undergone prior chronic stress. Moreover, optogenetic and pharmacogenetic studies 
have reported that several vHi neural pathways regulate anxiety in the open field 
and elevated plus maze (Felix-Ortiz et al. 2013, Padilla-Coreano et al. 2016, Parfitt 
et al. 2017). It is also important to note that a study demonstrated that both dHi and 
vHi can modulate anxiety behaviour in in open field and elevated plus maze in mice 
(Kheirbek et al. 2013). 
 
Taken together, these data suggest that the anxiolytic effects of hippocampal sub-
region lesions in stressed mice are test-dependent. One explanation for differential 
effects in the open field versus the marble burying test and novelty-induced 
hypophagia, may be that these tests interrogate different aspects of anxiety 
behaviour or that different neural circuits may underlie the manifestation of anxiety 
in these tests. For an example, it has been reported that the open field test increases 
expression of the immediate early gene c-FOS in the basolateral amygdala, mPFC 
and CA1 of the ventral hippocampus (Hale et al. 2008), while another study 
revealed that novelty-induced hypophagia increased c-FOS expression in the lateral 
septal nucleus, cingulate cortex and the CA1 of both the dorsal and ventral 
hippocampus (Olszewski et al. 2014). The precise vHi neural pathway underlying 
the anxiolytic effect in the open field have yet to elucidated but several vHi-
mediated pathways have been reported to regulate anxiety behaviour in the open 
field and also elevated plus maze, including projections from the amygdala (Felix-
Ortiz et al. 2013) or to the prefrontal cortex (Adhikari et al. 2011, Padilla-Coreano 
et al. 2016). In addition, a recent paper describes the presence of “anxiety cells”, 
cells which are thought to mediate anxiety behaviour, in the ventral hippocampus 




accordance with a previous study that show that the stimulation of the ventral 
hippocampus causes inhibition of the HPA axis (Casady and Taylor 1976). 
 
In the present study, chronic psychosocial stress induced an anhedonic effect in 
sham animals in the saccharin preference and female urine sniffing tests. This is in 
line with the effects of such a stressor in the female urine sniffing test (Finger et al. 
2011, Lehmann et al. 2013, Burokas et al. 2017),and in the saccharin preference 
test (Liu et al. 2018). In our study, we found that lesions of either the dHi or vHi 
prevented the stress-induced anhedonia in the saccharin preference test, and the 
lesion of dHi and vHi also attenuated stress-induced anhedonia in the female urine 
sniffing test. Interestingly, iHi lesions did not affect stress-induced anhedonia in 
either of these tests. Taken together, we show for the first time that the dHi and vHi, 
but not the iHi play a role in the stress-induced anhedonia. 
 
When we examined the impact of chronic stress and lesions on antidepressant-like 
behaviour, we found that chronic psychosocial stress did not alter immobility time 
in the forced swim test. This is in contrast to some other studies that also used 
chronic social defeat as the stress paradigm (Finger et al. 2011, Huang et al. 2013, 
Burokas et al. 2017, Liu et al. 2018). However, in accordance with our results, a 
growing number of studies have reported that chronic psychosocial stress increases 
anxiety, without altering depressive-like behaviours in the forced swim test 
(Keeney and Hogg 1999, Kinsey et al. 2007, Slattery et al. 2012, Hammels et al. 
2015). Interestingly however, we found that stressed vHi-lesioned animals showed 
reduced immobility time when compared to both sham groups thus indicating an 
antidepressant-like phenotype. Intriguingly, this effect is not apparent in non-




reported that chemogenetic activation of the vHi to medial prefrontal cortex 
pathway in non-stressed rats exerts an antidepressant-like effect in the immobility 
time in the forced swim test and that inactivation of this pathway is also required 
for the sustained antidepressant-like effects of ketamine in non-stressed rats in this 
test (Carreno et al. 2016). Here, we found that under chronic stress conditions vHi 
lesions induce antidepressant-like effects thus suggesting that, under chronic stress 
conditions, other vHi-mediated pathways regulate antidepressant like effects in this 
test. Taken together, we show what is to our knowledge for the first time that the 
vHi plays a role in modulating antidepressant-like behaviour in the mouse forced 
swim test under chronic stress conditions. 
 
Given the region-specific modulation of stress-induced changes in behaviour, we 
also investigated the corticosterone release after an acute stressor (swim stress, 30 
min and 120 min after the test), and after a dexamethasone challenge. In the swim 
stress experiment, chronic stress alone did not affect plasma corticosterone 
concentrations at any timepoint. In agreement, it has been previously reported that 
this chronic psychosocial stress paradigm does not affect plasma corticosterone 
concentrations during the light-phase (Reber et al. 2006, Finger et al. 2011, 
Hammels et al. 2015), although other studies showed that mice submitted to chronic 
psychosocial stress present higher basal corticosterone levels (Keeney et al. 2001, 
Burokas et al. 2017), and one study demonstrated that chronic social defeated mice 
present lower corticosterone levels (Savignac et al. 2011). Similarly, neither 
chronic stress nor lesions of any hippocampal sub-regions altered plasma 
concentrations of corticosterone after a dexamethasone challenge thus suggesting 
the GR-mediated negative feedback of the HPA-axis is unaffected by specific 





In summary, the present study shows what is to our knowledge for the first time 
evidence of a differential role of the dHi, iHi and vHi on emotional behaviours 
under chronic psychosocial stress. While all hippocampal sub-regions are involved 
in the anxiogenic effects of chronic stress, only dHi and vHi are involved in the 
stress-induced anhedonia. Interestingly, here we show that the iHi plays a more 
predominant role in stress-induced social avoidance, and the vHi is preferentially 
involved in antidepressant-like behaviour under chronic stress conditions and in 
active coping behaviour. Thus, we suggest that future studies of the hippocampus 
which are aimed at the identification of novel drug development targets should 
consider the differential roles of hippocampal sub-regions in stress-induced changes 
in behaviour and should focus primarily on the vHi. Moreover, future studies should 
consider grouping the chronically stressed animals into susceptible and resilient to 
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The hippocampus is one of few brain regions where neurogenesis, the birth of new 
neurons, occurs throughout life and this process has been shown to play roles in 
learning, memory and stress responses. These diverse roles may be related to a 
functional segregation of the hippocampus along its longitudinal axis; indeed, the 
dorsal hippocampus (dHi) plays a predominant role in spatial learning and memory, 
while the ventral hippocampus (vHi) is predominantly involved in the regulation of 
anxiety (a behaviour impacted by stress). Recent studies suggest that the area 
between them, the intermediate hippocampus (iHi) may also be functionally 
independent. This study aimed to determine whether stress-induced changes in 
neurogenesis could be related to differential intrinsic sensitivity of neural 
progenitor cells (NPCs; isolated from rats at 28PND) from the dHi, iHi, or vHi to 
the stress hormone, corticosterone (CORT), or the glucocorticoid receptor (GR) 
agonist, dexamethasone (DEX). Long-term exposure to CORT decreased neuronal 
differentiation in cultures derived from the vHi but not the dHi, while iHi cultures 
showed an intermediate response. A similar gradient-like response was observed 
with dexamethasone on neuronal differentiation and maturation of NPCs. The same 
trend was also observed on the GR nuclear translocation after CORT or DEX 
treatment. These data suggest that an intrinsic sensitivity of vHi NPC-derived 
neurons to chronic glucocorticoid exposure may underlie the increased 
vulnerability of the vHi to chronic stress-induced reductions in neurogenesis. They 
also highlight that the iHi deserves more attention as a mediator of stress-induced 






4.1. Introduction  
The hippocampus is one of just a few brain areas where resident stem cells produce 
new neurons throughout life through a process called adult hippocampal 
neurogenesis [AHN] (Kempermann et al. 2004, Ming and Song 2011). AHN occurs 
in the subgranular zone of the dentate gyrus of the hippocampus, where the neural 
progenitor cells (NPCs) reside, and is comprised of several stages including cell 
proliferation, neuronal differentiation, and survival and maturation of the newly-
born neurons (Christie and Cameron 2006). All of these processes can be influenced 
by several extrinsic factors including stress, antidepressant treatment, environment, 
physical activity, and learning and memory (Kempermann et al. 1997, Gould et al. 
1999, Malberg et al. 2000, Dobrossy et al. 2003, Simon et al. 2005, Fabel and 
Kempermann 2008, Schloesser et al. 2010, Surget et al. 2011, Tanti et al. 2012, 
Hueston et al. 2017). Indeed, learning and memory have been shown to increase 
AHN in rats (Gould et al. 1999, Dobrossy et al. 2003) and in turn, AHN is required 
for hippocampal-dependent learning (Marin-Burgin and Schinder 2012). In 
addition, stress and high levels of glucocorticoids impact the hypothalamus-
pituitary-adrenal (HPA) axis, the axis that control the release of glucocorticoids by 
the adrenal glands, and have been shown to decrease all stages of AHN (Simon et 
al. 2005, Dranovsky and Hen 2006, Jayatissa et al. 2006, Mitra et al. 2006, Jayatissa 
et al. 2009, Surget et al. 2011, Schoenfeld and Gould 2012, Lehmann et al. 2013). 
Specifically, different forms of stress reduce AHN, including predator odour (Galea 
et al. 2001), social stress (Gould et al. 1997, Czeh et al. 2001), and chronic mild 
stress (Alonso et al. 2004). Moreover, the neurogenic niche in which NPCs reside 
is located near blood vessels (Wurmser et al. 2004), which makes these cells 
vulnerable to blood-transported molecules and hormones, such as cytokines (Bauer 




Indeed, it has been shown that chronic treatment with corticosterone reduces AHN 
in mice (David et al. 2009) and rats (Ekstrand et al. 2008, Brummelte and Galea 
2010). Adrenalectomy, and the consequent removal of circulating plasma 
glucocorticoids, is also known to increase hippocampal cell proliferation (Krugers 
et al. 2007). In turn, AHN facilitates normalization of glucocorticoid levels after 
stress in mice (Snyder et al. 2011, Surget et al. 2011, Culig et al. 2017). 
 
Precisely how AHN plays a role in functions as seemingly diverse as spatial 
learning and memory and the response to stress is currently unclear but may be 
related to functional segregation of the hippocampus along its longitudinal axis into 
dorsal and ventral regions. Indeed, the dorsal hippocampus (dHi), corresponding to 
posterior hippocampus in primates, plays a predominant role in spatial learning and 
memory, while the ventral hippocampus (vHi), corresponding to the anterior 
hippocampus in primates, plays a predominant role in anxiety (Bannerman et al. 
2004, Fanselow and Dong 2010), a stress-sensitive behaviour. Emerging evidence 
suggests that regulation of AHN might also be functionally segregated along the 
longitudinal axis of the hippocampus (Winocur et al. 2006, Tanti and Belzung 2013, 
O'Leary and Cryan 2014, Wu and Hen 2014, Levone et al. 2015, O'Leary et al. 
2015). New neurons in the dHi are preferentially required for contextual 
discrimination and memory tasks in rats (Winocur et al. 2006), while new neurons 
in the vHi are necessary for anxiolytic effects of the antidepressant fluoxetine in 
mice (Wu and Hen 2014). It has also been reported that chronic stress decreases 
cell proliferation (Jayatissa et al. 2006, Tanti et al. 2012), neuronal differentiation, 
maturation and survival (Hawley and Leasure 2012, Lehmann et al. 2013), 
preferentially in the vHi of rodents. Indeed, our laboratory and others have reported 




within the sub-regions of the hippocampus in rats and mice (Jayatissa et al. 2006, 
O'Leary et al. 2012, Tanti and Belzung 2013, O'Leary and Cryan 2014, Levone et 
al. 2015). Similarly, it has been shown that chronic stress reduced the number of 
immature neurons in the anterior hippocampus, but not in the posterior 
hippocampus of non-human primates (Perera et al. 2011).  
 
Some of these conflicting data may be a function of the definition of the boundaries 
of the dorsal versus the ventral sub-regions (Tanti and Belzung 2013) which 
sometimes includes the intermediate hippocampus (iHi), a sub-region which may 
be functionally independent in its own right but has been understudied (Bast 2007, 
Thompson et al. 2008, Bast et al. 2009, Strange et al. 2014). Very few studies 
considered this third hippocampal sub-region as its own, but there are reports that 
it is not only a transitional area between dorsal and ventral hippocampus, but also 
an integrative region (Bast 2007, Bast et al. 2009), which mediates the binding of 
diverse sensory modalities (Bast et al. 2009). A recent paper also showed that the 
effects of fluoxetine on the proliferation of NPCs in vivo are preferentially in the 
transition between the intermediate and the ventral hippocampus (Zhou et al. 2016). 
The effects of corticosterone on the proliferation and differentiation of NPCs of the 
intermediate hippocampus, however, has not yet been assessed. 
 
The mechanisms underlying the increased sensitivity of the AHN in the vHi to the 
stress and corticosterone are currently unknown. Thus, the aim of this study was to 
determine whether such effects may be a result of differential intrinsic sensitivity 
of NPCs derived from the dHi, iHi, or vHi to the stress hormone, corticosterone, 














4.2.1. Experimental design 
To isolate the neural progenitor cells (NPCs) from any extrinsic influences they 
could receive on in vivo experiments, we used a protocol of isolation and culture of 
NPCs from adolescent rats. To assess whether NPCs derived from different sub-
regions of the hippocampus respond differently to the stress hormone, 
corticosterone (CORT), we assessed cell proliferation, neuronal differentiation and 
maturation in CORT-exposed cells. We allowed NPCs to grow for 4 days in vitro 
as neurospheres, dissociated them into single cells and exposed them to CORT for 
either 4 h (acute), 4 days (short-term) or 7 days (longer-term) in vitro. Cells were 
then fixed and proceeded for immunocytochemistry. 
 
4.2.2. Preparation of neurosphere cultures 
Procedures were performed under individual authorisations issued by the Health 
Products Regulatory Authority (HPRA) Ireland and in accordance with the 
European Parliament and the Council of the EU Directive (2010/63/EU). The whole 
hippocampi (Suppl. Fig 4.1A) or dHi, iHi and vHi (Suppl. Fig 4.1B) were dissected 
from male Sprague Dawley rats at postnatal day 28 (PND28) (bred at Biological 
Services Unit, UCC). To obtain a sufficient number of NPCs per independent 
experiment, whole hippocampi from 3 animals or each sub-region of 6 animals were 
pooled. NPCs were seeded at a density of 10 x 104 cells per well and allowed to 
proliferate as neurospheres (Suppl. Fig 4.1C) for 4 days in vitro (DIV). A detailed 






4.2.3. Dissociation of neurospheres and treatment of NPCs with corticosterone or 
dexamethasone 
After 4 DIV under proliferation conditions, neurospheres were dissociated and 
seeded at a density of 5 x 104 per well in a volume of 40 µl of cell suspension onto 
Poly-D-Lysine (1mg/ml, Sigma Aldrich, UK) coated coverslips in a 24-well plate. 
NPCs were allowed to adhere to the coverslips for 1 h prior to the addition of 460 
µl of treatment medium. 
 
To determine an appropriate dose range of corticosterone (CORT) to use for our 
sub-region experiments, we first determined the effect of acute (4 h) CORT 
exposure on cell proliferation from NPCs from the whole hippocampus. The 
treatment medium was composed of growth medium (Neurobasal A, 2% B27 minus 
vitamin A, 0.5mM Glutamax, 50 units/ml Penicillin/Streptomicin, 20 ng/ml FGF 
and 20 ng/ml EGF) with 0.2 µM of BrdU (Sigma-Aldrich, UK) and different 
concentrations of corticosterone (CORT, Sigma-Aldrich, UK, 1 µM or 5µM, 
diluted in 0.1% DMSO). Control cells were treated with vehicle (growth medium 
with BrdU and 0.1% DMSO). Cells were allowed to proliferate for 4 h in vitro prior 
to fixation. 
 
For acute (4 h) CORT exposure, cells were allowed to proliferate in growth medium 
with 0.2 µM BrdU and different concentrations of corticosterone (CORT; 0.5 µM, 
1 µM or 5 µM diluted in DMSO to a final concentration of 0.1% DMSO) or vehicle 
(growth medium with 0.2 µM BrdU and 0.1% DMSO). Cells were allowed to 





For short-term (4 DIV) CORT exposure, cells were allowed to differentiate in 
growth medium in the absence of growth factors or heparin, and in the presence of 
vehicle (0.1% DMSO) or different concentrations of CORT (0.5 µM, 1 µM or 5 
µM diluted in DMSO to a final concentration of 0.1% DMSO). Cells were allowed 
to differentiate for 4 DIV prior to fixation. 
 
For long-term (7 DIV) CORT or dexamethasone (DEX) exposure, cells were 
allowed to differentiate in growth medium in the absence of growth factors or 
heparin and in the presence of vehicle (0.1% DMSO) or different concentrations of 
CORT (0.5 µM, 1 µM or 5 µM diluted in DMSO to a final concentration of 0.1% 
DMSO) or DEX (10 nM, 100 nM or 1000 nM diluted in DMSO to a final 




Cells were washed with warm Hanks’ balanced salt solution (HBSS), fixed with ice 
cold methanol at -20ºC for 10 min followed by 4% paraformaldehyde at room 
temperature for 10 min. Cells were then washed for 3x5 min with PBS-
0.02%TritonX (PBS-T) and blocked overnight at 4ºC with 5% donkey serum (DS; 
Sigma Aldrich) diluted in PBS-T. 18 h later, cells were washed for 3x5 min with 
PBS-T and incubated overnight at 4ºC in the appropriate primary antibody diluted 
in 5% DS PBS-T [(rat monoclonal anti-BrdU (1:100, ab6326, Abcam), goat 
polyclonal anti-DCX (1:200, sc-8066, Santa Cruz) or mouse monoclonal anti β3-
tubulin (1:250 G7121, Promega)]. 18 h later cells were washed for 3x5 min in PBS-
T and incubated for 2 h at room temperature in the respective secondary antibody 




Invitrogen), Alexa Fluor 488 donkey anti-goat (1:500, A-11055, Invitrogen), Alexa 
Fluor 488 donkey anti-mouse (1:500, A-21202, Invitrogen)]. For experiments 
requiring dual labelling immunohistochemistry, cells were then washed 3x5min and 
incubated overnight at 4ºC in the appropriate primary antibody diluted in 5% DS in 
PBS-T [(goat polyclonal anti-Nestin (1:200, sc21249, Santa Cruz); rabbit 
polyclonal anti-GR (1:500 sc-1004, Santa Cruz)]. 18 h later, cells were washed 3x5 
min with PBS-T and incubated for 2 h at room temperature in the respective 
secondary antibody diluted in 5% DS in PBS-T [(Alexa Fluor 488 donkey anti-goat, 
(1:1000 A-11055, Invitrogen), Alexa Fluor 594 donkey anti-rabbit (1:500, A21207, 
Invitrogen)]. After 3x5 min washes, cells were incubated in DAPI (1:1000, from a 
stock of 1ul/ml, Sigma-Aldrich, UK) diluted in 2% DS in PBS-T for 10 min and 
then washed with PBS. Coverslips were mounted onto slides using DAKO 
Fluorescence mounting medium. 
 
4.2.5. Fluorescence microscopy and image analysis 
Fluorescent images of immunopositive cells were viewed under an Olympus BX53 
upright microscope and photomicrographs were captured (all with the same 
exposure time) at 40x magnification using an Olympus DP71 camera and cellSens 
Entry camera software™. For each treatment condition, five fields of view were 
randomly captured per coverslip, there were three coverslips per treatment per plate, 
and each experiment was repeated three times. Software Image J Version 1.44 was 
used to count cells, to measure the length of dendritic processes and to measure 





In the proliferation experiments, the percentage of NPCs [(Nestin+ cells/total DAPI+ 
nuclei) x 100] and the percentage of proliferating NPCs [(BrdU+ cells/Nestin+ cells) 
x 100] were calculated. 
 
In the experiment examining the effects of short-term (4 DIV) and long-term (7 
DIV) corticosterone treatment on neuronal differentiation and maturation, the 
percentage of neurons [(DCX+ cells/ DAPI+ cells) x 100 for short-term and (β3-
tubulin+ cells/DAPI+ cells) x 100 for long-term] was calculated. The percentage of 
neurons (DCX+ or β3-tubulin+) with a primary [(neurons with primary 
processes/total number of neurons) x 100] and a secondary process [(neurons with 
secondary processes/total number of neurons) x 100] were also calculated. As an 
index of neuronal maturation, the length of these processes was calculated [(sum of 
the length of all primary or secondary processes/number of neurons with that 
specific process) x 100]. The total length of processes was also measured [(sum of 
the length of all processes/number of neurons) x 100]. For long-term corticosterone 
treatment, the percentage and length of tertiary processes were also calculated. 
 
To determine the effects of long-term (7 DIV) corticosterone or dexamethasone 
treatment on glucocorticoid receptor (GR) translocation to the nucleus, the 
fluorescence intensity of all nuclei was assessed. For that end, the software 
recognised the contour of the nuclei and we measured the GR mean fluorescence 
intensity inside the nuclear contours. The results for each cell were then averaged 
and data are expressed as a % from the control group. The software Image J Version 
1.44 was used to draw around each nucleus and assess the fluorescence intensity, 





4.2.6. Cell viability analysis [Thiazolyl Blue Tetrazolium Bromide (MTT) assay] 
An MTT assay was used to verify whether the results of long-term exposure to 
corticosterone or dexamethasone were due to altered cell viability. Briefly, after 7 
DIV under differentiation conditions the media was removed and growth media 
containing 10% MTT solution (5 mg/ml, Sigma Aldrich, UK) was added. Four 
hours later, the medium was discarded and 100 µl of DMSO was added to each well 
to dissolve the formazan crystals. 75 µl from each well were plated in a 96-well 
plate and the absorbance at 570 nm wavelength was measured in an absorption 
spectrophotometer (Flexstation 3 Multimode Plate Reader, Molecular Devices). For 
each treatment condition, there were three samples per culture, and the experiment 
was repeated three times. 
 
4.2.7. Statistical analysis 
Data were analysed using IBM SPSS Statistics 23. For the characterisation of the 
culture, comparisons between medium and vehicle were determined using 
Student’s t test. The effects of corticosterone on NPCs from the whole hippocampus 
were determined using one-way ANOVA. For all other conditions, two-way 
ANOVA was used. If a main effect reached statistical significance, group-wise 
comparisons were made using Fishers post-hoc test. Data are expressed as the mean 






4.3.1 Characterisation of NPC cultures 
NPCs from whole hippocampus were allowed proliferate as neurospheres for 4 DIV 
prior to characterisation. We found that approximately 99% of the cells were nestin+ 
suggesting that the majority of the cells were indeed neural progenitor cells (NPCs) 
(Suppl. Fig 4.2A). Dissociated NPCs were allowed to proliferate for 4 h in the 
presence of BrdU. We found that approximately 54% of these cells were BrdU+ 
suggesting that NPCs were actively proliferating (Suppl. Fig 4.2B). To determine 
whether the vehicle (0.1% DMSO in culture medium) that would be used to dilute 
corticosterone and dexamethasone might affect the number of NPCs or cell 
proliferation, we compared the percentage of nestin+ cells and the percentage of 
BrdU+ cells in NPC cultures treated with the vehicle with those treated with growth 
medium. Student’s t-test showed that the vehicle did not affect the percentage of 
NPCs (nestin+ cells; t(16)=0.08, p=0.94; Suppl. Fig 4.2A) or cell proliferation 
(BrdU+ cells; t(16)=0.46, p=0.65; Suppl. Fig 4.2B). Therefore, we used the vehicle 
as the control group for all further experiments investigating the effects of 
corticosterone or dexamethasone. 
 
4.3.2 NPCs from the whole hippocampus express the glucocorticoid receptor (GR) 
and corticosterone decreases their proliferation 
We first determined whether the glucocorticoid receptor (GR) was expressed on 
NPCs. As shown in Suppl. Fig 4.3A, GR was expressed on nestin+ cells. The effects 
of corticosterone (4 h) on cell proliferation of NPCs from the whole hippocampus 
is shown in Suppl. Fig 4.3B-F. One-way ANOVA revealed that 4 h exposure to 
corticosterone decreased cell proliferation as indicated by a reduction in the 




hoc analysis revealed that both concentrations of corticosterone reduced the 
percentage of BrdU+ cells compared to the vehicle group (1 µM, p=0.011; 5 µM, 
p=0.031). Thus, for subsequent experiments examining the effects of corticosterone 
on cell proliferation and neuronal differentiation and maturation, we used these 
concentrations as well as including a lower concentration of 0.5 µM to investigate 
potential differences in sensitivity of dHi, iHi and vHi NPCs to CORT. 
 
4.3.3. NPCs derived from the dHi, iHi or vHi do not exhibit differential sensitivity 
to acute corticosterone-induced reductions in NPC proliferation 
The effects of corticosterone (CORT) on cell proliferation in NPC cultures derived 
from the dHi, iHi and vHi are shown in Fig 4.1A-M. Two-way ANOVA revealed a 
significant main effect of CORT (F3,96=42.26, p<0.001), but not hippocampal sub-
region (F2,96=1.16, p=0.32) nor a CORT x hippocampal sub-region interaction 
(F6,96=0.388, p=0.89) on NPC proliferation (Fig 4.1A). Specifically, post hoc 
analysis revealed that when compared to the respective vehicle-treated group, all 
CORT concentrations (0.5, 1 and 5 µM) reduced cell proliferation to a similar extent 
irrespective of the hippocampal sub-regions the NPCs were derived from [dHi 
(p=0.028, p<0.001, p<0.001, respectively); iHi (p=0.013, p<0.001, p<0.001, 
respectively); vHi (p=0.019, p<0.001, p<0.001, respectively)]. These CORT-
induced reductions in NPC proliferation were not due to CORT-induced decreases 








Figure 4.1: Effects of acute corticosterone exposure on cell proliferation. A, 
corticosterone reduced cell proliferation and NPCs derived from the dHi, iHi and 
vHi do not exhibit differential sensitivity to acute corticosterone-induced reductions 
in cell proliferation; B-M, representative images of cells stained with DAPI (blue) 
and BrdU (red). *p<0.05 and ***p<0.001, compared with respective 0 µM group, 





4.3.4. Short-term exposure to corticosterone reduced neuronal differentiation and 
maturation irrespective of the hippocampal sub-region 
The effects of short-term exposure (4 DIV) to CORT on neuronal differentiation of 
NPCs derived from the dHi, iHi and vHi into immature neurons (DCX+ cells) are 
shown in Fig 4.2A. Two-way ANOVA revealed a significant main effect of CORT 
(F3,96=23.18, p<0.001), but not hippocampal sub-region (F2,96=2.01, p=0.14), nor a 
CORT x hippocampal sub-region interaction (F6,96=0.94, p=0.147) on the 
percentage of DCX+ cells. Post hoc analysis revealed that all CORT concentrations 
(0.5, 1 and 5 µM) reduced neuronal differentiation of NPCs (derived from the dHi 
(p=0.04, p=0.003, p<0.001, respectively) and iHi (p=0.001, p=0.006, p<0.001, 
respectively), while only the concentrations of 1 and 5 µM reduced neuronal 
differentiation of NPCs derived from vHi (p=0.001 and p<0.001, respectively).  
 
As an index of neuronal maturation, we calculated the percentage of DCX+ cells 
that had a primary or a secondary process (Fig 4.2B-Q) and we also calculated the 
average length of these processes (Fig 4.2D,E). Two-way ANOVA revealed a 
significant main effect of CORT (F3,96=5.88, p=0.001), and of hippocampal sub-
region (F2,96=7.66, p=0.001), but not a CORT x hippocampal sub-region interaction 
(F6,96=0.33, p=0.92) on the percentage of DCX
+ with primary processes (Fig 4.2B). 
Post hoc analysis revealed that that the percentage of DCX+ cells with a primary 
process was significantly reduced by 1 µM and 5 µM of CORT in cells derived 
from the iHi (p=0.016, p=0.015, respectively), while only 5 µM CORT significantly 
reduced the percentage of DCX+ with a primary process in cells derived from the 





On the other hand, when we examined the impact of CORT on the percentage of 
DCX+ cells with a secondary process, we found that CORT decreased this 
population of immature neurons to a similar extent in all hippocampal sub-regions. 
Indeed, two-way ANOVA revealed a significant main effect of CORT (F3,96=14.92, 
p<0.001), but not hippocampal sub-region (F2,96=0.43, p=0.65), nor a CORT x 
hippocampal sub-region interaction (F6,96=0.58, p=0.75) on the percentage of DCX
+ 
cells with secondary processes (Fig 4.2C). Post hoc analysis revealed that the 
percentage of DCX+ with a secondary process was reduced by all CORT 
concentrations (0.5, 1 and 5 µM) in NPC cultures derived from the dHi (p=0.008, 
p=0.008, p<0.001, respectively), iHi (p=0.003, p<0.001, p=0.002, respectively) and 
vHi (p=0.012, p=0.04, p<0.001, respectively). 
 
As another index of neuronal maturation, we measured the average length of these 
primary and secondary dendrites. The effects of CORT on primary processes length 
are shown in Fig 4.2D. Two-way ANOVA revealed a significant effect of CORT 
(F3,96=5.48, p=0.002) but no effect of hippocampal sub-region (F2,96=2.98, p=0.55) 
nor a CORT x hippocampal sub-region interaction (F6,96=0.32, p=0.92). Post hoc 
analysis showed that the effects of CORT were dose-dependent. 5 µM CORT 
significantly reduced the primary process length in DCX+ cells derived from the 
dHi (p=0.025) and the vHi (p=0.016) while 1 µM CORT significantly reduced 
primary process length in DCX+ cells derived from iHi NPC cultures only 
(p=0.018).  
 
The effects of CORT on secondary processes length are shown in Fig 4.2E. Two-
way ANOVA revealed a significant effect of CORT (F3,96=16.23, p<0.001), but not 




region interaction (F6,96=0.35, p=0.91). Post hoc test revealed that all CORT 
concentrations (0.5, 1 and 5 µM) reduced secondary process length in DCX+ cells 
irrespective of the sub-region they were derived from [dHi (p=0.049, p=0.01, 
p<0.001, respectively); iHi (p=0.002, p=0.049, p<0.001, respectively); vHi 
(p=0.012, p=0.007, p<0.001)] and there were no sub-regional differences in this 
effect. The effects of corticosterone on the total average dendritic length was also 






Figure 4.2: Effects of short-term corticosterone exposure on NPCs differentiation 
into immature neurons (DCX+) and their maturation. A, short-term exposure to 
corticosterone reduces neuronal differentiation irrespective of the hippocampal 
sub-region; B-E, short-term exposure to corticosterone reduces neuronal 
maturation in all hippocampal sub-regions to a similar extent, reducing the 
percentage of DCX cells with primary (B) and secondary processes (C) and the 
length of these processes (D-E); F-Q, representative images of cells stained with 
DAPI (blue) and DCX (green). *p<0.05, **p<0.01, ***p<0.001, compared with 





4.3.5. Longer-term exposure to corticosterone decreased neuronal differentiation 
in NPCs derived from the vHi but not the dHi, while iHi NPCs show an intermediate 
response.  
The effects of longer-term exposure (7 DIV) to CORT on neuronal differentiation 
(β3-tubulin+ cells) of NPCs derived from the dHi, iHi and vHi and are shown in Fig 
4.3A. Two-way ANOVA revealed a significant main effect of CORT (F3,96=11.85, 
p<0.001), hippocampal sub-region (F2,96=24.36, p<0.001) and a CORT x 
hippocampal sub-region interaction (F6,96=3.68, p=0.002) on the percentage of β3-
tubulin+ cells. Post hoc analysis revealed that none of the concentrations of CORT 
affected neuronal differentiation in NPCs derived from the dHi (0.5 µM, p=0.82; 1 
µM, p=0.77; 5 µM, p=0.9) but all concentrations of CORT (0.5, 1, 5 µM) reduced 
neuronal differentiation of NPCs derived from the iHi (p=0.015, p=0.003, p=0.005, 
respectively), and the vHi (all p<0.001). CORT-induced reductions in neuronal 
differentiation were most pronounced in the NPCs derived from the vHi. Indeed, 
0.5, 1 µM and 5 µM CORT induced a greater reduction in β3-tubulin+ cells 
differentiated from vHi NPCs, but not those from iHi NPCs, compared with those 
differentiated from dHi NPCs (p<0.001 for all concentrations of CORT), and from 
the vHi compared to those differentiated from iHi NPCs (0.5 µM, p=0.018; 1 µM, 
p=0.006; 5 µM, p<0.001).  
 
4.3.6. Neurons derived from vHi NPCs are more sensitive to reductions in neuronal 
maturation induced by longer-term corticosterone exposure  
As an index of neuronal maturation, we calculated the percentage of β3-tubulin+ 
cells that had primary, secondary, or tertiary processes (Fig 4.3B-S). Two-way 




for hippocampal sub-region (F2,96=2.56, p=0.082) but no CORT x hippocampal 
sub-region interaction (F6,96=1.47, p=0.2) on the percentage of β3-tubulin
+ cells 
with a primary process (Fig 4.3B). Specifically, post hoc analysis revealed that the 
percentage of β3-tubulin+ cells with a primary process is reduced by all 
concentrations of CORT irrespective of the hippocampal sub-regions they were 
derived from (all p<0.001). However, the number of β3-tubulin+ cells with a 
primary process treated with 1uM CORT was higher in dHi-derived β3-tubulin+ 
cells than vHi cells (p=0.03) and the number of β3-tubulin+ cells with a primary 
process treated with 5 µM CORT was higher in dHi-derived β3-tubulin+ cells than 
iHi cells treated with the same concentration (p=0.013).  
 
When we measured the number of β3-tubulin+ cells with secondary processes, we 
observed sub-regional effects of CORT. Two-way ANOVA revealed an overall 
effect of CORT (F3,96=73.45, p<0.001), hippocampal sub-region (F2,96=11.66, 
p<0.001), and a marginal CORT x hippocampal sub-region interaction (F6,96=2.17, 
p=0.053) on the percentage of β3-tubulin+ cells with secondary processes (Fig 
4.3C). Post hoc analysis revealed that the percentage of β3-tubulin+ cells with 
secondary processes is reduced by all concentrations of CORT irrespective of the 
hippocampal sub-regions they were derived from (all p<0.001). However, fewer 
β3-tubulin+ cells derived from the vHi NPCs had secondary processes when 
compared to cells from the dHi [0.5 µM (p=0.006), 1 µM (p=0.001), 5 µM CORT 
(p=0.001)] or to cells from the iHi [1 µM CORT (p=0.01)]. In addition, when 
treated with 5 µM CORT, the percentage of β3-tubulin+ cells with secondary 
processes derived from the iHi NPCs was reduced in comparison to those derived 





When we measured the percentage of β3-tubulin+ cells with a tertiary process, two-
way ANOVA revealed an overall effect of CORT (F3,96=25.59, p<0.001), 
hippocampal sub-region (F2,96=3.92, p=0.023), but no CORT x hippocampal sub-
region interaction (F6,96=0.31, p=0.93) (Fig 4.3D). Specifically, post hoc analysis 
revealed that the percentage of β3-tubulin+ cells with tertiary processes was reduced 
by all concentrations of CORT (0.5, 1 and 5 µM) in cells differentiated from NPCs 
irrespective of the hippocampal sub-regions they were derived from (dHi, p=0.002, 
p<0.001, p<0.001, respectively; iHi, p<0.001 for all; vHi, p<0.001 for all). 
 
We also used dendritic complexity as an index of neuronal maturation by measuring 
the lengths of primary, secondary and tertiary processes on β3-tubulin+ cells. (Fig 
4.3E-G). Two-way ANOVA on the length of primary dendritic processes revealed 
a significant effect of CORT (F3,96=21.16, p<0.001), hippocampal sub-region 
(F2,96=7.54, p=0.001) and a CORT x hippocampal sub-region interaction 
(F6,96=3.35, p=0.005) (Fig 4.3E). Post hoc analysis revealed that the concentration 
of 0.5 µM of CORT had no effect on primary process length of β3-tubulin+ cells 
derived from the dHi (p=0.3) but it decreased primary process length in cells 
derived from the iHi and vHi (p=0.022, p<0.001). Although both of the higher 
concentrations of CORT (1 and 5 µM) reduced primary process length irrespective 
of the hippocampal sub-region (dHi: p=0.036, p=0.038, respectively; iHi: p=0.011, 
p=0.002, respectively; vHi: both p<0.001), these effects were most pronounced in 
β3-tubulin+ cells derived from the vHi. Indeed, all concentrations of CORT 
decreased primary dendritic process length to a greater extent in vHi-derived β3-
tubulin+ cells compared with those from the dHi (0.5 µM, p=0.003; 1 µM, p=0.003; 






Two-way ANOVA on the length of secondary dendritic processes (Fig 4.3F) 
revealed a significant effect of CORT (F3,96=15.11, p<0.001), hippocampal sub-
region (F2,96=14.68, p<0.001), and a CORT x hippocampal sub-region interaction 
between them (F6,96=5.15, p<0.001). Post hoc analysis revealed that while none of 
the CORT concentrations (0.5 µM, 1 µM and 5 µM) altered secondary process 
length of β3-tubulin+ cells derived from the dHi (p=0.62, p=0.14, p=0.37, 
respectively), all tested concentrations reduced secondary process length in β3-
tubulin+ cells derived from the vHi (p<0.001 in all cases). Interestingly, only the 
highest dose of CORT (5 µM) CORT reduced secondary process length in β3-
tubulin+ cells derived from the iHi (p=0.004). In addition, at all CORT 
concentrations, secondary dendritic process length of β3-tubulin+ cells derived from 
the vHi were significantly shorter than those derived from the dHi (0.5 µM, 
p<0.001; 1 µM, p<0.001; 5 µM p<0.001) and those derived from the iHi (0.5 µM, 
p<0.001; 1 µM, p=0.001; 5 µM, p=0.038). Interestingly, 5 µM CORT-induced 
reductions in secondary dendritic process length were also greater in β3-tubulin+ 
cells derived from the iHi than those from the dHi (p<0.001). 
 
Two-way ANOVA on the length of tertiary processes (Fig 4.3G) in β3-tubulin+ 
cells revealed a main effect of CORT (F3,96=14.43, p<0.001), hippocampal sub-
region (F2,96=8.19, p=0.001), and a CORT X hippocampal sub-region interaction 
(F6,96=3.98, p=0.001). While post hoc analysis revealed that none of the CORT 
concentrations (0.5 µM, 1 µM and 5 µM) altered tertiary process length of β3-
tubulin+ cells derived from the dHi (p=0.47, p=0.17, p=0.49, respectively), all doses 
reduced tertiary processes length in cells derived from the iHi (p=0.002, p=0.008, 




pronounced for the β3-tubulin+ cells derived from the vHi. Indeed, at all 
concentrations of CORT tertiary process length of β3-tubulin+ cells derived from 
the vHi were significantly shorter than those from the dHi (0.5 µM, p=0.003; 1 µM, 
p=0.01; 5 µM p=0.02). Similarly, at 1µM CORT, these processes of β3-tubulin+ 
cells derived from the vHi were significantly shorter than those derived from the 
iHi (p=0.035). Corticosterone also reduced the total average dendritic length in a 
region-dependent manner (Suppl. Fig 4.6A). 
 
An MTT assay revealed that increased sensitivity of vHi NPC cultures to CORT-
induced reduction in neuronal differentiation and maturation is not due to reduced 
cell viability [Suppl. Fig 4.6B; CORT (F3,96=2.05, p=0.11); hippocampal sub-region 






Figure 4.3: Effects of longer-term corticosterone exposure on NPCs differentiation 
into neurons (β3-tubulin+) and their maturation. A, corticosterone reduces 
neuronal differentiation, especially on cells derived from the vHi; B-G, 
corticosterone reduces neuronal maturation, especially in cells derived from the 
vHi, reducing the percentage of β3-tubulin cells with primary (B), secondary (C) 
and tertiary processes (D) and the length of these processes (E-G); H-S, 
representative images of cells stained with DAPI (blue) and β3-tubulin (green). 
*p<0.05, **p<0.01, ***p<0.001, compared with respective 0 µM group, #p<0.05, 
##p<0.01, ###p<0.001, compared to cells derived from the dHi treated with the 
same concentration of corticosterone, $p<0.05, $$p<0.01, $$$p<0.001, compared 






4.3.7. The long-term corticosterone effects in NPCs, at least in part, are due to 
changes in GR expression 
Glucocorticoids receptors have been shown to regulate hippocampal neurogenesis 
(Anacker et al. 2011, Saaltink and Vreugdenhil 2014) and these receptors are 
expressed on NPCs derived from the dHi, iHi and vHi (Suppl. Fig 4.8A-C). To 
assess whether the increased sensitivity of vHi-derived NPC cultures to longer-term 
corticosterone exposure might be related to differential effects of corticosterone on 
GR, we measured nuclear GR expression in dHi, iHi and vHi cultures after long-
term (7 DIV) exposure to corticosterone (Suppl. Fig 4.8D-P). Two-way ANOVA 
revealed a significant main effect of CORT (F3,96=38.37, p<0.001), hippocampal 
sub-region (F2,96=4.43, p=0.014) but not a CORT x hippocampal sub-region 
interaction (F6,96=0.69, p=0.66) on nuclear GR expression (Suppl. Fig 4.8D). 
Specifically, post hoc analysis showed that all concentrations of CORT (0.5, 1 and 
5 µM) reduced nuclear GR expression when compared to vehicle-treated cells 
derived from the dHi (p=0.003, p<0.001, p<0.001, respectively); iHi (p<0.001 in 
all cases); vHi (p<0.001 in all cases). However, vHi cells treated with 5 µM of 
CORT had lower nuclear GR expression compared to dHi-derived cells treated with 
the same dose of CORT (p=0.049). In addition, iHi-derived cells treated with either 
1 µM or 5 µM of CORT had lower nuclear GR expression compared with dHi-
derived cells treated with the same dose (1 µM p=0.035, 5 µM p=0.049, 
respectively). 
 
4.3.8. The GR agonist dexamethasone decreased neuronal differentiation in NPCs 





The effects of long-term (7 DIV) DEX exposure on βIII-tubulin+ cells derived from 
the dHi, iHi and vHi are shown in Fig 4.4. Two-way ANOVA revealed a significant 
main effect of DEX (F3,96=13.02, p<0.001), hippocampal sub-region (F2,96=106.48, 
p<0.001) and a DEX x hippocampal sub-region interaction (F6,96=6.36, p<0.001) 
on the percentage of βIII-tubulin+ cells (Fig 4.4A). Post hoc analysis revealed that 
none of the concentrations of DEX affected βIII-tubulin+ cells derived from the dHi 
(10 nM, p=0.94; 100 nM, p=0.87; 1000 nM, p=0.36) but all concentrations of 
CORT (0.5, 1, 5 µM) reduced the percentage of βIII-tubulin+ cells derived from the 
iHi (p=0.02, p=0.018, p=0.003, respectively), and the vHi (all p<0.001). Moreover, 
DEX-induced reductions in βIII-tubulin+ cells were most pronounced in NPCs 
derived from the vHi. Indeed, 10, 100 and 1000 nM DEX induced a greater 
reduction in the percentage of β3-tubulin+ cells differentiated from vHi NPCs 
compared with those differentiated from dHi NPCs (p<0.001 for all concentrations 
of DEX), and those differentiated from iHi NPCs (p<0.001 for all concentrations of 
DEX). Also, 10, 100 and 1000 nM DEX induced a greater reduction in β3-tubulin+ 
cells differentiated from the iHi NPCs compared with those differentiated from dHi 
(p<0.001 for all concentrations of DEX). It is also important to note that, in vehicle-
treated cells, the percentage of differentiated neurons in the vHi was lower than dHi 
(p=0.037). 
 
4.3.9. Neurons derived from vHi NPCs are more sensitive to reductions in neuronal 
maturation induced by dexamethasone exposure 
As an index of neuronal maturation, we calculated the percentage of β3-tubulin+ 
cells that had a primary, secondary or a tertiary process (Fig 4.4B-D) and also 
measured the length of these dendritic processes (Fig 4.4E-G). Primary, secondary 




significant main effect of DEX (F3,96=68.31, p<0.001), hippocampal sub-region 
(F2,96=17.05, p<0.001) and a DEX x hippocampal sub-region interaction 
(F6,96=4.35, p=0.001) on the percentage of β3-tubulin
+ cells with a primary process 
(Fig 2.4B). Specifically, post hoc analysis shows that although all concentrations of 
DEX (10, 100 and 1000 nM) decreased the percentage of β3-tubulin+ cells with a 
primary process irrespective of the hippocampal sub-region they were derived from 
(dHi: p=0.005, p<0.001, p<0.001, respectively; iHi: p<0.001 in all cases; vHi: 
p<0.001 in all cases), these DEX-induced reductions were most pronounced in 
cultures derived from the vHi. Indeed, 10, 100 and 1000 nM DEX induced a greater 
reduction in the percentage of β3-tubulin+ cells with primary processes in vHi 
cultures compared with those in dHi cultures (p<0.001, p<0.001, p=0.001, 
respectively) and iHi cultures (p=0.006, p= 0.001, p=0.002, respectively).  
 
We found a similar pattern of effects by DEX when we measured the percentage of 
β3-tubulin+ cells that had a secondary process. Two-way ANOVA revealed an 
overall effect of DEX (F3,96=91.99, p<0.001), hippocampal sub-region (F2,96=14.77, 
p<0.001), and a DEX x hippocampal sub-region interaction (F6,96=2.9, p=0.012) on 
the percentage of these cells (Fig 4.4C). Post hoc analysis revealed that although 
the percentage of β3-tubulin+ cells with secondary processes was reduced by all 
concentrations of DEX irrespective of the hippocampal sub-regions they were 
derived from (all p<0.001), these reductions were most pronounced in the vHi-
derived cultures. 10, 100 and 1000 nM DEX induced a greater reduction in the 
percentage of β3-tubulin+ cells with a secondary process in vHi cultures compared 
with those in dHi cultures (p<0.001, p<0.001, p=0.001, respectively). 10 nM DEX 
also induced a greater reduction in the percentage of β3-tubulin+ cells with a 




addition, iHi-derived cells were more sensitive to these effects than dHi-derived 
cells when treated with 100 nM DEX (p=0.01) thus suggesting a gradient effect of 
DEX along the dorso-ventral axis.  
 
Although only approximately 8% of β3-tubulin+ cells developed a tertiary process, 
we also assessed the impact of DEX on these cells. Two-way ANOVA 
demonstrated an overall effect of DEX (F3,96=41.02, p<0.001), hippocampal sub-
region (F2,96=5.07, p=0.001), and no DEX x hippocampal sub-region interaction 
(F6,96=0.82, p=0.55) on the percentage of β3-tubulin cells with tertiary processes 
(Fig 4.4D). Specifically, post hoc testing revealed that although the percentage of 
β3-tubulin+ cells with a tertiary process is reduced by all concentrations of DEX 
(10, 100 and 1000 nM) in cells differentiated from NPCs irrespective of the 
hippocampal sub-regions they were derived from (dHi, p=0.001, p<0.001, p<0.001, 
respectively; iHi, all p<0.001; vHi, all p<0.001), the effects of the lowest dose (10 
nM DEX) was most pronounced in the vHi cultures [vHi 10 nM DEX vs. dHi 10 
nM DEX, p<0.004)]. 
 
We also used dendritic complexity as an index of neuronal maturation by measuring 
the lengths of primary, secondary and tertiary processes on β3-tubulin+ cells (Fig 
4.4E-G). Two-way ANOVA on the length of primary dendritic processes (Fig 4.4E) 
revealed a significant effect of DEX (F3,96=99.53, p<0.001), hippocampal sub-
region (F2,96=12.26, p<0.001) and a DEX X hippocampal sub-region interaction 
(F6,96=4.5, p<0.001). Although post hoc analysis revealed that all DEX 
concentrations (10, 100 and 1000 nM) significantly decreased primary process 
lengths irrespective of the hippocampal sub-regions the cells were derived from (all 




vHi. Indeed, all concentrations of DEX decreased primary dendritic process length 
to a greater extent in vHi-derived β3-tubulin+ cells compared with those from the 
dHi (10 nM, p<0.001; 100 nM, p=0.001; 1000 nM, p<0.001, respectively), and at 
the 10 nM concentration the primary dendritic process lengths of vHi-derived β3-
tubulin+ cells were shorter than those from the iHi (p=0.005). Interestingly, 100 and 
1000 nM DEX-induced reductions in primary dendritic process length were also 
greater in β3-tubulin+ cells derived from the iHi than those from the dHi (p=0.015, 
p=0.004, respectively).  
 
Two-way ANOVA on the length of secondary dendritic processes (Fig 4.4F) 
revealed a significant effect of DEX (F3,96=50.63, p<0.001), hippocampal sub-
region (F2,96=46.32, p<0.001), and a DEX X hippocampal sub-region interaction 
(F6,96=6.75, p<0.001). Post hoc analysis revealed that while all concentrations of 
DEX (10, 100 and 1000 nM) reduced secondary process length of β3-tubulin+ cells 
derived from the vHi (all p<0.001) and the iHi (p=0.001, p<0.001, p<0.001, 
respectively) only the higher concentrations of 100 and 1000 nM DEX reduced the 
secondary dendritic process length of cells derived from the dHi (p=0.034, p=0.005, 
respectively). Interestingly, DEX-induced decreases in secondary dendritic process 
length were more pronounced in cells derived from the iHi compared to cells from 
dHi (10 nM, p=0.013; 100 nM, p<0.001; 1000 nM, p<0.001). However, DEX-
induced decreases in secondary dendritic process length were more pronounced in 
the cells derived from the vHi when compared to both cells from the dHi (10 nM, 
p<0.001; 100 nM, p<0.001; 1000 nM, p<0.001) and the iHi (10 nM, p<0.001; 1000 





We also observed a similar gradient-like effect of DEX when we measured tertiary 
dendritic process length of β3-tubulin+ cells (Fig 4.4G). Two-way ANOVA 
revealed a main effect of DEX (F3,96=19.97, p<0.001) and hippocampal sub-region 
(F2,96=33.19, p<0.001), but no DEX X hippocampal sub-region interaction 
(F6,96=1.54, p=0.17). Post hoc analysis revealed that while all concentrations of 
DEX (10, 100 and 1000 nM) reduced the tertiary dendritic process length of β3-
tubulin+ cells derived from the vHi (all p<0.001) and iHi (p=0.002, p<0.001, 
p<0.001, respectively) only 100 nM and 1000 nM DEX reduced tertiary dendritic 
process length in dHi-derived cells (p=0.02, p=0.001, respectively). DEX-induced 
decreases in tertiary dendritic process length were more pronounced in the cells 
derived from the iHi and the vHi when compared to cells from the dHi but and this 
effect appeared to be more robust in the vHi-derived cells [(dHi vs. iHi: 10 nM, 
p<0.001; 100 nM, p=0.01; 1000 nM, p=0.009); dHi vs vHi: 10 nM p<0.001; 100 





Figure 4.4: Effects of long-term dexamethasone exposure on NPCs differentiation 
into neurons (β3-tubulin+) and their maturation. A, dexamethasone reduces 
neuronal differentiation, specifically on cells derived from the iHi and especially 
from the vHi; B-G, dexamethasone reduces neuronal maturation, especially in cells 
derived from the vHi, reducing the percentage of β3-tubulin cells with primary (B), 
secondary (C) and tertiary processes (D) and the length of these processes (D-F); 
H-S, representative images of cells stained with DAPI (blue) and β3-tubulin 
(green). *p<0.05, **p<0.01, ***p<0.001, compared with respective 0 nM group, 
#p<0.05, ##p<0.01, ###p<0.001, compared to cells derived from the dHi treated 
with the same concentration of dexamethasone, $p<0.05, $$p<0.01, $$$p<0.001, 





Dexamethasone also decreased the total average dendritic length on β3-tubulin+ 
cells in a region-dependent manner (Suppl. Fig 4.7). 
 
4.3.10. Dexamethasone-induced reductions in nuclear GR expression are greater 
in vHi-derived cultures than dHi-derived cultures 
To assess whether the increased sensitivity of vHi-derived cultures to 
dexamethasone-induced reductions in neuronal differentiation and maturation may 
related to reduced GR nuclear translocation, we measured GR expression in cell 
nuclei after long-term (7 DIV) dexamethasone (DEX) exposure (Fig 4.5A-M). 
Two-way ANOVA revealed a significant main effect of DEX (F3,96=26.0, p<0.001), 
hippocampal sub-region (F2,96=6.12, p=0.003), but no DEX x hippocampal sub-
region interaction (F6,96=0.95, p=0.46) (Fig 4.5A). Post hoc analysis revealed that 
all doses of DEX (10, 100, 100 nM) reduced nuclear GR expression irrespective of 
the hippocampal sub-region [dHi (p=0.016, p=0.003, p=0.003, respectively); iHi 
(p=0.002, p<0.001, p<0.001, respectively); vHi (all p<0.001)]. However, the 
magnitude of effects of 10 nM and 100 nM DEX were more robust in vHi-derived 
cells than those derived from the dHi (10 nM dHi vs 10 nM vHi p=0.011; 100 nM 





Figure 4.5: Effects of long-term dexamethasone exposure on nuclear GR 
expression. A, dexamethasone-induced reductions in nuclear GR expression are 
greater in vHi-derived cultures; B-M, representative images of cells stained with 
DAPI (blue) and GR (red). *p<0.05, **p<0.01, ***p<0.001, compared with 
respective 0 nM group, #p<0.05, ##p<0.01, compared to cells derived from the dHi 
treated with the same concentration of dexamethasone, according to Fishers LSD 





Stress has been shown to affect AHN preferentially in the ventral sub-region of the 
longitudinal axis of the hippocampus, but the mechanisms remain unresolved. Here 
we show differential intrinsic sensitivity of NPCs residing in this hippocampal sub-
region to the stress hormone, corticosterone which offers a possible explanation for 
such effects. We observed that NPCs derived from the dHi, iHi and vHi did not 
exhibit differential sensitivity to acute (4 h) or short-term (4 DIV) corticosterone-
induced reductions in cell proliferation and neuronal differentiation. However, 
longer-term (7 DIV) treatment with corticosterone or the glucocorticoid receptor 
(GR) agonist dexamethasone, decreased neuronal differentiation in cultures derived 
from the vHi but not the dHi, while iHi cultures showed a response intermediate to 
those of the dHi and vHi. A similar gradient-like response to corticosterone-induced 
and dexamethasone-induced reductions in both neuronal maturation and in GR 
nuclear translocation was also observed.  
 
In the present study, acute corticosterone showed detrimental effects on the 
proliferation of hippocampal NPCs, which was expected and in agreement with in 
vivo experiments that demonstrate that corticosterone and chronic stress reduce cell 
proliferation in the dentate gyrus of the hippocampus of rats (Jayatissa et al. 2006, 
Brummelte and Galea 2010). Acute stress has also been shown to transiently reduce 
hippocampal NPCs proliferation (Falconer and Galea 2003, Heine et al. 2004) in 
rats. In vitro studies show that short and long-term glucocorticoids exposure reduce 
hippocampal NPCs proliferation (Boku et al. 2009, Anacker et al. 2013) in human 
and rat NPCs. Here we also show that acute corticosterone decreases proliferation 
of NPCs to a similar extent in cells derived from the three hippocampal sub-regions. 




proliferation of NPCs, preferentially in the vHi rather than the dHi (Tanti and 
Belzung 2013, O'Leary and Cryan 2014). There is also evidence that acute restraint 
stress in rats reduces proliferation of hippocampal NPCs, preferentially in the vHi 
(Kim et al. 2005). This may indicate that the acute effects of stress or corticosterone 
on NPCs proliferation observed in vivo are not due to the intrinsic characteristics of 
the NPCs residing in each hippocampal sub-region, but to other extrinsic factors. It 
should also be noted that stress-induced reductions in NPCs proliferation are 
through cell cycle arrest (Heine et al. 2005). In rats, chronic stress has also been 
shown to elevate levels of p27Kip1, an endogenous cell cycle inhibitor, in the DG, 
which suggests that stress prevents the NPCs from re-entering the cell cycle (Heine 
et al. 2004). 
 
Corticosterone induced detrimental effects on the differentiation of NPCs into 
neurons as well as their maturation. Short-term CORT exposure reduced the 
percentage of NPCs differentiated into immature neurons (DCX cells) in all sub-
regions, as well as having a detrimental effect on the development of these DCX 
cells. Interestingly, many in vivo studies showed that the ventral part of the 
hippocampus tend to be more sensitive to corticosterone and to the effects of 
chronic stress in cell differentiation (Tanti and Belzung 2013, O'Leary and Cryan 
2014), but these studies used coronal sections for the segregation of the 
hippocampus into dHi and vHi only.  
 
Longer-term exposure to corticosterone also reduced the differentiation of NPCs 
into neurons and their maturation. Here we observed that, in these conditions, 
corticosterone reduced the percentage of NPCs differentiated into neurons (βIII-




derived from the iHi and especially the vHi are more sensitive to this long-term 
CORT effect. Raising levels of circulating glucocorticoids are known to inhibit 
differentiation of hippocampal NPCs in vivo (Wong and Herbert 2006). The present 
results are also in line with in vivo studies that show that the vHi is more sensitive 
to the effects of chronic stress (Zuena et al. 2008, Brummelte and Galea 2010, 
Morley-Fletcher et al. 2011, Hawley et al. 2012, Tanti et al. 2012, Tanti and 
Belzung 2013). Moreover, here we show for the first time that cells from the iHi 
are also more sensitive to these CORT-induced effects on hippocampal 
neurogenesis and thus more attention should be given to this hippocampal sub-
region in future studies that assess the effects of stress on AHN. Importantly, vHi 
is more sensitive to CORT only after long-term, but not short-term exposure. We 
suggest that the expression of GR may play a role in these changes, as it is known 
that the expression of the GR is variable during the neuronal differentiation of 
transient-amplifying cells to neuroblasts and then immature neurons (Garcia et al. 
2004, Egeland et al. 2015). 
 
Besides having detrimental effects in the differentiation of NPCs into neurons, 
longer-term CORT exposure also blunts the development of neuronal dendrites of 
the differentiated neurons derived from each hippocampal sub-region, but again 
preferentially in cells from the iHi and especially the vHi. It has previously been 
shown that chronic stress reduces hippocampal volume, causing dendritic atrophy 
(Lee et al. 2009) in rats. However, some studies show a specific decrease in 
hippocampal volume only in the dHi, with a corresponding increase in hippocampal 
volume in the vHi after chronic stress (Pinto et al. 2015). Nevertheless, few studies 
have reported the effects of stress on the maturation of neurons along the 




maturation in rodents, preferentially in the vHi (Tanti et al. 2012) or not (Hawley 
et al. 2012). Chronic stress also reduces neuronal maturation in non-human 
primates (Perera et al. 2011), preferentially in the anterior hippocampus. 
 
Here we used high concentrations of corticosterone, which are thought to 
demonstrate their effects on glucocorticoid receptors (Anacker et al. 2013). At low 
concentrations, corticosterone activates preferentially mineralocorticoid receptors 
(MR), which have more affinity to the stress hormone (De Kloet et al. 1998). 
Interestingly, previous studies show that GR is expressed only in 50% of the NPCs 
(Garcia et al. 2004, Boku et al. 2009, Egeland et al. 2015), while the MR is almost 
undetectable, but expressed once these cells are differentiated. To assess whether 
the preferential effects of long-term CORT exposure in cells from iHi and vHi are 
due to changes in GR translocation into the nucleus, we then assessed the expression 
of these receptors in the nuclei of cells after 7 DIV treatment with CORT. We 
observed that the longer-term treatment with CORT reduces the nuclear 
translocation of GR, specifically in cells derived from the iHi and vHi. Interestingly, 
it has been shown in vivo that 5 days stress is able to decrease GR immunoreactivity 
and that 20 days of stress can increase that, both preferentially in the dHi (Robertson 
et al. 2005). Also, blockade of GR prevents the negative effects of CORT 
administration on the proliferation of NPCs (Wong and Herbert 2005). 
 
To follow up with these results, we then confirmed that the results were GR-
dependent using the GR agonist, dexamethasone (DEX). The exposure of NPCs to 
DEX for 7 DIV reduced neuronal differentiation and maturation, in a more 
pronounced way than the CORT did. The susceptibility of vHi NPCs was even more 




characteristics in relation to the response to GR challenge. GR activation has 
already been shown to affect neurogenesis in vitro. Indeed, an in vitro study using 
human NPCs found that high levels of cortisol decreases proliferation and neuronal 
differentiation (Anacker et al. 2013). Importantly, corticosteroids activate 
glucocorticoid and mineralocorticoid receptors, translocating them from the cytosol 
into the nucleus. Interestingly, it has also been shown that chronically stressed rats 
have increased GR in the cytoplasm, but not in the nucleus in the vHi cells, while 
no changes were observed in the dHi cells (Guidotti et al. 2013). 
 
A recent study suggests that the dHi has more active neurogenesis, as it is enriched 
in maturing neurons markers, such as NeuroD1 and DCX, while the vHi is enriched 
in radial glia markers, such as Sox2 and Hes5 (Zhang et al. 2018). This is in 
accordance to previous literature that shows that dHi NPCs display faster 
maturation rate, associated with higher basal network activity (Piatti et al. 2011). 
Interestingly, we did not observe major changes in the maturation rate in vehicle-
treated NPCs, which reinforces in vivo data that the dHi NPCs faster maturation is 
connectivity-related, rather than intrinsic properties. 
 
While there is a general agreement that chronic stress decreases AHN, it is 
important to note that controverse findings have also been reported (Hanson et al. 
2011, O'Leary et al. 2012). These conflicting findings could be explained as a 
genomic heterogeneity has also been shown to occur along the longitudinal axis of 
the hippocampus of rodents, primates and humans (Thompson et al. 2008, 
Hawrylycz et al. 2012, Strange et al. 2014, O'Reilly et al. 2015) and recently it has 
been proposed that the hippocampus is a gradient, and the presence of an 




discrepancies found in literature are possibly due to the boundaries used to define 
dorsal versus ventral hippocampus (Zuena et al. 2008, Morley-Fletcher et al. 2011, 
Tanti and Belzung 2013). Most studies use coordinates of coronal slices of the 
hippocampus for the segregation into its sub-regions. It is important to note that 
these sections are not functionally independent and in the same slice there may be 
one or more hippocampal sub-region. The tripartite model of the hippocampus is 
supported by developmental gene expression study in rats, but the precise number 
of hippocampal domains is currently unknown (O'Reilly et al. 2015). Although the 
roles of the iHi have yet to be determined, the introduction of this third hippocampal 
sub-region might tackle the finding of confounding factors when assessing the 
neurogenesis across the dorso-ventral axis of the hippocampus. The few studies on 
this intermediate hippocampal sub-region show that it seems to be not only a 
transitional area, but also an integrative region (Bast 2007, Bast et al. 2009), 
mediating the integration of diverse sensory modalities (Bast et al. 2009). In the 
present study, we included this third hippocampal sub-region and we suggest that 
further research consider this possibility in the future. 
 
In summary, we have shown in the present study for the very first time that NPCs 
derived from the iHi and vHi but not the dHi are sensitive to the deleterious effects 
of the stress hormone, corticosterone, in neurogenesis. These effects are correlated 
with reduced translocation of GR into the nucleus, especially in cells from the iHi 
and vHi. Therefore, we suggest that the iHi and vHi sub-regions are promising 
targets for the treatment of stress-related psychiatric disorders and future studies 
should focus in these sub-regions, rather than in the hippocampus as a whole. 
Although NPCs culture from embryonic animals are easier to handle, here used a 




cells in embryonic animals has been shown to be located in the vHi, and cells 
migrate along the longitudinal axis of the hippocampus during early postnatal days 
(Li et al. 2013). This could lead to the interpretation that the NPCs from different 
adult hippocampal sub-regions might have the same intrinsic characteristics, but in 
the present study we observed for the first time that NPCs isolated from different 
sub-regions of the hippocampus have unique intrinsic characteristics in response to 
the stress hormone, corticosterone. This suggests that NPCs probably develop these 
intrinsic characteristics in response to glucocorticoids after migration, and this is 
probably due to the input influences they receive and differential gene expressions.  
 
Future studies should focus at the development of these sub-regional differences 
along the longitudinal axis of the hippocampus. Interestingly, at the time we 
dissected the hippocampi (at P28), the neurogenic pool from the dHi is younger 
than the one from the vHi (once the NPCs pool is initially located in the vHi and 
migrates during the first weeks of life). Thus, we suggest that, besides having 
functional changes during this migration, the age difference of NPCs from the vHi 
versus dHi might have had an impact in our research findings. Additionally, a 
complementary experiment would be to inject corticosterone directly into dHi, iHi 
and vHi and assess changes in emotional behaviours and neurogenesis. Specifically, 
the local injection of corticosterone and/or dexamethasone directly into the dHi, iHi 
and vHi would give us an insight of how the acute activation of MR/GR (in the case 
of corticosterone) or GR only (in the case of dexamethasone) may change emotional 
behaviours, including anxiety, sociability, depressive-like behaviours and learning 
& memory, but also the cell proliferation, neuronal differentiation and neuronal 





Chapter 4 - Supplementary Material 
 
S4.1. Methods 
S4.1.1. Preparation and dissociation of neurospheres 
Hippocampal tissue was collected in ice cold HABG medium [Hibernate A 
(Invitrogen, UK), B-27 minus Vitamin A (2%, Invitrogen, UK) and Glutamax (0.5 
mM, Invirogen, UK). Depending upon the experiment, neurosphere cultures were 
prepared either from the whole hippocampus (Suppl. Fig 4.1A), or from 
hippocampal sub-regions: dorsal (dHi), intermediate (iHi) and ventral (vHi) 
hippocampus (Suppl. Fig 4.1B). To obtain a sufficient number of NPCs per 
independent experiment, tissue from whole hippocampi or each hippocampal sub-
region was pooled from three or six animals, respectively. Tissue was minced and 
incubated in a warm enzymatic mix (Dispase 1 U/ml, Papain 2.5 U/ml and DNase 
I 250 U/ml); gently mixed every 3 minutes for a total of 30 min, being triturated 
after 20 min with a polished glass Pasteur pipette and with regular plastic tips at the 
end of the 30 min enzymatic digestion. The tissue was then centrifuged at 300g for 
5 minutes at room temperature (RT) and the pellet was resuspended in 1 ml HABG 
solution. After further centrifugation at 300g for 5 min at RT, the pellet was 
resuspended in 20% Percoll solution diluted in Neurobasal-A. After 10 minutes 
centrifugation at 800g at RT, the pellet was resuspended in 10 ml HABG solution. 
After 5 min centrifugation at 300g at RT, the pellet was resuspended in growth 
medium [Neurobasal A (Invitrogen, UK), B-27 minus Vitamin A (2%, Invitrogen, 
UK), Glutamax (0.5 mM, Invitrogen, UK), Penicillin/Streptomycin (50 units/ml, 
Sigma-Aldrich, UK), Heparin (2 µg/ml, Sigma-Aldrich, UK), basic fibroblast 
growth factor (bFGF, 20 ng/ml, Millipore, UK) and epidermal growth factor (EGF, 




haemocytometer/Trypan blue (Sigma Aldrich, UK) and seeded at a density of 10 x 
104 cells per well with 500 µl of medium in ultralow adherence 24-wells plates 
(Corning Life Sciences, UK), and allowed to proliferate as neurospheres for 4 days 
in vitro (DIV) under a humidified atmosphere containing 5% CO2 at 37ºC (Suppl. 




Supplementary Figure 4.1: Dissection of the hippocampus and growth of NPCs as 
neurospheres. For some experiments, NPCs were isolated from the whole 
hippocampus (A), and for most of the experiments, NPCs were isolated from the 
hippocampus segregated into three equal thirds (B), the dorsal, intermediate and 
ventral hippocampus. NPCs are isolated and cultured for 4 DIV as neurospheres 
(C), which are then dissociated and follow for the respective treatment with 
corticosterone or dexamethasone. 
 
After 4 DIV, all the content from each well of each sub-region was pooled together 
and centrifuged at 300g for 5 min at RT. The pellet was resuspended in 3 ml of 
0.08% Trypsin diluted in Neurobasal-A. After 5 minutes of enzymatic digestion, 3 
ml of trypsin inhibitor (0.125 mg/ml) with DNase I (250 U/ml) were added and the 
cell suspension was centrifuged at 300g for 5 minutes at RT. The pellet was 
resuspended in growth medium and then dissociated with a pipette, followed by 
dissociation with a syringe and needle. Viable cells were counted with 
haemocytometer/Trypan blue (Sigma Aldrich, UK) and seeded at a density of 5 x 




Aldrich, UK) coverslip in a 24-wells plate. After allowing 1 h for attachment of the 
NPCs to the surface, 460 µl of treatment medium was added. 
 
S4.1.2. Immunocytochemistry 
Cells were washed with warm Hanks’ balanced salt solution (HBSS), fixed with ice 
cold methanol at -20ºC for 10 min followed by 4% paraformaldehyde at room 
temperature for 10 min. Cells were then washed 3x5 min with PBS-0.02%TritonX 
(PBS-T) and blocked overnight at 4ºC with 5% donkey serum (DS; Sigma Aldrich) 
diluted in PBS-T. 18 h later, cells were washed 3x5 min with PBS-T and incubated 
overnight at 4ºC in the appropriate primary antibody diluted in 5% DS PBS-T [(rat 
monoclonal anti-BrdU (1:100, ab6326, Abcam), goat polyclonal anti-DCX (1:200, 
sc-8066, Santa Cruz) or mouse monoclonal anti β3-tubulin (1:250 G7121, 
Promega)]. 18 h later, cells were washed 3x5 min in PBS-T and incubated for 2 h 
at room temperature in the respective secondary antibody diluted in 5% DS PBS-T 
[(Alexa Fluor 594 donkey anti-rat (1:1000, A21209, Invitrogen), Alexa Fluor 488 
donkey anti-goat (1:500, A-11055, Invitrogen), Alexa Fluor 488 donkey anti-mouse 
(1:500, A-21202, Invitrogen)]. For experiments requiring dual labelling 
immunohistochemistry, cells were then washed 3x5min and incubated overnight at 
4ºC in the next appropriate primary antibody diluted in 5% DS in PBS-T [(goat 
polyclonal anti-Nestin (1:200, sc21249, Santa Cruz); rabbit polyclonal anti-GR 
(1:500 sc-1004, Santa Cruz)]. 18 h later, cells were washed 3x5 min with PBS-T 
and incubated for 2 h at room temperature in the respective secondary antibody 
diluted in 5% DS in PBS-T [(Alexa Fluor 488 donkey anti-goat, (1:1000 A-11055, 
Invitrogen), Alexa Fluor 594 donkey anti-rabbit (1:500, A21207, Invitrogen)]. 
After 3x5 min washes, cells were incubated in DAPI (1:1000, from a stock of 




with PBS. Coverslips were mounted onto slides using DAKO Fluorescence 
mounting medium. 
 
S4.1.3. Fluorescence microscopy and image analysis 
Fluorescent images of immunopositive cells were viewed under an Olympus BX53 
upright microscope and photomicrographs were captured (all with the same 
exposure time) at 40x magnification using an Olympus DP71 camera and cellSens 
Entry camera software™. For each treatment condition, 5 fields of view were 
randomly captured per coverslip, there were 3 coverslips per treatment per plate, 
and each experiment was repeated 3 times. Software Image J Version 1.44 was used 
to count cells, to measure the length of dendritic processes and to measure 
fluorescence intensity of GR-immunopositive nuclei.  
 
In the proliferation experiments, the percentage of NPCs [(Nestin+ cells/total DAPI+ 
nuclei) x 100] and the percentage of proliferating NPCs [(BrdU+ cells/Nestin+ cells) 
x 100] were calculated. 
 
In the experiment examining the effects of short-term (4 DIV) corticosterone 
treatment on neuronal differentiation and maturation, the percentage of immature 
neurons [(DCX+ cells/ DAPI+ cells) x 100] was calculated. The number of DCX+ 
neurons with a primary [(DCX+ cells with primary processes/total DCX+ cells) x 
100] and a secondary process [(DCX+ with secondary processes/total DCX+ cells) 
x 100] were also calculated. As an index of neuronal maturation, the average total 
length of all dendrites was calculated [(length of all dendrites/number of DCX+ 




were also measured [(length of all primary or secondary processes/number of DCX+ 
cells with primary or secondary processes, respectively) x 100].   
 
In the experiments examining the effects of long-term (7 DIV) corticosterone or 
dexamethasone treatment on neuronal differentiation, the percentage of neurons 
[(β3-tubulin+ cells/DAPI+ cells) x 100] was calculated. The percentage of β3-
tubulin+ neurons with a primary [(β3-tubulin+ cells with primary processes/total β3-
tubulin+ cells) x 100], a secondary [(β3-tubulin+ with secondary processes/total β3-
tubulin+ cells) x 100] and a tertiary process [(β3-tubulin+ with tertiary 
processes/total β3-tubulin+ cells) x 100] were also calculated. As an index of 
neuronal maturation, the total dendritic length was also calculated [(length of all 
dendrites/number of β3-tubulin+ cells) x 100]. The individual lengths of primary, 
secondary and tertiary dendritic processes were also measured [(length of all 
primary, or secondary, or tertiary processes/number of DCX+ cells with primary, or 
secondary, or tertiary processes, respectively) x 100].  
 
To determine the effects of long-term (7 DIV) corticosterone or dexamethasone 
treatment on glucocorticoid receptor (GR) translocation to the nucleus, the 
fluorescence intensity of all nuclei was assessed. The software Image J Version 1.44 
was used to draw around each nucleus and assess the fluorescence intensity, as a 
measure of nuclear GR expression. 
 
S4.1.4. Cell viability analysis [Thiazolyl Blue Tetrazolium Bromide (MTT) assay] 
An MTT assay was used to verify whether the results of long-term exposure to 
corticosterone or dexamethasone were due to altered cell viability. Briefly, after 7 




containing 10% MTT solution (5 mg/ml, Sigma Aldrich, UK) was added. 4h later, 
the medium was discarded and 100 µl of DMSO was added to each well to dissolve 
the formazan crystals. 75 µl from each well were plated in a 96-well plate and the 
absorbance at 570 nm wavelength was measured in an absorption 
spectrophotometer (Flexstation 3 Multimode Plate Reader, Molecular Devices). For 
each treatment condition, there were 3 samples per culture, and the experiment was 










Supplementary Figure 4.2: Characterisation of NPCs cultures, comparing the 
percentage of NPCs and cell proliferation between cells exposed to growth medium 
alone and cells exposed to growth medium with the vehicle used to dissolve 
corticosterone and dexamethasone (0.1% DMSO). The vehicle did not change the 
percentage of NPCs (A) or the percentage of proliferating cells (B); C-D, 
representative images of cells stained with DAPI (blue) and nestin (green); E-F, 
representative images of cells stained with DAPI (blue) and BrdU (red). 
 
 
Supplementary Figure 4.3: Effects of acute corticosterone exposure (4 h) on cell 
proliferation of NPCs derived from the whole hippocampus. A, representative 
image showing that NPCs (green) express the GR (red); B, acute corticosterone 
exposure reduced cell proliferation on NPCs from the whole hippocampus; C-E, 





S4.2.1. Acute corticosterone (4 h in vitro) exposure did not alter the percentage of 
NPCs in cultures derived from the dHi, iHi and vHi 
The effects of corticosterone (CORT) on the percentage of nestin+ cells in cultures 
derived from the dHi, iHi and vHi are shown in Suppl Fig 4.4. Two-way ANOVA 
revealed no significant effect of CORT (F3,96=2.14, p=0.1), hippocampal sub-region 
(F2,96=1.28, p=0.28) nor a CORT x hippocampal sub-region interaction (F6,96=0.43, 
p=0.86) on the percentage of nestin+ cells. 
 
S4.2.2. The effects of short-term (4DIV) corticosterone exposure on total dendritic 
length in DCX+ cells derived from the dHi, iHi or vHi 
As another index of neuronal maturation, we measured the average combined 
length of these primary and secondary dendrites per DCX+ cell. Two-way ANOVA 
revealed a significant main effect of CORT (F3,96=7.11, p<0.001), hippocampal 
sub-region (F2,96=5.9, p=0.004) but no CORT X hippocampal sub-region 
interaction (F6,96=0.24, p=0.96) on the total length of processes (Fig 4.5). 
Specifically, Fishers LSD post hoc test revealed that all concentrations of CORT 
(0.5, 1 and 5 µM) significantly reduced the total process length in cells derived from 
the iHi (p=0.017, p=0.011, p=0.032, respectively), while 1 and 5 µM of CORT 
reduced the length in cells derived from the vHi (p=0.038, p=0.037, respectively), 









Supplementary Figure 4.4: Effects of acute corticosterone (4 h) on the percentage 
of NPCs in cultures derived from the dHi, iHi and vHi. A, acute corticosterone does 
not alter the percentage of NPCs; B-M, representative images of cells stained with 






Supplementary Figure 4.5: Short-term (4 DIV) exposure to corticosterone reduces 
the total dendritic length of DCX+ cells. *p<0.05, compared with respective 0 µM 
group, according to Fishers LSD post hoc test. 
 
S4.2.3. Neurons derived from vHi NPCs are more sensitive to reductions in 
neuronal dendritic length induced by longer-term (7 DIV) corticosterone exposure 
As another feature of cellular maturation, we assessed the total length of the 
processes. Two-way ANOVA revealed a significant main effect of CORT treatment 
(F3,96=55.69, p<0.001), by hippocampal sub-region (F2,96=3.96, p=0.022), and by a 
CORT X hippocampal sub-region interaction (F6,96=2.82, p=0.014) on the total 
length of processes (Suppl. Fig 4.6A). Specifically, Fishers LSD post hoc test shows 
that the length of processes is reduced by all concentrations of CORT (0.5, 1 and 5 
µM) in cells differentiated from NPCs irrespective of the hippocampal sub-regions 
they were derived from (p<0.001 in all cases). Additionally, processes are further 
reduced in cells from the vHi, when compared to cells from the dHi, when treated 
with 0.5 µM (p=0.031), 1 µM (p=0.008) and 5 µM (p=0.014), and when compared 






Supplementary Figure 4.6: Effects of longer-term (7 DIV) exposure to 
corticosterone on neuronal maturation and cell viability. A, longer-term exposure 
to corticosterone reduces the total dendritic length of β3-tubulin+ cells, especially 
the ones derived from the vHi; B, longer-term exposure to corticosterone does not 
affect cell viability, as shown by an MTT assay. ***p<0.001, compared with 
respective 0 µM group; #p<0.05, compared to cells derived from the dHi treated 
with the same concentration of corticosterone; $p<0.05, compared to cells derived 
from the iHi treated with the same concentration of corticosterone, according to 
Fishers LSD post hoc test. 
 
S4.2.4. Neurons derived from vHi NPCs are more sensitive to reductions in 
neuronal dendritic length induced by dexamethasone 
As another feature of cellular maturation, we assessed the total length of the 
processes. Two-way ANOVA revealed a significant main effect of DEX 
(F3,96=103.65, p<0.001), hippocampal sub-region (F2,96=6.41, p=0.002), and a DEX 
X hippocampal sub-region interaction (F6,96=3.58, p=0.003) on the total length of 
processes (Suppl. Fig 4.7). Specifically, Fishers LSD post hoc test revealed that all 
concentrations of DEX decreased the average total length of dendritic processes per 
β3-tubulin+ cell irrespective of the hippocampal sub-regions they were derived 
from (all p<0.001), however these effects were more pronounced in vHi-derived 
cultures. Indeed, all concentrations of DEX decreased total dendritic process length 
to a greater extent in vHi-derived β3-tubulin+ cells compared with those from the 




DEX-induced reductions in total dendritic process length were larger in vHi-
derived β3-tubulin+ cells compared with those from the iHi (p=0.035). It is 
important to note that the total dendritic process length was longer in vehicle-treated 
cells derived from the vHi than those from the dHi- (p=0.034). 
 
 
Supplementary Figure 4.7: Effects of long-term (7 DIV) exposure to 
dexamethasone on neuronal maturation. Longer-term exposure to dexamethasone 
reduces the total dendritic length of β3-tubulin+ cells, especially the ones derived 
from the vHi. ***p<0.001, compared with respective 0 nM group; ##p<0.05, 
compared to cells derived from the dHi treated with the same concentration of 
dexamethasone; $p<0.05, compared to cells derived from the iHi treated with the 






Supplementary Figure 4.8: Effects of longer-term (7 DIV) exposure to 
corticosterone on nuclear GR expression. A-C, GR (red) is expressed in NPCs 
(green) derived from dHi (A), iHi (B) and vHi (C); D, corticosterone-induced 
reductions in nuclear GR expression are greater in iHi and vHi-derived cultures; 
E-P, representative images of cells stained with DAPI (blue) and GR (red). 
***p<0.001, compared with respective 0 µM group, #p<0.05, compared to cells 
derived from the dHi treated with the same concentration of corticosterone, 
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The hippocampus has been implicated in the pathophysiology of depression and is 
a target for antidepressant action. Adult hippocampal neurogenesis (AHN), the birth 
of new neurons throughout adult life, has been shown to play roles in learning, 
memory, and response to stress and antidepressants. Accumulating evidence 
suggests that the hippocampus is functionally segregated along its longitudinal axis 
such that the dorsal hippocampus (dHi) plays a preferential role in spatial learning 
and memory, while the ventral hippocampus (vHi) plays a preferential role in 
anxiety and stress response. The area between these two, the intermediate 
hippocampus (iHi), also seem to be functionally independent. Recent in vivo studies 
suggest that stress and antidepressants preferentially affect neurogenesis in the vHi. 
The aim of this study was to determine whether NPCs derived from the dHi, iHi, or 
vHi exhibit differential intrinsic sensitivity to the neurogenesis-promoting effects 
of the antidepressant fluoxetine (FLX). To that end, we isolated and cultured NPCs 
from the three hippocampal sub-regions of 28 days old rats, treated these cells with 
either fluoxetine alone or with fluoxetine in the presence of the stress hormone 
corticosterone and measure cell proliferation and neuronal differentiation. 
Fluoxetine alone has no effect on cell proliferation or neuronal differentiation but 
prevented the effects of corticosterone on neurogenesis. However, NPCs of the iHi 
and vHi were more sensitive to fluoxetine’s effects than those from the dHi. In 
conclusion, this study highlights the important role for iHi and vHi in mediating the 







The hippocampus has been implicated in the pathophysiology of depression and is 
a target for antidepressant action (Bremner et al. 2000, Malberg et al. 2000, Frodl 
et al. 2002, Sheline et al. 2003, Morais et al. 2017). This brain area is also one of 
just a few regions of the mammalian brain where neurogenesis, the birth of new 
neurons, occurs throughout life (Spalding et al. 2013, Kempermann et al. 2018, 
Sorrells et al. 2018). Adult hippocampal neurogenesis is a complex process 
encompassing several stages including cell proliferation, neuronal differentiation, 
maturation and integration onto the neural circuitry of the hippocampus, a process 
which takes approximately 5-6 weeks to complete. In the subgranular zone (SGZ) 
of the dentate gyrus (DG) of the hippocampus, quiescent radial glia-like neural 
progenitor (type 1) cells rarely divide but give rise to highly proliferative 
intermediate progenitor cells first with a glial (type 2a) and then a neuronal (type 
2b) phenotype. Type 2b cells then develop into neuroblasts (type 3) which exit the 
cell cycle to become post-mitotic and migrate into the granule cell layer. These 
immature neurons then enter a maturation stage whereby they extend their axon to 
CA3 and their dendrites into the molecular layer eventually becoming functionally 
integrated into the neural circuitry of the hippocampus (Christie and Cameron 2006, 
Kempermann et al. 2015).    
 
While many immature neurons are generated, many die by apoptosis and do not 
survive to become mature hippocampal granule cells. Indeed, each of the stages of 
hippocampal neurogenesis is under regulation by endogenous intrinsic and extrinsic 
factors in the neurogenic niche as well non-endogenous extrinsic factors (Gould et 
al. 1999, Malberg et al. 2000, Ming and Song 2011, Surget et al. 2011, Hueston et 




the TLX receptor (Shi et al. 2004, O'Leime et al. 2017), Wnt, Notch and Nuclear 
factor kappa ß (Mu et al. 2010, Aimone et al. 2014) have been shown to increase 
adult hippocampal neurogenesis; others such as corticosterone (Wong and Herbert 
2006) and pro-inflammatory cytokines (Bauer 2009) decrease hippocampal 
neurogenesis. Non-endogenous extrinsic factors also influence adult hippocampal 
neurogenesis. Indeed, learning and memory have been shown to increase adult 
hippocampal neurogenesis in both rats and mice (Gould et al. 1999, Dobrossy et al. 
2003, Snyder et al. 2005, Tronel et al. 2010, Epp et al. 2013) and in turn, adult 
hippocampal neurogenesis is required for some types of hippocampal-dependent 
learning (Marin-Burgin and Schinder 2012). Voluntary running and environmental 
enrichment have also been shown to increase adult hippocampal neurogenesis 
(Kempermann et al. 1997, van Praag et al. 1999, Kozareva et al. 2018). On the other 
hand, chronic stress has been shown to decrease adult hippocampal neurogenesis 
(Gould et al. 1997, Jayatissa et al. 2009, Schloesser et al. 2010, Eisch and Petrik 
2012, Levone et al. 2015). In addition, chronic treatment with antidepressant drugs 
such as fluoxetine has been shown to increase adult hippocampal neurogenesis in 
rodents (Malberg et al. 2000, Dranovsky and Hen 2006, Zhou et al. 2016). 
Moreover, inhibition of adult hippocampal neurogenesis in mice has been shown to 
prevent the behavioural effects of chronic treatment with some antidepressants 
including fluoxetine in the novelty suppressed feeding test (Santarelli et al. 2003, 
David et al. 2009). 
 
How adult hippocampal neurogenesis can play a role in processes as diverse as 
learning and memory and response to stress is not yet fully understood, but 
accumulating evidence suggests that the hippocampus is functionally divided along 




hippocampus (vHi) is plays a predominant role in anxiety, stress and antidepressant 
response and the dorsal hippocampus (dHi) preferentially regulates spatial learning 
and memory (Bannerman et al. 2004, Fanselow and Dong 2010). Recent gene 
expression studies suggest that the hippocampus is a gradient of gene expression 
along its longitudinal axis (Thompson et al. 2008, Strange et al. 2014, Cembrowski 
et al. 2016, Cembrowski et al. 2016) and the presence of an intermediate 
hippocampus (iHi) is suggested, however little is known about the specific 
functional roles of this hippocampal sub-region (Bast 2007, Bast et al. 2009). 
However, in our recent findings (Levone et al., unpublished; Chapter 2) we found 
that the iHi lesion prevents the antidepressant effects of chronic fluoxetine, 
suggesting that along with the vHi, these regions can regulate fluoxetine-induced 
changes in emotional behaviours. Moreover, iHi lesion attenuated fluoxetine-
induced anxiolytic effect in the novelty-induced hypophagia test (Levone et al., 
unpublished; Chapter 2), which is a neurogenesis-related behaviour (Santarelli et 
al. 2003, David et al. 2009). In parallel, emerging studies suggest that adult 
neurogenesis may be preferentially regulated in the dHi or the vHi, depending upon 
the stimulus (Tanti and Belzung 2013, O'Leary and Cryan 2014). Indeed, in our 
recent study (Levone et al., unpublished; Chapter 4) we found that corticosterone 
reduced neuronal differentiation and maturation preferentially in NPCs derived 
from the iHi and vHi. Moreover, some studies have reported that antidepressant-
induced increases in cytogenesis and neurogenesis occur preferentially in the vHi 
under both non-stress conditions in mice (Paizanis et al. 2010) and in rats (Banasr 
et al. 2006, Soumier et al. 2009) and under stress conditions in mice (Tanti et al. 
2012) and in rats (Jayatissa et al. 2006); chronic corticosterone also reduced 
neurogenesis preferentially in the vHi of female rats (Brummelte and Galea 2010). 




fluoxetine in the proliferation of NPCs occur preferentially in the transition between 
intermediate and ventral hippocampus (Zhou et al. 2016). Moreover a recent study 
also showed that the behavioural effects of fluoxetine both in a model of chronic 
stress and chronic corticosterone are dependent on the neurogenesis in the vHi (Wu 
and Hen 2014). Correspondingly, post-mortem human brain studies have reported 
that antidepressants increase the proliferation of neural progenitor cells 
preferentially in the anterior hippocampus (equivalent to vHi in rodents) in humans 
(Boldrini et al. 2009, Boldrini et al. 2012).   
 
Together, these data suggest that adult hippocampal neurogenesis, specifically in 
the iHi and vHi, may be an important for the neurogenic and behavioural effects of 
antidepressant drugs. However, whether the preferential effects of antidepressants 
on neurogenesis in the vHi are due to increased intrinsic sensitivity of the neural 
progenitor cells residing in this hippocampal sub-region to antidepressants is 
unclear. Thus, the aim of the present study is to assess whether neural progenitor 
cells derived from the dorsal, intermediate and ventral hippocampal sub-regions 
have differential intrinsic sensitivity to the effects of fluoxetine alone and to 
fluoxetine modulation of corticosterone-induced reductions in neurogenesis. To 
this end, we isolated neural progenitor cells from dHi, iHi and vHi, and treated them 
with fluoxetine with or without corticosterone and measured cell proliferation, 






5.2.1. Animals and preparation of hippocampal neural progenitor cell (NPC) 
neurospheres 
Procedures were performed under individual authorisations issued by the Health 
Products Regulatory Authority (HPRA) Ireland and in accordance with the 
European Parliament and the Council of the EU Directive (2010/63/EU). The dHi, 
iHi and vHi (Fig 5.1A) were dissected from male Sprague Dawley rats (postnatal 
day 28), bred at Biological Services Unit, University College Cork) as previously 
described (Walker and Kempermann 2014) (Chapter 4; Levone et al, unpublished). 
To obtain a sufficient number of NPCs per independent experiment, NPCs from 
each sub-region of 6 individual rats were pooled together. NPCs were seeded at a 
density of 10 x 104 cells per well and allowed to proliferate as neurospheres 
Neurobasal A (A2477501, Gibco), 2% B27 minus vitamin A, 0.5mM Glutamax, 50 
units/ml Penicillin/Streptomicin, 2µg/ml heparin, 20 ng/ml FGF and 20 ng/ml EGF 
4 days in vitro (DIV) prior to experimental treatment (Fig 5.1B). 
 
5.2.2. Dissociation of neurospheres and treatment of NPCs with fluoxetine and/or 
corticosterone 
After 4 DIV under proliferation conditions, neurospheres were dissociated and 
seeded at a density of 5 x 104 per well in a volume of 40 µl onto Poly-D-Lysine-
coated (1mg/ml, Sigma Aldrich, UK) coverslips in a 24-well plate. NPCs were 
allowed to adhere to the coverslips for 1 h prior to the addition of 460 µl of the 
treatment medium (for proliferation experiments: Neurobasal A (A2477501, 
Gibco), 2% B27 minus vitamin A, 0.5mM Glutamax, 50 units/ml 
Penicillin/Streptomicin, 20 ng/ml FGF and 20 ng/ml EGF; for differentiation 




Glutamax, 50 units/ml Penicillin/Streptomicin) containing the relevant 
experimental treatment. 
 
To measure the effects of fluoxetine treatment alone on cell proliferation, NPCs 
were dissociated and allowed to proliferate in growth medium (Neurobasal A, 2% 
B27 minus vitamin A, 0.5mM Glutamax, 50 units/ml Penicillin/Streptomicin, 20 
ng/ml FGF and 20 ng/ml EGF) containing 0.2 µM BrdU or growth medium 
containing 0.2 µM BrdU and different concentrations of fluoxetine (FLX; 0, 0.1 
µM and 1 µM) for 4 h in vitro prior to fixation (Fig 5.1C). 
 
To measure the effects of fluoxetine treatment alone on neuronal differentiation and 
maturation, NPCs were dissociated and allowed to differentiate in growth medium 
(Neurobasal A, 2% B27, 0.5mM Glutamax and 50 units/ml 
Penicillin/Streptomicin,) alone or growth medium with different concentrations of 
fluoxetine (0, 0.1 µM, 1 µM). Cells were allowed to differentiate for 4 DIV (Fig 
5.2A) or 2 DIV (Fig 5.2B) prior to fixation. 
 
To measure the effects of fluoxetine on corticosterone-induced reductions in 
neuronal differentiation, neuronal maturation, cell viability, and nuclear GR 
expression, NPCs were allowed to differentiate in growth medium (Neurobasal A, 
2% B27, 0.5mM Glutamax, 50 units/ml Penicillin/Streptomicin and DMSO 0.1%) 
or growth medium with corticosterone alone (CORT, 1 µM, diluted in DMSO 
0.1%), or growth medium with CORT 1 µM plus different concentrations of 
fluoxetine (0.1 µM and 1 µM). Cells were allowed to differentiate and mature for 4 






Cells were washed with warm Hanks’ balanced salt solution (HBSS), fixed with ice 
cold methanol at -20ºC for 10 min followed by 4% paraformaldehyde at room 
temperature for 10 min. Cells were then washed 3x5 min with PBS-0.02%TritonX-
100 (PBS-T) and blocked overnight at 4ºC with 5% donkey serum (DS; Sigma 
Aldrich) diluted in PBS-T. 18 h later, cells were washed 3x5 min with PBS-T and 
incubated overnight at 4ºC in the appropriate primary antibody diluted in 5% DS 
PBS-T [(rat monoclonal anti-BrdU (1:100, ab6326, Abcam) or goat polyclonal anti-
DCX (1:200, sc-8066, Santa Cruz)]. 18 h later cells were washed 3x5 min in PBS-
T and incubated for 2 h at room temperature in the respective secondary antibody 
diluted in 5% DS PBS-T [(Alexa Fluor 594 donkey anti-rat (1:1000, A21209, 
Invitrogen), Alexa Fluor 488 donkey anti-goat (1:500, A-11055, Invitrogen)]. For 
experiments requiring dual labelling immunohistochemistry, cells were then 
washed 3x5min and incubated overnight at 4ºC in the appropriate primary antibody 
diluted in 5% DS in PBS-T [(goat polyclonal anti-Nestin (1:200, sc21249, Santa 
Cruz); rabbit polyclonal anti-GR (1:500 sc-1004, Santa Cruz)]. 18 h later, cells were 
washed 3x5 min with PBS-T and incubated for 2 h at room temperature in the 
respective secondary antibody diluted in 5% DS in PBS-T [(Alexa Fluor 488 
donkey anti-goat, (1:1000 A-11055, Invitrogen), Alexa Fluor 594 donkey anti-
rabbit (1:500, A21207, Invitrogen)]. After 3x5 min washes, cells were incubated in 
DAPI (1:1000, from a stock of 1ul/ml, Sigma-Aldrich, UK) diluted in 2% DS in 
PBS-T for 10 min and then washed with PBS. Coverslips were mounted onto slides 
using DAKO Fluorescence mounting medium. 
 




Fluorescent images of immunopositive cells were viewed under an Olympus BX53 
upright microscope and photomicrographs were captured (all with the same 
exposure time) at 40x magnification using an Olympus DP71 camera and cellSens 
Entry camera software™. For each treatment condition, five fields of view were 
randomly captured per coverslip, there were three coverslips per treatment per plate, 
and each independent experiment was repeated three times. Software Image J 
Version 1.44 was used to count cells, to measure the length of dendritic processes 
and to measure fluorescence intensity of GR-immunopositive nuclei.  
 
In the proliferation experiments, the percentage of NPCs [(Nestin+ cells/total DAPI+ 
nuclei) x 100] and the percentage of proliferating cells [(BrdU+ cells/DAPI cells) x 
100] were calculated. 
 
In the neuronal differentiation experiments, the percentage of immature neurons 
[(DCX+ cells/ DAPI+ cells) x 100] was calculated. As an index of neuronal 
maturation, the average length of processes per DCX+ cells was measured [(sum of 
all processes length)/ (number of DCX+ cells)]. 
 
To determine the effects of fluoxetine treatment on glucocorticoid receptor (GR) 
translocation to the nucleus, the fluorescence intensity of nuclear GR of all cells in 
each field of view was measured. For each treatment condition, five fields of view 
were randomly captured per coverslip, there were three coverslips per treatment per 
plate, and each experiment was repeated three times. The software Image J Version 
1.44 was used to draw around each nucleus and assess the fluorescence intensity, 





5.2.5. Cell viability analysis [Thiazolyl Blue Tetrazolium Bromide (MTT) assay] 
An MTT assay were used to determine whether the effects of fluoxetine on 
corticosterone-induced reduction in neuronal differentiation and maturation were 
due to altered cell viability. Briefly, following 4 DIV under differentiation 
conditions the media was removed and growth media containing 10% MTT solution 
(5 mg/ml, Sigma Aldrich, UK) was added. Four hours later, the medium was 
discarded and 100 µl of DMSO was added to each well to dissolve the formazan 
crystals. 75 µl from each well were plated in a 96-well plate and the absorbance at 
570 nm wavelength was measured in an absorption spectrophotometer (Flexstation 
3 Multimode Plate Reader, Molecular Devices). For each treatment condition, there 
were three samples per plate, and the experiment was repeated three times. 
 
5.2.6. Statistical analysis 
Data were analysed using IBM SPSS Statistics 23. For the experiment measuring 
the effects of fluoxetine on NPC proliferation and differentiation, two-way 
ANOVA was used. For the experiment measuring the effects of fluoxetine on 
corticosterone-induced reductions in neuronal differentiation and maturation, three-
way ANOVA was used. If a main effect reached statistical significance, group-wise 
comparisons were made using Fishers LSD post-hoc test. Data are expressed as the 









5.3.1. Fluoxetine did not affect cell proliferation in dHi, iHi or vHi NPC cultures 
We first characterised the NPCs cultures from dHi, iHi and vHi by calculating the 
percentage of cells in the culture that were indeed NPCs (Nestin+/total number of 
DAPI nuclei). We observed that 90-95% of cells were nestin+, thus confirming the 
purity of the NPC cultures.  
 
The effects of fluoxetine on cell proliferation in NPC cultures derived from the dHi, 
iHi or vHi are shown in Fig 5.1D, E. Two-way ANOVA revealed no main effect of 
fluoxetine (F2,72=0.31, p=0.73), hippocampal sub-region (F2,72=0.97, p=0.39), nor a 








Figure 5.1: Effects of acute fluoxetine exposure (4 h in vitro) on cell proliferation 
from NPCs derived from dHi, iHi and vHi. A, dHi, iHi and vHi dissected from P28 
Sprague-Dawley rats. B, NPCs growing as neurospheres. C, Experimental 
timeline: NPCs were isolated and cultured as neurospheres for 4 DIV, then 
dissociated and treated with fluoxetine (0.1 µM or 1 µM) for 4h in vitro prior to 
fixation and immunocytochemistry. D, Fluoxetine did not affect cell proliferation 
(BrdU+ cells) in NPCs derived from the dHi, iHi or vHi. E, Representative images 
of proliferating cells derived from the dHi, iHi and vHi; stained with DAPI (blue) 






5.3.2. Fluoxetine treatment alone did not affect neuronal differentiation  
The effects of 4 days treatment with fluoxetine on neuronal differentiation 
(percentage of DCX+ cells) of NPCs from the dHi, iHi and vHi are shown in Fig 
5.2C, E. Two-way ANOVA revealed no main effect of either fluoxetine (F2,72=0.44, 
p=0.65), hippocampal sub-region (F2,72=0.04, p=0.96), nor a fluoxetine x 
hippocampal sub-region interaction (F4,72=0.43, p=0.79) on neuronal 
differentiation. 
 
We noticed that in the control groups, the majority of cells had differentiated into 
neurons (i.e. 90% - 95% were DCX+). Such a high starting point may have 
precluded any potential fluoxetine-induced increases in neuronal differentiation 
from being observed. Therefore, in the next experiment we reduced the time 
allowed for differentiation to 2 DIV and then measured the effects of fluoxetine on 
neuronal differentiation (percentage of DCX+ cells) in dHi, iHi and vHi NPC 
cultures (Fig 5.2D). Again, two-way ANOVA revealed no main effect of fluoxetine 
(F2,72=1.94, p=0.15), hippocampal sub-region (F2,72=0.51, p=0.6) nor a fluoxetine x 







Figure 5.2: Effects of fluoxetine on neuronal differentiation of NPCs derived from 
the dHi, iHi and vHi. A, Timeline of the 4 DIV exposure experiment: neurospheres 
were dissociated after proliferating for 4 days and exposed to fluoxetine for further 
4 DIV under differentiation conditions prior to fixation and immunocytochemistry. 
B, Timeline of the 2 DIV exposure experiment: neurospheres were dissociated and 
exposed to fluoxetine for 2 DIV prior to fixation and immunocytochemistry. C, 4 
DIV exposure to fluoxetine had no effects on neuronal differentiation of NPCs 
derived from either the dHi, iHi or vHi. D, 2 DIV exposure to fluoxetine had no 
effects on neuronal differentiation of NPCs derived from either the dHi, iHi or vHi. 
E, representative images of immature neurons differentiated from dHi, iHi and vHi 
NPCs; stained with DAPI (blue) and DCX (green). 
 
5.3.3. vHi and iHi NPC cultures were more sensitive to fluoxetine prevention of 
corticosterone-induced reductions in neuronal differentiation  
There are some reports from in vivo studies that the effects of antidepressants on 




(Tanti et al. 2012) or in the presence of corticosterone (Rainer et al. 2012). Indeed, 
it has been reported that antidepressant-induced neurogenesis from a human 
hippocampal progenitor cell line (HPC03A/07) are mediated by the glucocorticoid 
receptor (Anacker et al. 2011) and we have previously found that 4 DIV treatment 
with corticosterone decreased neuronal differentiation in hippocampal NPCs from 
P28 rats (Levone et al., unpublished; Chapter 4). Thus, we next investigated 
whether fluoxetine could counteract corticosterone-induced reductions in neuronal 
differentiation and whether such effects might be differentially affected in NPCs 
isolated from the dHi, iHi or vHi.  
 
The effects of fluoxetine on corticosterone-induced reductions in neuronal 
differentiation are shown in the Fig 5.3B, C. Three-way ANOVA revealed a main 
effect of corticosterone (F1,96=14.66, p<0.001) and of fluoxetine (F2,96=5.98, 
p=0.004) but not of hippocampal sub-region (F2,96=0.32, p=0.73), nor 
corticosterone x hippocampal sub-region (F2,96=0.17, p=0.85) nor fluoxetine x 
hippocampal sub-region (F4,96=0.4, p=0.81). Post-hoc analysis revealed that 
corticosterone significantly reduced neuronal differentiation from dHi NPCs 
(p=0.043) and vHi NPCs (p=0.009) and a similar trend was observed in the iHi 
cultures (p=0.06). These corticosterone-induced reductions in neuronal 
differentiation were prevented by 1 μM (but not 0.1 μM) fluoxetine in the iHi 
(p=0.038 vs. 1 μM CORT) and vHi (p=0.008 vs. 1 μM CORT) cultures. 
Interestingly, the fluoxetine-treated dHi cultures were not significantly different to 
the dHi cultures treated with corticosterone alone (0.1 μM, p=0.5; 1 μM, p=0.3 vs. 
1 μM CORT), thus suggesting that the vHi and iHi cultures were more sensitive to 





5.3.4. Neither fluoxetine alone nor fluoxetine plus corticosterone significantly affect 
neurite length of neurons differentiated from dHi, iHi or vHi NPCs 
The average neurite length per DCX+ cells was measured as an index of neuronal 
maturation. The effects of 4 days treatment with fluoxetine alone on neuronal 
average neurite length in DCX+ cells differentiated from dHi, iHi and vHi NPC 
cultures are shown in Fig 5.4A. Two-way ANOVA revealed no effects of fluoxetine 
(F2,72=0.005, p=0.99), hippocampal sub-region (F2,72=0.036, p=0.97), nor a 
fluoxetine x hippocampal sub-region interaction (F4,72=0.65, p=0.63). 
 
The effects of fluoxetine in combination with corticosterone on average neurite 
length per DCX+ cells differentiated from dHi, iHi and vHi NPC cultures are shown 
in Fig 5.4B. Three-way ANOVA revealed a main effect of corticosterone 
(F1,96=4.15, p=0.044), but no effect of fluoxetine (F2,96=0.32, p=0.73) or 
hippocampal sub-region (F2,96=2.19, p=0.12), nor corticosterone x hippocampal 
sub-region (F2,96=0.12, p=0.89) nor fluoxetine x hippocampal sub-region 
(F4,96=0.46, p=0.77). However, post hoc analysis revealed no significant differences 





Figure 5.3: Neural progenitor cells of the iHi and vHi are more sensitive to 
fluoxetine prevention of corticosterone-induced reductions in neurogenesis than 
those from the dHi. A, Timeline of the experiment: neurospheres were dissociated 
after 4 days growth and exposed to either corticosterone alone or corticosterone 
and fluoxetine (0.1 µM or 1 µM) for 4 DIV. B, Fluoxetine prevented corticosterone-
induced reductions in neuronal differentiation, preferentially in cells derived from 
the iHi and vHi. C, Representative images of immature neurons differentiated from 
the dHi, iHi and vHi; stained with DAPI (blue) and DCX (green). *p<0.05, 
**p<0.01, compared with respective 0 µM group, #p<0.05, ##p<0.01, compared 






Figure 5.4: No differences were found on the average total length of neurites per 
DCX+ cell treated with fluoxetine alone for 4 DIV (A) or corticosterone and 
fluoxetine for 4 DIV (B). 
 
5.3.5. The sub-regional effects of fluoxetine prevention of corticosterone-induced 
reductions in neuronal differentiation are not due to alterations in cell viability or 
nuclear GR expression 
The effects of corticosterone and fluoxetine on neuronal differentiation are not due 
to alterations in cell viability, as shown in Fig 5.5A. Three-way ANOVA 
demonstrated that there was no effect of corticosterone (F1,96=2.06, p=0.16), 
fluoxetine (F2,96=1.7, p=0.19), or hippocampal sub-region (F2,96=1.01, p=0.37). 
Similarly, there were no significant interactions [corticosterone x hippocampal sub-










Figure 5.5: Effects of fluoxetine and corticosterone on cell viability and nuclear 
GR expression. A, Neither corticosterone alone nor corticosterone plus fluoxetine 
co-treatment affected cell viability as assessed with an MTT assay. B, Fluoxetine 
seems to alleviate corticosterone-induced reductions on nuclear GR expression 
irrespective of the hippocampal sub-region cells were derived from. C, 
representative images of cells derived from the dHi, iHi and vHi stained with DAPI 





The effects of corticosterone and fluoxetine on nuclear glucocorticoid receptor 
(GR) expression are shown in Fig 5.5B, C. Three-way ANOVA revealed a 
significant effect of corticosterone (F1,96=8.71, p=0.004), a trend for an effect of 
fluoxetine (F2,96=2.75, p=0.069) and no effect of hippocampal sub-region 
(F2,96=0.24, p=0.79). There was no interaction between hippocampal sub-region 
and corticosterone (F2,96=0.11, p=0.9) or sub-region and fluoxetine (F4,96=0.07, 
p=0.99). Post-hoc analysis revealed that while there were trends for corticosterone 
to decrease nuclear GR in cells derived from the dHi (p=0.054) and vHi (p=0.07), 
but not iHi (p=0.19) when compared their respective vehicle group, this pattern of 
effects was not apparent in fluoxetine-treated cells from any hippocampal sub-
region (dHi, 0.1 μM p=0.23, 1 μM p=0.38; vHi, 0.1 μM p=0.16, 1 μM p=0.18 vs. 








Understanding the cellular actions of antidepressants is a key goal in developing 
novel more efficacious strategies for treating depression. The present study 
investigated whether NPCs isolated from the dHi, iHi or vHi sub-regions of the 
hippocampus exhibit differential intrinsic sensitivity to the neurogenic effects of 
the antidepressant, fluoxetine, in the absence or presence of the stress hormone, 
corticosterone. We found that fluoxetine alone did not affect neurogenesis in any 
of the NPC cultures. However, NPCs of the intermediate and ventral hippocampus 
were more sensitive to fluoxetine prevention of corticosterone-induced reductions 
in neurogenesis than those from the dorsal hippocampus.  
 
In vivo studies have reported that chronic fluoxetine increase cell proliferation in 
rats (Malberg et al. 2000) and in mice (Zhou et al. 2016), preferentially in the iHi 
and vHi (Zhou et al. 2016). However, in the present in vitro study we did not see 
an effect of fluoxetine alone on cell proliferation thus suggesting that fluoxetine 
does not exert its effects via direct actions on NPCs. In contrast to our findings, 
other studies have demonstrated that fluoxetine increases cell proliferation in vitro 
(Hui et al. 2014, Wang et al. 2014). The primary pharmacological target of 
fluoxetine is the serotonin transporter, but studies have shown that it is not 
expressed on hippocampal NPCs (Schmitt et al. 2007) which may perhaps explain 
the absence of a direct effect of fluoxetine on the cell proliferation in vitro. 
 
In addition to not affecting cell proliferation, we also found that fluoxetine had no 
effect on neuronal differentiation of NPCs after 4 DIV exposure to fluoxetine. We 
observed in the control group that the majority of cells had differentiated into 




neuronal differentiation from being observed. Therefore, in the next experiment we 
reduced the time allowed for differentiation to 2 DIV and then measured the effects 
of fluoxetine on neuronal differentiation. However, most cells had differentiated 
into neurons, and again no effects of fluoxetine were observed. This suggests that 
the fluoxetine-induced increases in neuronal differentiation reported in in vivo 
studies (Wang et al. 2008, Wang et al. 2011) are via indirect mechanisms. However, 
it is worth noting that fluoxetine has been shown to increase neuronal differentiation 
from embryonic hippocampal NPCs of rats (Wang et al. 2014). In addition, an in 
vitro study demonstrated that sertraline, which like fluoxetine is a selective 
serotonin reuptake inhibitor, increased neuronal differentiation from isolated 
human NPCs and that this effect was mediated through activation of the 
glucocorticoid receptor (Anacker et al. 2011). As described above, several in vivo 
studies report fluoxetine increase AHN, but negative findings have also been 
reported in vivo, for example, a study showed that chronic fluoxetine has no effect 
on neuronal differentiation in mice (Wang et al. 2008). In fact, some studies have 
shown that antidepressant-like drugs, including fluoxetine, increase neurogenesis 
in the presence of stress only (Banasr et al. 2006, Jayatissa et al. 2006, O'Leary et 
al. 2012, Tanti et al. 2012, O'Leary and Cryan 2014). 
 
Given the reports that some antidepressants exert neurogenic effects via GR and 
that some studies only observe neurogenic effects of fluoxetine under stress 
conditions, we then assessed the effects of the fluoxetine on corticosterone-induced 
reductions of neuronal differentiation. We have previously observed that 4 DIV 
exposure to corticosterone reduced neuronal differentiation at the same extent in 
NPCs isolated from the dHi, iHi and vHi, while 7 DIV exposure to corticosterone 




(Levone et al., in preparation). Thus, we decided to use 4 DIV exposure rather than 
7DIV to fluoxetine to avoid any confounding effects of preferential effects of 
corticosterone on vHi NPCs. Here, we replicated the findings of our previous study 
(Levone et al., in preparation), in which we observed that 4 DIV exposure to 1 µM 
corticosterone reduced neuronal differentiation. However, fluoxetine (1 µM) 
significantly prevented this effect in iHi and vHi-derived while only attenuating it 
in dHi cultures. Although these are modest effects, this is the first time to our 
knowledge that fluoxetine shows a preferential neurogenic effect on isolated iHi 
and vHi-derived NPCs. 
 
Although we found a promising effect of fluoxetine on preventing corticosterone-
induced reductions on neuronal differentiation, here we found no effects of 
fluoxetine alone, corticosterone alone, or co-treatment of fluoxetine plus 
corticosterone on neurite length of dHi, iHi or vHi NPCs. In contrast, an in vivo 
study showed that chronic fluoxetine treatment increases neuronal maturation in 
mice, increasing the number of DCX+ cells with tertiary dendrites (Wang et al. 
2008). Chronic corticosterone has been shown to reduce maturation of immature 
neurons (Fenton et al. 2015), an effect that was prevented by chronic co-treatment 
with imipramine, a tricyclic antidepressant. However, the present study found that 
only a very low percentage of cells had secondary processes, thus we hypothesise 
that if neurons were allowed to mature for a longer time, more robust effects of 
corticosterone and fluoxetine on neurite length and branching might be observed. 
Indeed, in our previous study (Levone et al., in preparation), we found that the 
effects of 7 days treatment with corticosterone on neuronal maturation in these 
cultures were much more robust than the findings shown here. Further studies 




induced reductions in cell proliferation and neuronal maturation in these 
hippocampal sub-region-specific NPC cultures. 
 
To determine if differential sensitivity of the NPC cultures to fluoxetine prevention 
of corticosterone-induced reductions on neuronal maturation were due to 
differential GR sensitivity, we measured nuclear expression of GR. Although 1 µM 
corticosterone did not cause a statistically significant reduction in nuclear GR 
expression, cells derived from the dHi and vHi showed a trend for reduced nuclear 
GR expression. This trend was no longer observed when any of the cell cultures 
were co-treated with either concentration of fluoxetine. Thus, differential effects of 
fluoxetine on preventing corticosterone-induced decreases in neuronal 
differentiation in different NPC cultures were not due to differential sensitivity of 
GR to fluoxetine plus corticosterone.  
 
In summary, here we showed that iHi and vHi NPCs were more sensitive to 
fluoxetine in preventing corticosterone-induced reductions in neuronal 
differentiation than those from the dorsal hippocampus. Interestingly, fluoxetine 
alone had no direct effect on cell proliferation, neuronal differentiation and 
maturation on NPCs derived from the dHi, iHi or vHi. Taken together, we suggest 
that fluoxetine neurogenic effects reported in vivo are likely through indirect 
mechanisms. However, fluoxetine showed a direct neurogenic effect in vitro under 
stress-like conditions, and these effects were predominantly observed in the iHi and 
vHi thus suggesting that NPCs along the longitudinal axis of the hippocampus 
likely exhibit differential intrinsic sensitivities to antidepressants under stress 




















































6.1. General Summary of Results 
The overall aim of this thesis was to determine whether specific sub-regions of the 
longitudinal axis of the hippocampus play differential roles in the behavioural and 
neurogenesis responses to stress, the stress hormone corticosterone and an antidepressant 
drug. To achieve this goal, this thesis investigated whether neural progenitor cells 
(NPCs) derived from either dorsal (dHi), intermediate (iHi) or ventral hippocampus 
(vHi) have differential intrinsic sensitivities to the stress hormone, corticosterone, 
and to the glucocorticoid receptor (GR) agonist, dexamethasone. Using 
hippocampal sub-region-specific ibotenic acid-induced lesions, the roles of the dHi, 
iHi and vHi on emotional behaviours and neuroendocrine responses under chronic 
psychosocial stress conditions were then investigated. Then using the same lesion 
approach, the roles of the dHi, iHi and vHi on emotional behaviours and the 
neuroendocrine response under baseline and under antidepressant (fluoxetine) 
treatment were assessed. Finally, whether NPCs derived from the dHi, iHi or vHi 
have differential intrinsic sensitivities to the reported neurogenesis-promoting 
effects of fluoxetine was then investigated. 
 
As summarised in Table 1, the most important findings in this thesis were that the 
vHi plays the most predominant role in regulation of emotional behaviours followed 
by the iHi, while the contribution of the dHi, particularly in the absence of stress 
was comparably smaller. In parallel, we found that NPCs derived from the iHi and 
especially the vHi were more sensitive to long-term exposure to corticosterone and 
fluoxetine. These results indicate that both the iHi and especially the vHi are 
important areas in the regulation of emotional behaviours and thus are promising 





In Chapter 4, we determined that NPCs derived from the dHi, iHi and vHi did not 
exhibit differential sensitivity to acute (4 h in vitro) corticosterone-induced 
reductions in cell proliferation or to short-term (4 DIV) corticosterone-induced 
reductions in neuronal differentiation and maturation. However, longer-term (7 
DIV) exposure to corticosterone or the GR agonist dexamethasone decreased 
neuronal differentiation in cultures derived from the vHi but not the dHi, while iHi 
cultures showed an intermediate response to those of the dHi and vHi. A similar 
gradient-like response was observed on effects on nuclear GR expression after 
corticosterone or dexamethasone. These results suggest that cells derived from the 
vHi and to some extent iHi, are intrinsically more sensitive to the detrimental effects 
of corticosterone and dexamethasone on hippocampal neurogenesis in vitro. 
 
Given the increased sensitivity of iHi and vHi-derived NPCs to the stress hormone 
corticosterone, we next explored in Chapter 3 whether there may be differences in 
the expression of genes related to the stress response and neurogenesis across the 
different hippocampal sub-regions. Indeed, we found differences in the expression 
of some such genes along the longitudinal axis of the hippocampus thus suggesting 
potentially different contributions of the dHi, iHi and vHi in response to stress. To 
test this hypothesis, we lesioned the dHi, iHi or vHi and examined its impact on the 
behavioural and neuroendocrine responses to chronic psychosocial stress. We 
observed that iHi lesions increased stress-induced social avoidance. Stress-induced 
increases in anxiety in the novelty-induced hypophagia and marble burying tests 
were prevented by all lesions irrespective of hippocampal sub-region. However, 
only vHi lesions attenuated stress-induced anxiety in the open field test. Stress-
induced anhedonia was reduced by dHi and vHi, but not iHi lesions. Interestingly, 




increased the latency to adopt a defeat posture during social defeat thus indicating 
increased active coping behaviour in vHi lesioned mice. Taken together, these 
results suggest specific sub-regions along the longitudinal axis of the hippocampus 
modulate specific behavioural responses to chronic psychosocial stress. 
 
Since we found that the vHi was involved in antidepressant-like behaviour in the 
FST, we then decided to investigate the roles of the dHi, iHi or vHi in the regulation 
of social, anxiety, anhedonia and depressive-like behaviour in the absence or 
presence of the antidepressant fluoxetine (Chapter 2). In the absence of fluoxetine, 
vHi lesions reduced anxiety, while none of the lesions affected sociability, 
anhedonia or depressive-like behaviour under these conditions. On the other hand, 
only vHi lesions prevented the antidepressant effects of acute fluoxetine treatment 
in the tail suspension test and the anxiolytic effects of chronic fluoxetine treatment 
in the novelty-induced hypophagia test. Interestingly, only iHi lesions prevented 
the antidepressant effect of chronic fluoxetine treatment in the forced swim test, 
while dHi lesions did not impact antidepressant- or anxiety-related behaviour either 
in the absence or presence of fluoxetine. These data showed for the first time that 
both the iHi and vHi play distinct roles in fluoxetine-induced anxiolytic and 
antidepressant-like behaviour.  
 
Since we observed a role for the vHi in modulating the effects of fluoxetine in the 
novelty-induced hypophagia test, a behaviour previously reported to be dependent 
on adult hippocampal neurogenesis (AHN) (Santarelli et al. 2003), we then decided 
to investigate whether dHi, iHi and vHi NPCs may exhibit differential sensitivity 
to fluoxetine. While we found no effects of fluoxetine alone on neurogenesis in any 




differentiation of NPCs derived from the iHi and vHi, while only attenuating those 
effects in NPCs derived from the dHi (Chapter 5). 
 
Taken together, these data suggest that the vHi regulates anxiety and the anxiolytic 
and acute antidepressant behavioural effects of fluoxetine, and antidepressant-like 
behaviour under chronic stress conditions. On the other hand, like the dHi, the iHi 
does not seem to regulate emotional behaviour under baseline conditions. However, 
the iHi has a role in mediating social avoidance under chronic stress conditions and 
also plays a role in the antidepressant effects of chronic fluoxetine treatment. In 
parallel, we observed that vHi NPCs were more sensitive to the effects of long-term 
exposure to the stress hormone corticosterone when compared to those from the iHi 
and the dHi. However, we also observed that iHi NPCs were more sensitive to 
corticosterone than those from the dHi. Similarly, under stress-like conditions only 
(i.e. in the presence of corticosterone) we found that NPCs derived from the vHi 
and iHi and were more sensitive to the effects of fluoxetine than those derived from 
the dHi. For an overview of all findings in the present thesis, see Table 6.1. Taken 
together, we suggest that future studies aimed at identifying novel hippocampal-












Table 6.1. General summary of results 
 dHi iHi vHi 
In vitro findings 
Corticosterone 
4 h ↓ Proliferation ↓ Proliferation ↓ Proliferation 






7 DIV ↔ Differentiation 
↓ Maturation  
↓ Nuclear GR  
↓↓ Differentiation 
↓↓ Maturation  
↓↓ Nuclear GR 
↓↓↓ Differentiation 
↓↓↓ Maturation  
↓↓ Nuclear GR 
Dexamethasone 
7 DIV ↔ Differentiation 
↓ Maturation  
↓ Nuclear GR 
↓↓ Differentiation 
↓↓ Maturation  
↓ Nuclear GR 
↓↓↓ Differentiation 
↓↓↓ Maturation  
↓↓ Nuclear GR 
Fluoxetine 
4 h ↔ Proliferation ↔ Proliferation ↔ Proliferation 






Fluoxetine on corticosterone-treated cells 






In vivo findings 
Anxiety Behaviours 
Baseline conditions ↔ ↔ ↓ in EPM, MBT, 
NIH, OF 
Chronic Stress  ↓ in MBT, NIH ↓ in MBT, NIH ↓ in MBT, NIH 
↓ in OF 
Fluoxetine  ↔ ↔ ↑ NIH 
Anhedonia 
Baseline conditions ↔ ↔ ↔ 
Chronic Stress  ↓ in SP, FUST ↔ ↓ in SP, FUST 
Fluoxetine  ↔ ↔ ↔ 
Depression 
Baseline conditions ↔ ↔ ↔ 
Chronic Stress  ↔ ↔ ↓ in FST 
Fluoxetine  ↔ ↑ in FST ↑ in TST 
Abbreviations: FST: forced swim test, FUST: female urine sniffing test, GR: 
glucocorticoid receptor, MBT: marble burying test, NIH: novelty-induced 
hypophagia, OF: open field, SP: saccharin preference test, TST: tail suspension 
test. 
 
6.2. Stuck in the Middle: Rationale for Subdividing the 
Hippocampus into Three Sub-Regions  
Accumulating evidence suggests that the hippocampus is segregated along its 




posterior and anterior sub-regions in primates (Moser and Moser 1998, Fanselow 
and Dong 2010). A growing body of evidence has been supporting the idea that the 
hippocampus is actually a gradient and differential gene expression is found along 
its longitudinal axis (Moser and Moser 1998, Thompson et al. 2008, Strange et al. 
2014, Cembrowski et al. 2016, Cembrowski et al. 2016). Using an RNAseq 
database (Cembrowski et al. 2016), we confirmed these differences in the 
expression of several genes in the dentate gyrus of the dHi (dDG) versus vHi (vDG) 
of the mouse hippocampus. In agreement, several studies have reported differential 
gene expression in the dDG versus vDG in rats (Christensen et al. 2010) and in 
mice (Cembrowski et al. 2016). Besides finding changes in several systems of 
neurotransmission, here we described differential expression in the 
mineralocorticoid receptor, growth factor genes and genes related to neurogenesis 
in the vDG compared to dDG, supporting that the vHi expresses more genes that 
favour cell proliferation, while dHi expresses more genes that favour neuronal 
differentiation (Chapter 3). In agreement, a recent study suggests that the dHi has 
more active neurogenesis and is enriched with maturing neurons markers, such as 
NeuroD1 and DCX, while the mouse vHi is enriched of radial glia markers, such as 
Sox2 and Hes5 (Zhang et al. 2018). Accordingly, dHi neural progenitor cells have 
been shown to mature faster, associated with higher basal network activity (Piatti 
et al. 2011). Interestingly, we did not observe this in our cell cultures, in which dHi 
and vHi NPCs had a similar rate of proliferation, differentiation and maturation. 
Perhaps this is not surprising, given that these cells were isolated from the 
surrounding brain environment. 
 
Although these findings demonstrate a clear differential expression of some genes 




are expressed as a gradient along the hippocampal longitudinal axis in mice 
(Thompson et al. 2008, Strange et al. 2014, Cembrowski et al. 2016), and as such, 
the presence of an intermediate hippocampus is suggested. In this thesis, we also 
used a database to assess whether some genes are differentially expressed along the 
longitudinal axis of the hippocampus, more specifically in the dorsal CA1 (dCA1), 
intermediate CA1 (iCA1) and ventral CA1 (vCA1) (Chapter 3). Again, we found 
differentially expressed genes between dorsal and ventral sub-regions, but also 
between intermediate and dorsal and between intermediate and ventral sub-regions. 
These changes include genes related to several neurotransmission systems and 
plasticity. In agreement, previous studies have shown that genes are differentially 
expressed along the longitudinal axis of the CA1 (Leonardo et al. 2006, Dong et al. 
2009, Cembrowski et al. 2016, Pacheco et al. 2017) and CA3 (Thompson et al. 
2008). Interestingly, we also found that the mineralocorticoid receptor was 
expressed at lower level in the vCA1 versus dCA1, while the iCA1 had an 
intermediate expression of this receptor, supporting a gradient expression of the 
MR along the longitudinal axis of the hippocampus. This may suggest that cells 
derived from the dHi, iHi and vHi respond differentially to stress. Indeed, a study 
supports the idea that the dHi and vHi have distinct epigenetic responses to acute 
stressors (Floriou-Servou et al. 2018), with the vHi being particularly more 
sensitive to the stressor. Moreover, the receptor NMDA3a was also expressed in a 
gradient along the longitudinal axis of the hippocampus, and the vHi showed higher 
levels of expression. Interestingly, a previous study showed that glutamatergic 
receptors are differently expressed between dorsal and ventral hippocampus (Pandis 
et al. 2006). Most of the previous studies, however, compared only the dorsal half 
versus the ventral half of the hippocampus. A study dissected the rat hippocampus 




and also found that some genes are differentially expressed in the vHi versus the 
dHi (Lee et al. 2017). 
 
In addition to these gene expression studies, other studies used different boundaries 
to define dorsal versus ventral hippocampus (Zuena et al. 2008, Morley-Fletcher et 
al. 2011, Tanti and Belzung 2013). Most studies use coordinates of coronal slices 
of the hippocampus for the segregation into its sub-regions. Perhaps, it is important 
to note that a coronal brain section might not contain one specific hippocampal sub-
region only but may also contain more than one sub-region. The precise number of 
hippocampal domains is currently unknown (O'Reilly et al. 2015). Although the 
roles of the iHi have yet to be precisely determined, the few studies on this 
hippocampal sub-region show that it seems to be not only a transitional area 
between the dHi and vHi, but also an integrative region (Bast 2007, Bast et al. 
2009), mediating the integration of diverse sensory modalities (Bast et al. 2009). 
The intermediate hippocampus is also involved in cognitive flexibility, engaging in 
rapid place encoding (Bast et al. 2009), and, like the dHi, plays a role in processing 
spatial information (Kenney and Manahan-Vaughan 2013). In this thesis, we 
included this third hippocampal sub-region and analysed its roles in emotional 
behaviours under chronic stress and chronic antidepressant treatment and, in vitro, 
the isolated NPCs response to corticosterone and fluoxetine. Here, we describe for 
the first time that the intermediate hippocampus plays no role in emotional 
behaviours in the absence of stress or antidepressants, however, this hippocampal 
sub-region mediates the antidepressant effects of chronic fluoxetine in the FST, and 





It is important to notice that, besides the important circuits we cited in this thesis, 
there are other circuits that may play a role in the behavioural effects of chronic 
stress or fluoxetine. For example, the bed nucleus of the stria terminalis (BNST) 
has been shown to play critical roles in anxiety (Lebow and Chen 2016). Besides 
that, the intrahippocampal circuitry may play an important role on the results found 
in this thesis and should be further studied in the future. In fact, based on the 
information that the iHi has already been shown to be as a region of association 
between dHi and vHi (Bast et al. 2009), here we suggest that the lesions of the iHi 
may cause a disruption on the coherence between the dHi and vHi and the results 
observed after iHi lesion could be due to a lack of communication between these 
two hippocampal sub-regions.  
 
For the in vivo part of the present study, we used the coordinates shown in Fig 6.1 
to segregate the hippocampus into dHi, iHi and vHi. According to the Paxinos atlas 
for mouse brain (Paxinos 2012), the coordinates are as follows (in coronal slices, 
distance from bregma: dHi: -1.22 to -2.54 mm; iHi: -2.7 to -3.5 mm (dorsal part); 
vHi: -3.28 to -3.88 mm (ventral part). We decided to segregate the hippocampus 
into three sub-regions once there is already evidence in the literature showing that 
the intermediate part seems to be an independent sub-region on its own, and thus 
we suggest that future studies should segregate the hippocampus into these three 
independent sub-regions. However, we acknowledge that the hippocampus might 
be segregated into more independent sub-regions (Zhou et al. 2016), which need to 
be further studied. Even by segregating the hippocampus into only three sub-
regions, there is a heterogeneity in the cell population between these regions. 
Specifically, it has been described that field CA1 cytoarchitecture is heterogeneous 




this might influence the segregation of the hippocampus, but in the present study 
we cannot precise the impact that this might have on the information flow. We 
suggest, however, that the introduction of more sub-regions would increase this 
heterogeneity between the regions.  
 
 
Figure 6.1: In the left, the coordinates used to segregate the hippocampus into dHi, 
iHi and vHi, according to the atlas of Paxinos for mice brain (Paxinos 2012) in our 
in vivo studies (coordinates in relation to bregma). In the right the segregation of 
the hippocampus in dHi, iHi and vHi used for our in vitro studies. dHi in blue, iHi 
in green and vHi in pink. 
 
For the in vitro part of this study, however, the hippocampus was segregated into 
three equal thirds, to ease the process of gross dissection and segregation of the 
hippocampus. Here we acknowledge that this difference in the segregation 
coordinates used in the in vitro and in vivo parts of this thesis may at some extent 
hinder the comparison between both studies. Moreover, another confounding factor 
that may interfere in the comparison between the in vitro and in vivo parts of this 
thesis is that we used mice for our in vivo part and rats for our in vitro part. We 
suggest that future studies should be more consistent and use the same species for 




cannot discount the possibility that behavioural effects observed could be due to the 
other two remaining intact sub-regions. A control lesioning the whole hippocampus 
could be a form of counteracting this limitation. 
 
6.3. From the Dish to Disease: In Vitro Models to Predict In Vivo 
Efficacy in Stress and Antidepressant Research 
It is common agreement that cells in culture do not perfectly mimic cells in a 
complex living system. However, isolating them to single cells in a dish might help 
us understand the intrinsic characteristics of the individual cells, without the 
interference of the environment where these are located in an organism. They are 
also useful tools to allow us to study the dynamics of their intracellular molecular 
signalling pathways. Organoids, for example, derive from cells which self-organise 
in three-dimensional cultures (Foley 2017) and are one of most physiologically 
relevant ways to have them in culture. 2D monolayer cell cultures can also be 
useful, as it is easier to control their homogeneous exposure to the culture medium 
with a treatment of choice, and they are easier to be analysed using relatively 
standard microscopy tools. 
 
While embryonic hippocampal NPCs are more numerous, easier to culture, grow 
better and produce more cells than hippocampal NPCs from the adult brain, they 
are unsuitable for our research questions involving the interrogation of NPCs from 
specific regions along the longitudinal axis of the hippocampus. The niche of 
neurogenic cells in embryonic mice has been shown to be initially located in the 
ventral pole of the hippocampus, and these cells migrate along the longitudinal axis 
towards the dorsal hippocampus during early postnatal life and is thought to be 




is a suitable time to interrogate NPCs along the longitudinal axis of the 
hippocampus. Here, we adapted a protocol used to isolate and culture adult mouse 
NPCs (Walker and Kempermann 2014) for use for the isolation of NPCs from P28 
rats, thus limiting the challenges associated with working with adult hippocampus-
derived NPCs. The fact that all sub-regional NPCs arise from the same neurogenic 
pool (initially located in the vHi) could lead to the interpretation that the NPCs from 
different adult hippocampal sub-regions should have the same intrinsic 
characteristics. However, in the present study we demonstrated for the first time 
that NPCs isolated from different sub-regions of the hippocampus have unique 
intrinsic sensitivities in response to the stress hormone, corticosterone (Chapter 4), 
but not to the antidepressant, fluoxetine (Chapter 5). These findings suggest that 
NPCs from different hippocampal sub-regions probably develop these intrinsic 
characteristics in response to glucocorticoids after migration, and this is probably 
due to the neural input influences (the connections that each hippocampal sub-
region does) they receive which might cause them to differentially express some 
relevant genes. However, we also hypothesise that the age of the animals is a critical 
factor and should always be taken into consideration, as these NPCs have recently 
finished the migration along the longitudinal axis of the hippocampus, and whether 
their response to corticosterone change in an age-dependent manner is unknown. 
We do know, however, that it would not be possible to study the differences of dHi, 
iHi and vHi in embryonic NPCs or NPCs from younger animals since they are 
predominantly located in the ventral pole. Taken together, the differential 
sensitivities of dHi, iHi and vHi to longer-term corticosterone exposure may at least 
in part explain the in vivo reported that AHN in the vHi is particularly vulnerable 





Several in vivo studies have shown that chronic stress and chronic antidepressant 
treatment affect AHN preferentially in the ventral sub-region of the hippocampus, 
which is also a sub-region related to the control of the HPA axis in response to 
stress. In the in vitro part of this thesis, we isolated neural progenitor cells (NPCs) 
from the dHi, iHi and vHi, in an effort to determine whether these cells, when 
isolated and free from external influences, respond differentially to the stress 
hormone corticosterone, the glucocorticoid receptor agonist dexamethasone, or the 
antidepressant fluoxetine (Chapters 4 and 5). In vivo, corticosterone and chronic 
stress have been shown to reduce cell proliferation in the dentate gyrus of the 
hippocampus of rats (Jayatissa et al. 2006, Brummelte and Galea 2010). Acute 
stress has also been shown to transiently reduce hippocampal NPCs proliferation 
(Falconer and Galea 2003, Heine et al. 2004) in rats. In vitro studies show that short 
and long-term glucocorticoids exposure reduce cell proliferation in human 
(Anacker et al. 2013) and rat (Boku et al. 2009) NPCs. In agreement, this thesis 
reports that acute corticosterone decreases cell proliferation to a similar extent in 
cells derived from the three hippocampal sub-regions (Chapter 4). However, we 
found no effects of fluoxetine on cell proliferation (Chapter 5 of this thesis for more 
details). 
 
In contrast to our findings, several in vivo studies have reported that corticosterone 
(Brummelte and Galea 2010, Anacker et al. 2013) and chronic stress (Malberg and 
Duman 2003, Heine et al. 2005, Kim et al. 2005, Mitra et al. 2006, Dagyte et al. 
2009, Jayatissa et al. 2009) decrease proliferation of NPCs, preferentially in the vHi 
rather than the dHi, and that antidepressants increase neurogenesis preferentially in 
the iHi and vHi (Zhou et al. 2016). Taken together, our results may indicate that the 




proliferation in the vHi as observed in vivo are not due to the intrinsic characteristics 
of the NPCs residing in each hippocampal sub-region, but due to other factors 
perhaps related to the influences that these cells receive where they reside. Another 
possibility is that the NPCs were not exposed to corticosterone or fluoxetine long 
enough.  
 
We next exposed the cells to corticosterone or fluoxetine for 4 DIV under 
differentiation conditions and found that most NPCs differentiated into neurons. 
The preferential differentiation into neurons was intentional, as the culture media 
was serum-free conditions, and this is known not to favour astrocytic 
differentiation. Under these conditions, we found again that corticosterone reduces 
neuronal differentiation and maturation to a similar extent in all hippocampal 
cultures irrespective of the sub-regional source, and fluoxetine alone had no effect 
on neuronal differentiation or maturation. Interestingly however, we found that 
fluoxetine prevents corticosterone effects on neuronal differentiation in iHi and 
vHi-derived cultures, while it only attenuates these effects in dHi-derived cultures. 
This suggests that preferential neurogenic effects of fluoxetine observed under 
chronic stress conditions in vivo could in part be due to differential intrinsic 
characteristics of NPCs residing in different sub-regions along the longitudinal axis 
of the hippocampus. However, we observed that very few (2-4%) of the immature 
neurons obtained after 4 DIV had secondary processes, which suggests that they 
were still in the process of maturation. Thus, longer term exposure to fluoxetine 
may be required to obtain a more complete insight into the effects of fluoxetine and 





Taking into consideration the in vivo studies that show that the vHi is more sensitive 
to the effects of chronic stress (Zuena et al. 2008, Brummelte and Galea 2010, 
Morley-Fletcher et al. 2011, Hawley et al. 2012, Tanti et al. 2012, Tanti and 
Belzung 2013) combined with the limited number of neurons with a more mature 
morphological phenotype in the 4 DIV cultures, we then decided to expose the 
NPCs to corticosterone for a longer period (7 DIV). 7 DIV corticosterone exposure 
reduced neuronal differentiation and their maturation in cultures derived from all 
hippocampal sub-regions. However, cells derived from the iHi and more especially 
those derived from the vHi were more sensitive to these effects of long-term 
corticosterone exposure. This is in accordance with the in vivo studies previously 
cited. Thus, here we show for the first time that cells from the iHi are also more 
sensitive to these CORT-induced effects on hippocampal neurogenesis and thus 
more attention should be given to this hippocampal sub-region in future studies that 
assess the effects of stress on hippocampal function. In addition, we suggest that 
the preferential effects of chronic stress on vHi AHN observed in vivo could at least 
in part be due to the differential intrinsic sensitivity of NPCs resident in the vHi to 
corticosterone.  
 
Taking into consideration that the vHi is more sensitive to the effects of 
corticosterone after long-term, but not short-term exposure, we suggest that the 
expression of GR may play a role in differential response to corticosterone, as it is 
known that the expression of the GR is variable during the neuronal differentiation 
of transient-amplifying cells to neuroblasts and then immature neurons (Garcia et 
al. 2004, Egeland et al. 2015), and different expression of GR on our short-term 
versus longer-term experiments may have been responsible for or diverse results in 




the longer-term treatment with corticosterone (7 DIV) reduced the nuclear 
translocation of GR, specifically in cells derived from the iHi and vHi. These results 
were in accordance with our results on cell differentiation and maturation. 
However, it has been shown in vivo that 5 days stress is able to decrease GR 
immunoreactivity, while 20 days of stress increase it, both preferentially in the dHi, 
but not in the vHi (Robertson et al. 2005), but the expression of GR specifically in 
NPCs or adult born neurons was not investigated thus making it more difficult to 
make direct comparison to our data. To follow up with these results, we then 
interrogated whether there were sub-regional differences in the intrinsic sensitivity 
of differentiating neurons to the GR agonist, dexamethasone. Indeed, exposure of 
NPCs to dexamethasone for 7 DIV reduced neuronal differentiation and maturation, 
and in a more pronounced way than corticosterone did. The sensitivity of vHi NPCs 
to dexamethasone was even more apparent suggesting that neurons generated from 
vHi NPCs display intrinsically higher GR sensitivity. Moving forward, it will be 
important that future studies determine whether these in vitro findings will translate 
to the in vivo setting. To test whether these in vitro findings on neurogenesis might 
contribute to the behavioural results from the lesion studies, the manipulation of 
AHN in specific areas of hippocampus (e.g. the overexpression/knockdown of 
TLX, etc) would be informative. Indeed, it has been reported irradiation-induced 
ablation of AHN in the vHi but not dHi prevents the behavioural effects of 
fluoxetine (Wu and Hen 2014). The roles of AHN in specific sub-regions including 







6.4. Lesion Studies and Other Approaches on the Neuroscience Era 
of Circuit-Dissection 
Many of the previous studies which assessed the roles of the hippocampus used 
specific cytotoxic lesions to unveil the differential functional roles of dHi versus 
vHi (Morris et al. 1982, Moser et al. 1995, Bannerman et al. 2002, Kjelstrup et al. 
2002, Bannerman et al. 2003). More recent studies, however, have been using more 
modern techniques, including optogenetics and chemogenetics (Felix-Ortiz et al. 
2013, Felix-Ortiz and Tye 2014, Carreno et al. 2016, Padilla-Coreano et al. 2016, 
Parfitt et al. 2017, Jimenez et al. 2018). Briefly, here we used ibotenic lesions of 
the dHi, iHi, or vHi to investigate whether these hippocampal sub-regions play 
distinct roles on emotional behaviours in baseline and in response to chronic 
antidepressants (Chapter 2) or chronic psychosocial stress (Chapter 3). 
 
In Chapter 3 of this thesis, we described the roles of dHi, iHi and vHi in the 
behavioural and neuroendocrine responses to chronic psychosocial stress. We chose 
to use a protocol of social defeat and overcrowding, as previous studies in our 
laboratory demonstrated that this protocol of stress promotes consistent reductions 
in social interaction (Finger et al. 2011, Burokas et al. 2017). While stress decreased 
social interaction in all experimental groups, we did observe that iHi lesions 
exacerbated stress-induced social avoidance and that vHi lesions increased the 
latency to adopt a defeat posture during social defeat protocol, possibly suggesting 
that vHi mediates active coping behaviour. To the best of our knowledge, this is the 
first time that a role for the iHi in stress-induced social avoidance has been reported. 
However, previous studies have implicated the vHi in resilience to social defeat 






Interestingly, in Chapter 2 of this thesis we showed that lesions of the vHi but not 
of the dHi or iHi robustly reduced anxiety in the elevated plus maze, novelty-
induced hypophagia, marble burying and open field tests in mice in baseline (with 
no stress or antidepressant treatment). Our findings of vHi modulation of anxiety 
are in agreement with previous reports, which showed that vHi lesions in rats 
reduced hyponeophagia (Bannerman et al. 2002, Bannerman et al. 2003, McHugh 
et al. 2004, Esposito et al. 2005, Ge et al. 2006) and decreased anxiety in several 
behavioural tests (Bannerman et al. 2002, Kjelstrup et al. 2002, Bannerman et al. 
2003, McHugh et al. 2004, Esposito et al. 2005, Ge et al. 2006, Pentkowski et al. 
2006). Moreover, optogenetic and pharmacogenetic studies have reported that 
several vHi neural pathways regulate anxiety in the open field and elevated plus 
maze (Felix-Ortiz et al. 2013, Padilla-Coreano et al. 2016, Parfitt et al. 2017). 
However, It is also important to note that an optogenetic study demonstrated that 
the activation of mature granule cells of both the dHi and vHi DG reduces anxiety 
behaviour in the elevated plus maze in mice (Kheirbek et al. 2013). In Chapter 3 of 
this thesis we found that in agreement with previous studies, chronic stress 
increased anxiety in several behavioural tests (Finger et al. 2011, Slattery et al. 
2012, Burokas et al. 2017). Interestingly, we found that lesions of either the dHi, 
iHi or vHi all prevented stress-induced anxiety in the marble burying and in 
novelty-induced hypophagia tests. To the best of our knowledge, this is the first 
time that this has been shown in these behavioural tests under chronic stress 
conditions. While the present results might suggest that all hippocampal sub-
regions mediate stress-induced anxiety, this effect may be test-dependent, as a 
different picture emerged in the open field test, whereby lesions of the vHi had an 




of the open field, an effect not due to alterations in locomotor activity. Again, this 
further highlights the predominant role that the vHi seems to have in anxiety.  
 
In agreement with previous studies, in Chapter 2 of this thesis reported that chronic 
fluoxetine treatment had anxiolytic effects in the novelty-induced hypophagia test 
(Santarelli et al. 2003, Dulawa et al. 2004, Dulawa and Hen 2005), and in the 
marble burying test (Nicolas et al. 2006, Greene-Schloesser et al. 2011). vHi lesions 
prevented the anxiolytic effects of chronic fluoxetine treatment in the novelty-
induced hypophagia test but not in the marble burying test. The reasons underlying 
this differential effect are currently unclear but may indicate that fluoxetine-induced 
anxiolytic effects occur through different mechanisms or different pathways in 
these two tests. For example, AHN has been shown to be important for the 
anxiolytic effects of fluoxetine in a similar test of neohypophagia, the novelty-
suppressed feeding (Santarelli et al. 2003, David et al. 2009). Moreover, several 
studies report that chronic treatment with antidepressants (Banasr et al. 2006, 
Soumier et al. 2009, Paizanis et al. 2010, O'Leary and Cryan 2014) including 
fluoxetine (Tanti et al. 2012), preferentially increase AHN in the vHi. Moreover, it 
was recently reported that new neurons in the mouse vHi are required for the 
anxiolytic effects of chronic fluoxetine treatment to be manifested in the novelty-
supressed feeding test (Wu and Hen 2014). 
 
In Chapter 2, we found that none of the hippocampal sub-region lesions affected 
anhedonia (in the saccharin preference and female urine sniffing tests). Here we 
also found that fluoxetine did not have an effect in the female urine sniffing test. 
This is a relatively new test (Malkesman et al. 2010) which has yet to be fully 




However, in Chapter 3, we found that the chronic psychosocial stress paradigm 
induced an anhedonic effect in the saccharin preference and female urine sniffing 
tests. This is in contrast with some reports, which showed that this specific stress 
paradigm increased anxiety without altering saccharin preference (Slattery et al. 
2012) or sucrose preference (Hammels et al. 2015). However, it has been reported 
that chronic social defeat stress does induce anhedonia in the female urine sniffing 
test (Finger et al. 2011, Lehmann et al. 2013, Burokas et al. 2017), and in the 
saccharin preference test (Liu et al. 2018). In our study, we found that lesions of 
either the dHi or vHi prevented stress-induced anhedonia in both the saccharin 
preference test and the female urine sniffing test. Interestingly, iHi lesions did not 
affect stress-induced anhedonia in either of these tests. Taken together, we show for 
the first time that the dHi and vHi, but not the iHi play a role in the stress-induced 
anhedonia. 
 
In Chapter 2, we describe that the lesion of any hippocampal sub-region in baseline 
did not alter depressive-like behaviour in the forced swim test. Interestingly vHi 
lesions prevented the antidepressant effects of acute fluoxetine treatment in the tail 
suspension test. To the best of our knowledge, this is the first time that the vHi is 
shown to mediate the antidepressant effects of acute treatment with an 
antidepressant drug. Here we found that iHi lesions prevented the antidepressant 
effects of chronic fluoxetine in the forced swim test. This is the first time that the 
iHi has been shown to play a role in the antidepressant effects of chronic fluoxetine. 
When we examined the impact of chronic stress and lesions on antidepressant-like 
behaviour, we found that chronic psychosocial stress did not alter immobility time 
in the forced swim test. In accordance with our results, a growing number of studies 




depressive-like behaviours in the forced swim test (Keeney and Hogg 1999, Kinsey 
et al. 2007, Slattery et al. 2012, Hammels et al. 2015). Interestingly however, we 
found that stressed vHi-lesioned animals showed reduced immobility time when 
compared to both sham groups thus indicating an antidepressant-like phenotype. 
Intriguingly, this effect is not apparent in non-stressed vHi-lesioned mice (Chapter 
3). Others have reported that chemogenetic activation of the vHi to medial 
prefrontal cortex pathway in non-stressed rats exerts an antidepressant-like effect 
in the forced swim test and that inactivation of this pathway is also required for the 
sustained antidepressant-like effects of ketamine in this test (Carreno et al. 2016). 
Here, we found that under chronic stress conditions vHi lesions induce 
antidepressant-like effects thus suggesting that, under chronic stress conditions, 
other vHi-mediated pathways regulate antidepressant like effects in this test. Taken 
together, we show for the first time that the vHi plays a role in modulating 
antidepressant-like behaviour in the mouse forced swim test under chronic stress 
conditions 
 
Comparing the results of the same tests, used in different experiments, we found 
some differences in the performance of sham animals. Specifically, the largest 
difference we found was in the novelty-induced hypophagia test, in which we 
found, that control sham animals in the baseline, fluoxetine and stress experiments 
had an average latency difference of 150 s, 300 s and 70 s, respectively. 
Interestingly, sham animals in the antidepressant study were injected with saline 
daily and this per se could have been a stressor that might have increased latency 
in this test. However, the same pattern was not observed in the open field test in 
which we found that control sham animals in the baseline, fluoxetine and stress 




behavioural tests showed very consistent results across all experiments including 
the marble burying test (approximately 10 marbles buried by sham animals in all 
experiments), the saccharin preference test (approx. 80%, in the baseline 
experiment; 60-70% preference in the chronic stress experiment), the female urine 
sniffing test (80% for baseline and stress experiments; 70% for antidepressant 
experiment). Finally, for the forced swim test, we found an average of 140 s 
immobility for sham animals in the baseline experiment, 110 s for chronic stress 
experiment and 125 s for antidepressant experiment. Taken together, differences 
found might have been due to differences in experimental conditions as outlined 
below. 
 
In the baseline experiment, animals started behavioural tests one week after the 
stereotaxic surgery. For chronic antidepressant and chronic stress studies, however, 
this happened 26 and 28 days after, respectively. Moreover, animals in the baseline 
and antidepressant experiments were group housed, while animals in the chronic 
stress experiment were singly housed after the surgery. The findings observed here 
are in contrast with a previous study that showed that singly housing increases 
anxiety and depression-like behaviour (Berry et al. 2012). In the present thesis, we 
singly housed the animals in the chronic stress experiment in accordance with 
previous studies performed in our laboratory (Finger et al. 2011, Burokas et al. 
2017), but future studies should consider including a sham-group housed group. 
  
Finally, it is important to emphasise that the hippocampus has connections with 
many other brain regions and plays diverse other roles not cited in the present thesis. 
These other brain connections, however, could also be involved in the results shown 




hippocampus to the lateral septum is involved in feeding behaviour (Sweeney and 
Yang 2015). The novelty-induced hypophagia test, a test used here to assess 
anxiety, has also a feeding component. Whether the vHi to lateral septum circuit is 
involved with the results obtained in the novelty-induced hypophagia is unknown. 
Also, it has been shown by optogenetics that the stimulation of the nucleus 
accumbens to the ventral hippocampus circuit increases locomotor activity (Bagot 
et al. 2015). The marble burying test, a test used here to assess anxiety, also has an 
active/locomotor behaviour component. Whether the nucleus accumbens to vHi 
circuit is involved in the marble burying test, however, is still unknown. Also, the 
elevated plus maze (EPM), the most classical test used to assess anxiety, also 
involves other components, including risk assessment and spatial navigation. While 
the risk assessment is an emotional behaviour and thus preferentially regulated by 
the vHi, spatial navigation is preferentially regulated by the dHi. Interestingly, we 
only observed an anxiolytic effect of the vHi lesion in the EPM, but we did not use 
any test to assess spatial navigation, thus we cannot argument this other component 
of the EPM. 
 
Finally, it is important to emphasise that the hippocampus also plays role in many 
other functions not related in this thesis. Indeed, the ventral hippocampus has also 
been shown to play roles in olfactory functions (Vanderwolf 2001), reward (Riaz et 
al. 2017) and contextual decision making (Ross et al. 2011), thus the ventral 
hippocampus lesion performed in the present study could have altered several other 
functions not assessed in the present thesis. Additionally, the intermediate 
hippocampus has also been shown to send projections to the lateral septum rostral, 
which in turn projects to hypothalamic medial zone nuclei, a brain region involved 




study, the lesion of iHi did not alter social behaviour, but did prevent chronic 
fluoxetine-induced reductions in anxiety and antidepressant-like behaviour. 
 
6.5. Limitations and Future Directions: Towards New Treatment 
Strategies for Depression and Stress-Related Disorders 
 
6.5.1. Intermediate hippocampus 
Throughout this thesis, we demonstrated that the iHi seems to be a separate 
hippocampal sub-region, with its own functional roles. Some studies, however, 
suggest that the hippocampus is composed of many independent areas along the 
longitudinal axis. While most of the studies segregate the hippocampus into dHi 
and vHi, we segregated it into three sub-regions, including the iHi, in an effort to 
tackle discrepancies found in the literature, which use diverse boundaries to 
segregate the hippocampus into dorsal and ventral regions. We suggest that future 
studies should consider the intermediate hippocampus as a functionally independent 
sub-region. Moreover, we suggest that future studies should have a consensus on 
the specific coordinates used for dorsal, intermediate and ventral hippocampus, 
both in rats and in mice. 
 
6.5.2. Cell culture studies 
Several in vivo and in vitro studies have shown that chronic stress and chronic 
glucocorticoid or antidepressant treatment affect neurogenesis. Whether this 
happens differentially along the dorsoventral axis of the hippocampus is not 
completely clear. In this thesis, we isolated NPCs from P28 SD rats, specifically 
from the dHi, iHi and vHi, although culture of NPCs from non-embryonic animals 




protocol used in the laboratory. Future work by other researchers planning to use 
this protocol should be willing to spend several months on protocol validation. 
Here, NPCs were grown as neurospheres for 4 DIV, then the neurospheres were 
dissociated into single cells and then treated them with corticosterone for 4 h, 4 DIV 
or 7 DIV. We found a strong detrimental effect of 7 DIV corticosterone and 
dexamethasone on the differentiation and maturation of NPC-derived neurons, 
especially on those derived from the iHi and vHi. To confirm whether these results 
are really GR-dependent, future studies should focus on the reversal of these effects, 
using the GR antagonist RU486. 
 
The isolation of NPCs from dHi, iHi and vHi could also be used as a tool to verify 
whether these cells, when isolated, show differential gene expression, both at 
baseline and after corticosterone and/or an antidepressant treatment. To the best of 
our knowledge, this assessment has never been done and would help unveil if and 
which genes are differentially expressed in these NPCs. After identifying the 
potential genes or proteins of interest, these could be silenced/overexpressed, in an 
effort to identify targets that could induce AHN more rapidly than current 
antidepressant agents. 
 
6.5.3. Lesion studies 
Many previous studies have used the lesion approach to find out the functional roles 
of the dHi and vHi. In the current era of optogenetic and chemogenetic neural 
circuitry dissection, this technique may be considered old-fashioned, but it is still 
useful to assess the functional roles of these regions. A limiting factor, however, is 
that the lesions with ibotenic acid do not allow the lesion of a specific area of the 




limited idea of what specific vHi inputs or outputs actually mediate the various 
findings. To do this, optogenetics or DREADDs would be a useful approach. 
 
In the present study, we used the lesions approach to assess whether dHi, iHi and 
vHi mediate emotional behaviours and neuroendocrine response under baseline, 
under chronic psychosocial stress and under chronic fluoxetine treatment. Here, we 
discussed our data using other studies that focused specifically on the network 
between the ventral hippocampus and other brain regions, such as nucleus 
accumbens, amygdala and medial prefrontal cortex. However, several other brain 
regions could be involved in the results found in this thesis. 
 
Using lesion approach, future work should first assess whether dHi, iHi and vHi 
mediate the fluoxetine-induced recovery from stress-induced anxiety and 
depressive-like behaviour. Then, the specific mechanistic processes of how the vHi 
mediates anxiety under baseline conditions, antidepressant-like behaviour under 
chronic stress conditions, and anxiolytic and antidepressant effects of chronic 
fluoxetine treatment should be more deeply assessed. For that, in vivo optogenetics 
or DREADDs could be a possible approach. Excitation and inhibition of specific 
pathways between the dHi, iHi and vHi and other brain areas under baseline, 
chronic stress and chronic antidepressant treatment conditions would help to 
elucidate the mechanism underlying how these hippocampal sub-regions lesions 
exerted their effects. 
 
6.5.4. Towards new treatment strategies for depression and stress-related disorders 
Studying the mechanisms underlying antidepressant action can help on the 




anaesthetic that showed acute antidepressant effects in human trials, brought the 
hope that the discovery of a better antidepressant could be near. However, after 
finding that ketamine has adverse effects, and its effects are actually limited, we 
understand that much research still has to be done in this regard for the discovery 
of better antidepressants.  
 
For future work, the identification and understanding of the mechanism of how 
newly-born neurons contribute to the response and recovery from stress, and to the 
response to antidepressants would make a big step towards new treatment strategies 
for depression and stress-related disorders. The knowledge on the roles of different 
hippocampal sub-regions should be deepened, aiming for a better understanding of 
the pathophysiology of anxiety, depression and stress-related disorders. We suggest 
that future studies should focus on understanding the pathways to and from the 
diverse hippocampal sub-regions, and how they modulate emotional behaviours 
and the response to stress and antidepressants. A useful tool would be to study this 
comparing stress-susceptible with stress-resilient animals. A gene expression study 
along the longitudinal axis of the hippocampus of stress susceptible versus stress 
resilient animals would be helpful to identify new antidepressant targets. Similarly, 
it would be also helpful to identify differential gene expressions along the 
longitudinal axis of the hippocampus of antidepressant responder versus non-
responder animals. 
 
In the near future, the role of genetics and epigenetics in the pathophysiology of 
depression should also be better understood. Mutant genetic code and molecular 
abnormalities, besides the classical neurotransmission malfunction, should be taken 




abnormalities can change the efficiency of cell signalling (Stahl 2013). Genetic 
polymorphisms of serotonergic, noradrenergic and dopaminergic transporters and 
receptors have also been identified. Finally, given that genetic factors can influence 
drug response (Schosser et al. 2012), the use of pharmacogenomics, tests which 
analyse an individual’s genes and match the results to the available antidepressant 
drug, should be widely used, as this allows a personalised treatment, faster response 
and higher chances of remission (Hall-Flavin et al. 2013). 
 
6.6. Concluding Remarks 
In summary, the present thesis corroborates with the current literature, showing 
evidence of a functional segregation of the hippocampus into its longitudinal axis. 
Also, we reinforce the importance of segregating the hippocampus using a tripartite 
model, given that there is enough evidence that the iHi is an independent sub-region 
on its own right. Specifically, this thesis reports for the very first time that NPCs 
derived from the iHi and vHi but not the dHi are more sensitive to the deleterious 
effects of the stress hormone, corticosterone, on neurogenesis. These effects are 
correlated with reduced translocation of GR into the nucleus, especially in cells 
from the iHi and vHi. In vivo, iHi seems to mediate social avoidance and vHi 
mediates antidepressant-like behaviour under chronic stress conditions. Moreover, 
iHi and vHi seem to mediate fluoxetine behavioural effects. Therefore, we suggest 
that the iHi and vHi sub-regions are promising targets for the treatment of stress-
related psychiatric disorders and future studies should focus in these sub-regions, 
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Cell culture protocols 
 
Dissection (should take approximately 10 minutes per animal) 
- Decapitate the animal; 
- Dissect out the brain, open the meninges; 
- Put it on a wet sterilized filter paper in a 100 mm Petri dish; 
- Pour some cold HBSS on the brain; 
- With the scalpel remove the brain steam and cerebellum; 
- With the scalpel cut the interhemispheric fissure; 
- Take out the hippocampus carefully; 
- Put it in “collection medium”. 
PS: While dissecting, put the enzyme at 37°C (approximately 20 minutes before 
starting the incubation), growth media should also be in the incubator 
 
Cell Isolation 
- Pour the hippocampi in a 100 mm Petri dish; 
- With a scalpel, transfer from the petri dish to a horizontal 15 mL tube; 
- Mince the tissue with the scalpel in the 15 mL tube until you can no longer see no 
big tissue pieces; 
- Pour 5mL of the warmed enzyme mix into the 15 mL tube; 
- Gently vortex; 
- Incubate at 37°C for a total time of 30 minutes; 
- Gently vortex every 3 minutes; 
- At 20 minutes of incubation, pipette up and down with a glass Pasteur; 
- At 30 minutes of incubation, pipette up and down with a micropipette (first with 
the p1000 30 times and then with the p200 30 times); 
- Centrifugate at 300 g for 5 min at RT; 
- Remove the supernatant and resuspend pellet in 1 mL of buffer; 
- Centrifugate at 300g for 5 min at RT;  
- Remove the supernatant and resuspend in 1mL of 20% Percoll. Then pour the rest 
of the Percoll and mix (5mL final volume); 




- Remove the upper phase. Remove gently the liquid in the middle. Resuspend the 
pellet in 10 mL buffer; 
- Centrifugate at 300 g for 5 min at RT; 
- Remove the supernatant and resuspend the pellet in 1 mL of the growth medium;  
- Pass the cell suspension through a 40 µm cell strainer; 
- Count the cells using a hemocytometer and trypan blue; 
- 1 x 105 cells are seeded per well in an ultra-low attachment 24-wells plate (final 
volume per well of 500 µL). 
  
Solutions: 




- 2% B-27 minus Vitamin A; 
- 0.5 mM Glutamax. 
 
Enzyme mix:  
- 5.5 mL 1 U/ml Dispase; 
- 2.5 U/ml Papain; 
- 250 U/ml DNaseI; 
- Mix until homogeneous and sterile filter. 
 
Percoll: 
- For 90% Percoll: 0.5 ml of 10X PBS and 4.5 ml of Percoll 100%; 
- For 20% Percoll: 1.1 ml of 90% Percoll and 3.9 ml of Neurobasal-A. 
 
Growth media (for proliferation): 
- 24 mL Neurobasal-A; 
- 2 % B-27 minus Vitamin A; 
- 0.5 mM Glutamax; 




- 2 µg/ml Heparin; 
- 20 ng/mL bFGF; 
- 20 ng/mL EGF. 
 
Growth media (for differentiation): 
- 24 mL Neurobasal-A (Attention, it is a different Neurobasal than the one used for 
the proliferation step); 
- 2 % B-27 with Vitamin A; 
- 0.5 mM Glutamax; 







Dilutions for cell culture 
 
Epidermal growth factor 
EGF (25μg) (Sigma) was reconstituted using 0.2μm filtered sterile 10mM acetic 
acid (Sigma) containing 0.01% Bovine serum albumin (BSA) (Sigma, Ireland) to 
give a stock of 20μg/ml. Aliquots were stored at -20°C. 
Heparin (50mg/ml) 
Heparin (50mg) (Sigma) was dissolved in 1ml of sterile PBS (10mM). The solution 
was sterile filtered and stored at 4°C 
Fibroblast growth factor 
bFGF (25μg) (Millipore) was reconstituted using 0.2μm filtered sterile PBS 
(10mM) containing 0.1% BSA, 1mM DTT, and heparin (5μg/ml), to give a stock 
solution of 20μg/ml. Aliquots were stored at -20°C.  
DNAseI 
The DNAseI was diluted in sterile deionised water (to keep its inactivity) and stored 
at -20°C for no longer than 6 months. The stock solutions had a concentration of 
25,000 U/ml. When use it, make sure to use a medium with Magnesium to activate 
it. 
Poly-D-lysine 
Poly-D-lysin was diluted in sterile deionised water (1 mg/ml) and kept at -20°C. 
Corticosterone 
Corticosterone was preferentially freshly diluted in 100% DMSO (or else frozen for 
no longer than 1 month). The stock solutions prepared had a concentration of 10-
50 mM. 
Fluoxetine 
Fluoxetine was freshly diluted in sterile deionised water. The stock solutions 
prepared had a concentration of 1-10 mM. 
Dexamethasone 
Dexamethasone was preferentially freshly diluted in 100% DMSO (or else frozen 





Protocols for perfusions 
 
PBS (to make 1 litre): 
- Dilute 5 tablets of PBS (Sigma) in deionised water; 
- Filter. 
 
PFA 4% (to make 1 litre): 
- Dilute 5 tablets of PBS (Sigma) in 200 ml of deionised water; 
- Dilute 40g of PFA in 800 ml of deionised water at around 70°C (warmed in 
microwave); 




- Clean tubing with dH2O and then ice-cold PBS; 
- Anaesthetise animal and check for reflexes (feet, eyes, etc); 
- Open chest and expose the heart; 
- Circulate PBS from the left ventricle at the speed of 25 for around 5 min; 
- Turn off pump and switch tube to PFA; 
- Circulate PFA at the speed of 35 for around 8-10 min; 
- Wash tubing with PBS at the speed of 45 for 3-5 min between animals. 
 
Antifreezing solution (for free-floating slicing) 
- 25% PBS 0.2M (pH 7.4); 
- 30% ethylene glycol; 
- 25% glycerol; 









Gelatin coating slides 
- 5g Gelatin; 
- 250mg Chromic Potassium Sulphate; 
- 500ml dH2O; 
- Microscope slides. 
 
- Heat 500ml of dH2O to 40°C; 
- Add the gelatin slowly to dissolve, using a stir bar; 
- Add the chromic potassium sulphate; 
- Prepare the slides by cleaning with 70% ethanol and placing in the holders; 
- Cool subbing media to 35°C; 
- Pour the media into two black slide boxes and remove the foam; 
- Place the slide holders into the subbing media for approximately 1 minute; 
- Remove carefully, tap the edges and clean the slide holders with paper; 






Cresyl violet staining from frozen sections 
- 300ml dH2O; 
- 0.3g Cresyl violet; 
- 30ml acetic acid; 
- Add cresyl violet to dH2O and stir for 24h; 
- Filter and add acetic acid; 
- Top up to 300ml to replace water lost from evaporation. 
 
Staining: 
- Remove sections from freezer and let them dry to RT; 
- Place sections into 70% ethanol overnight at RT (de-fat step); 
- Dry slides holders and wash in dH2O for 2 minutes; 
- Dry and place in cresyl violet solution for 10 minutes; 
- Rinse with dH2O; 
- Differentiate in 95% ethanol for 5 minutes; 
- Dehydrate in 100 % ethanol 2x5 minutes; 
- Clear in histolene 2x5 minutes; 





RNA extraction (Mirvana kit) 
- Remove tissue from -80°C and add 300uL of lysis 
- Transfer to bigger Eppendorf and mash with pestil 
- Add 30 uL of miRNA homogenate additive  
- Leave for 10 min in wet ice 
- Add 300 uL of Acid Phenol Chloroform (cold room) and vortex for 30s (do not 
forget APC at RT) 
- Centrifuge at 7000rpm for 5 min (put elution to heat at 95°C - 100 uL per sample) 
- Remove supernatant and add 3.75 ml of molecular ethanol (1.25 volumes) 
- Add to new tube with filter and centrifuge for 15 s 
- Throw liquid away 
- Add 700 uL of wash solution 1 and centrifuge for 10-15 s 
- Throw liquid away 
- Add 500 uL of wash solution 2/3 and centrifuge for 10-15 s 
- Throw liquid away 
- Add 500 uL of wash solution 2/3 and centrifuge for 10-15 s 
- Throw liquid away and centrifuge again for 10-15 s to dry the filter 
- Transfer filter to a new tube and add 100 uL of elution to each tube 
- Centrifuge for 30 s 
- Throw away filter 
- Keep tubes on ice 
To measure RNA with NanoDrop: 
- ND100 - nucleic acid - RNA 
- Click blank (1 uL of RNA free water) 
- Clean 
- Put sample (1 uL), then Measure 
- 260/280 has to be >1.8 and 260/230 has to be >1.0 - measure of cleanliness 






ELISA kit for corticosterone 
- Remove kit from the cold room 30 min before use; 
- Prepare the assay buffer by diluting 1/10 in distilled water (approx. 20 ml per 
plate); 
- Prepare the corticosterone standard: solution should be at RT; label 5 eppendorf 
from 1 to 5; 
- Put 900 uL of buffer in tube 1 and 800 uL of buffer in tubes 2-5; 
- Add 100 uL of standard CORT to tube 1 and vortex; 
- Add 200 uL from tube 1 to tube 2 and vortex; 
- Add 200 uL from tube 2 to tube 3 and vortex; 
- Add 200 uL from tube 3 to tube 4 and vortex; 
- Add 200 uL from tube 4 to tube 5 and vortex; 
- USE DILUTED ST WITHIN 1H OF DILUTION. 
 
- The dilution of the samples are as follows: 
- T0 - 1/21 - 10 µL of sample + 200 µL of buffer (or 12 uL + 240 uL, if 
possible)  
- T30 - 1/60 - 4.16 µL of sample + 245.84 µL of buffer 
- T120 - 1/40 - 6.25 µL of sample + 243.84 µL of buffer 
- Pipet 100 uL of buffer into the NSB and B0 wells 
- Pipet 100 uL of ST1-5 into appropriate wells 
- Pipet 100 uL of the samples into appropriate wells 
- Pipet 50 uL of buffer into NSB wells 
- Pipet 50 uL of blue conjugate into each well, except TA and BLANK wells 
- Pipet 50 uL yellow antibody into each well, except the BLANK, TA and NSB 
wells 
 
- Every well should be GREEN, except the NSB that should be BLUE. The BLANK 
and TA are empty and should have no colour. 
- Seal plate with the sealer and incubate the plate at RT on a plate shaker for 2h at 
600 rpm 
 




 1 2 3 4 5 6 7 8 9 10 11 12 
A BLANK St 1 St 5 S 4 S 4 S 12 S 12 S 20 S 20 S 28 S 28 S 36 
B BLANK St 1 St 5 S 5 S 5 S 13 S 13 S 21 S 21 S 29 S 29 S 36 
C TA St 2 S 1 S 6 S 6 S 14 S 14 S 22 S 22 S 30 S 30 S 37 
D TA St 2 S 1 S 7 S 7 S 15 S 15 S 23 S 23 S 31 S 31 S 37 
E NSB St 3 S 2 S 8 S 8 S 16 S 16 S 24 S 24 S 32 S 32 S 38 
F NSB St 3 S 2 S 9 S 9 S 17 S 17 S 25 S 25 S 33 S 33 S 38 
G Bo St 4 S 3 S 10 S 10 S 18 S 18 S 26 S 26 S 34 S 34 S 39 
H Bo St 4 S 3 S 11 S 11 S 19 S 19 S 27 S 27 S 35 S 35 S 39 
 
- Prepare the wash buffer by diluting 1/20 in distilled water (approx. 70ml per 
plate); 
- Empty the content of the wells and wash by adding 200 uL of wash solution to 
each well; repeat the wash 2 more times; 
 
- Empty the wells and tap the plate on a paper towel to remove remaining buffer; 
- Remove the bubbles with the pink needle (be very careful in this step); 
- Add 5 uL of blue conjugate to TA wells; 
- Add 200 uL of pNpp Substrate solution to every well and check for bubbles again; 
- Incubate at RT for 1h without shaking, with tin foil; 
 
- Add 50 uL of stop solution to every well and read plate. 
 
- Turn on machine (1st floor) and open software; 
- Open the file “Corticosterone final final” in Loreto’s folder. 
- Click in read plate (this will make the plate go in the machine); the plate will go 
out and then in again in the middle of the reading; 
- Results will be in “Matrix” → Statistics → Data: Conc, well type: samples; 
- An acceptable CV is 15%; 
- Click in the Excel symbol and then “Save”. 
